{"parse":{"title":"Glioblastoma","pageid":1023575,"revid":860473497,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"infobox\" style=\"width:22em\"><tbody><tr><th colspan=\"2\" style=\"text-align:center;font-size:125%;font-weight:bold;background:#ccc\">Glioblastoma</th></tr><tr><th scope=\"row\">Synonyms</th><td>\nGlioblastoma multiforme, grade IV astrocytoma</td></tr><tr><td colspan=\"2\" style=\"text-align:center\">\n<a href=\"/wiki/File:Glioblastoma_-_MR_coronal_with_contrast.jpg\" class=\"image\"><img alt=\"Glioblastoma - MR coronal with contrast.jpg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/cb/Glioblastoma_-_MR_coronal_with_contrast.jpg/300px-Glioblastoma_-_MR_coronal_with_contrast.jpg\" width=\"300\" height=\"292\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/cb/Glioblastoma_-_MR_coronal_with_contrast.jpg/450px-Glioblastoma_-_MR_coronal_with_contrast.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/cb/Glioblastoma_-_MR_coronal_with_contrast.jpg/600px-Glioblastoma_-_MR_coronal_with_contrast.jpg 2x\" data-file-width=\"974\" data-file-height=\"947\" /></a></td></tr><tr><td colspan=\"2\" style=\"text-align:center\">\nCoronal <a href=\"/wiki/MRI\" class=\"mw-redirect\" title=\"MRI\">MRI</a> with contrast of a glioblastoma WHO grade IV in a 15-year-old male</td></tr><tr><th scope=\"row\"><a href=\"/wiki/Specialty_(medicine)\" title=\"Specialty (medicine)\">Specialty</a></th><td>\n<a href=\"/wiki/Oncology\" title=\"Oncology\">Oncology</a>, <a href=\"/wiki/Neurosurgery\" title=\"Neurosurgery\">neurosurgery</a></td></tr><tr><th scope=\"row\">Symptoms</th><td>\nInitially non-specific, <a href=\"/wiki/Headache\" title=\"Headache\">headaches</a>, personality changes, <a href=\"/wiki/Nausea\" title=\"Nausea\">nausea</a>, symptoms similar to a <a href=\"/wiki/Stroke\" title=\"Stroke\">stroke</a><sup id=\"cite_ref-Young2015_1-0\" class=\"reference\"><a href=\"#cite_note-Young2015-1\">&#91;1&#93;</a></sup></td></tr><tr><th scope=\"row\">Usual onset</th><td>\n~ 64 years old<sup id=\"cite_ref-WCR2014,5.16_2-0\" class=\"reference\"><a href=\"#cite_note-WCR2014,5.16-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Gal2015_3-0\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup></td></tr><tr><th scope=\"row\">Causes</th><td>\nUsually unclear<sup id=\"cite_ref-WCR2014,5.16_2-1\" class=\"reference\"><a href=\"#cite_note-WCR2014,5.16-2\">&#91;2&#93;</a></sup></td></tr><tr><th scope=\"row\"><a href=\"/wiki/Risk_factor\" title=\"Risk factor\">Risk factors</a></th><td>\n<a href=\"/wiki/Genetic_disorder\" title=\"Genetic disorder\">Genetic disorders</a> (<a href=\"/wiki/Neurofibromatosis\" title=\"Neurofibromatosis\">neurofibromatosis</a>, <a href=\"/wiki/Li%E2%80%93Fraumeni_syndrome\" title=\"Li\u2013Fraumeni syndrome\">Li\u2013Fraumeni syndrome</a>), previous <a href=\"/wiki/Radiation_therapy\" title=\"Radiation therapy\">radiation therapy</a><sup id=\"cite_ref-WCR2014,5.16_2-2\" class=\"reference\"><a href=\"#cite_note-WCR2014,5.16-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Gal2015_3-1\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup></td></tr><tr><th scope=\"row\"><a href=\"/wiki/Diagnostic_method\" class=\"mw-redirect\" title=\"Diagnostic method\">Diagnostic method</a></th><td>\n<a href=\"/wiki/CT_scan\" title=\"CT scan\">CT scan</a>, <a href=\"/wiki/MRI_scan\" class=\"mw-redirect\" title=\"MRI scan\">MRI scan</a>, <a href=\"/wiki/Tissue_biopsy\" class=\"mw-redirect\" title=\"Tissue biopsy\">tissue biopsy</a><sup id=\"cite_ref-Young2015_1-1\" class=\"reference\"><a href=\"#cite_note-Young2015-1\">&#91;1&#93;</a></sup></td></tr><tr><th scope=\"row\">Prevention</th><td>\nUnknown<sup id=\"cite_ref-Gal2015_3-2\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup></td></tr><tr><th scope=\"row\">Treatment</th><td>\n<a href=\"/wiki/Surgery\" title=\"Surgery\">Surgery</a>, <a href=\"/wiki/Chemotherapy\" title=\"Chemotherapy\">chemotherapy</a>, <a href=\"/wiki/Radiation_therapy\" title=\"Radiation therapy\">radiation</a><sup id=\"cite_ref-Gal2015_3-3\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup></td></tr><tr><th scope=\"row\">Medication</th><td>\n<a href=\"/wiki/Temozolomide\" title=\"Temozolomide\">Temozolomide</a>, <a href=\"/wiki/Corticosteroids\" class=\"mw-redirect\" title=\"Corticosteroids\">steroids</a><sup id=\"cite_ref-Young2015_1-2\" class=\"reference\"><a href=\"#cite_note-Young2015-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Hart2013_4-0\" class=\"reference\"><a href=\"#cite_note-Hart2013-4\">&#91;4&#93;</a></sup></td></tr><tr><th scope=\"row\">Prognosis</th><td>\n<a href=\"/wiki/Life_expectancy\" title=\"Life expectancy\">Life expectancy</a> ~ 14 months with treatment<sup id=\"cite_ref-WCR2014,5.16_2-3\" class=\"reference\"><a href=\"#cite_note-WCR2014,5.16-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Gal2015_3-4\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup></td></tr><tr><th scope=\"row\">Frequency</th><td>\n3 per 100,000 per year<sup id=\"cite_ref-Gal2015_3-5\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup></td></tr></tbody></table>\n<p><b>Glioblastoma</b>, also known as <b>glioblastoma multiforme</b> (<b>GBM</b>), is the most aggressive <a href=\"/wiki/Cancer\" title=\"Cancer\">cancer</a> that begins within the <a href=\"/wiki/Brain\" title=\"Brain\">brain</a>.<sup id=\"cite_ref-Ble2012_5-0\" class=\"reference\"><a href=\"#cite_note-Ble2012-5\">&#91;5&#93;</a></sup> Initially, signs and symptoms of glioblastoma are non-specific.<sup id=\"cite_ref-Young2015_1-3\" class=\"reference\"><a href=\"#cite_note-Young2015-1\">&#91;1&#93;</a></sup> They may include <a href=\"/wiki/Headache\" title=\"Headache\">headaches</a>, personality changes, <a href=\"/wiki/Nausea\" title=\"Nausea\">nausea</a>, and symptoms similar to those of a <a href=\"/wiki/Stroke\" title=\"Stroke\">stroke</a>.<sup id=\"cite_ref-Young2015_1-4\" class=\"reference\"><a href=\"#cite_note-Young2015-1\">&#91;1&#93;</a></sup> Worsening of symptoms often is rapid.<sup id=\"cite_ref-WCR2014,5.16_2-4\" class=\"reference\"><a href=\"#cite_note-WCR2014,5.16-2\">&#91;2&#93;</a></sup> This may progress to <a href=\"/wiki/Unconsciousness\" title=\"Unconsciousness\">unconsciousness</a>.<sup id=\"cite_ref-WCR2014,5.16_2-5\" class=\"reference\"><a href=\"#cite_note-WCR2014,5.16-2\">&#91;2&#93;</a></sup>\n</p><p>The cause of most cases is unclear.<sup id=\"cite_ref-WCR2014,5.16_2-6\" class=\"reference\"><a href=\"#cite_note-WCR2014,5.16-2\">&#91;2&#93;</a></sup> Uncommon risk factors include <a href=\"/wiki/Genetic_disorder\" title=\"Genetic disorder\">genetic disorders</a> such as <a href=\"/wiki/Neurofibromatosis\" title=\"Neurofibromatosis\">neurofibromatosis</a> and <a href=\"/wiki/Li%E2%80%93Fraumeni_syndrome\" title=\"Li\u2013Fraumeni syndrome\">Li\u2013Fraumeni syndrome</a>, and previous <a href=\"/wiki/Radiation_therapy\" title=\"Radiation therapy\">radiation therapy</a>.<sup id=\"cite_ref-WCR2014,5.16_2-7\" class=\"reference\"><a href=\"#cite_note-WCR2014,5.16-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Gal2015_3-6\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup> Glioblastomas represent 15% of <a href=\"/wiki/Brain_tumor\" title=\"Brain tumor\">brain tumors</a>.<sup id=\"cite_ref-Young2015_1-5\" class=\"reference\"><a href=\"#cite_note-Young2015-1\">&#91;1&#93;</a></sup> They can either start from normal brain cells or develop from an existing <a href=\"/wiki/Low-grade_astrocytoma\" class=\"mw-redirect\" title=\"Low-grade astrocytoma\">low-grade astrocytoma</a>.<sup id=\"cite_ref-WCR2014,3.8_6-0\" class=\"reference\"><a href=\"#cite_note-WCR2014,3.8-6\">&#91;6&#93;</a></sup> The diagnosis typically is made by a combination of <a href=\"/wiki/CT_scan\" title=\"CT scan\">CT scan</a>, <a href=\"/wiki/MRI_scan\" class=\"mw-redirect\" title=\"MRI scan\">MRI scan</a>, and <a href=\"/wiki/Tissue_biopsy\" class=\"mw-redirect\" title=\"Tissue biopsy\">tissue biopsy</a>.<sup id=\"cite_ref-Young2015_1-6\" class=\"reference\"><a href=\"#cite_note-Young2015-1\">&#91;1&#93;</a></sup>\n</p><p>There is no clear way to prevent the disease.<sup id=\"cite_ref-Gal2015_3-7\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup> Typically, treatment involves <a href=\"/wiki/Surgery\" title=\"Surgery\">surgery</a>, after which <a href=\"/wiki/Chemotherapy\" title=\"Chemotherapy\">chemotherapy</a> and <a href=\"/wiki/Radiation_therapy\" title=\"Radiation therapy\">radiation therapy</a> are used.<sup id=\"cite_ref-Gal2015_3-8\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup> The medication <a href=\"/wiki/Temozolomide\" title=\"Temozolomide\">temozolomide</a> is used frequently as part of chemotherapy.<sup id=\"cite_ref-Gal2015_3-9\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-RTG1_7-0\" class=\"reference\"><a href=\"#cite_note-RTG1-7\">&#91;7&#93;</a></sup><sup id=\"cite_ref-Hart2013_4-1\" class=\"reference\"><a href=\"#cite_note-Hart2013-4\">&#91;4&#93;</a></sup> High dose <a href=\"/wiki/Corticosteroids\" class=\"mw-redirect\" title=\"Corticosteroids\">steroids</a> may be used to help reduce swelling and decrease symptoms.<sup id=\"cite_ref-Young2015_1-7\" class=\"reference\"><a href=\"#cite_note-Young2015-1\">&#91;1&#93;</a></sup> It is unclear whether trying to remove all or simply most of the cancer is better.<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup>\n</p><p>Despite maximum treatment, the cancer usually recurs.<sup id=\"cite_ref-Gal2015_3-10\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup> The most common length of survival following diagnosis is 12 to 15 months, with fewer than 3% to 5% of people surviving longer than five years.<sup id=\"cite_ref-WCR2014,5.16_2-8\" class=\"reference\"><a href=\"#cite_note-WCR2014,5.16-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Gal2015_3-11\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup> Without treatment, survival is typically three months.<sup id=\"cite_ref-Sch2007_9-0\" class=\"reference\"><a href=\"#cite_note-Sch2007-9\">&#91;9&#93;</a></sup> It is the most common cancer that begins within the brain and the second most common brain tumor, after <a href=\"/wiki/Meningioma\" title=\"Meningioma\">meningioma</a>.<sup id=\"cite_ref-Ble2012_5-1\" class=\"reference\"><a href=\"#cite_note-Ble2012-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-Mc2016_10-0\" class=\"reference\"><a href=\"#cite_note-Mc2016-10\">&#91;10&#93;</a></sup> About 3 per 100,000 people develop the disease a year.<sup id=\"cite_ref-Gal2015_3-12\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup> It most often begins around 64 years of age and occurs more commonly in males than females.<sup id=\"cite_ref-WCR2014,5.16_2-9\" class=\"reference\"><a href=\"#cite_note-WCR2014,5.16-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Gal2015_3-13\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup> <a href=\"/wiki/Immunotherapy\" title=\"Immunotherapy\">Immunotherapy</a> is being studied in glioblastoma with promising results.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup>\n</p>\n<div class=\"toclimit-3\"><div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Signs_and_symptoms\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Signs and symptoms</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Risk_factors\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Risk factors</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Genetics\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Genetics</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Environmental\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Environmental</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Pathogenesis\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Pathogenesis</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Molecular_alterations\"><span class=\"tocnumber\">3.1</span> <span class=\"toctext\">Molecular alterations</span></a></li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Glioblastoma_stem-like_cells\"><span class=\"tocnumber\">3.2</span> <span class=\"toctext\">Glioblastoma stem-like cells</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Metabolism\"><span class=\"tocnumber\">3.3</span> <span class=\"toctext\">Metabolism</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Ion_channels\"><span class=\"tocnumber\">3.4</span> <span class=\"toctext\">Ion channels</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#Diagnosis\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Diagnosis</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#Treatment\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Treatment</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-12\"><a href=\"#Symptomatic_therapy\"><span class=\"tocnumber\">5.1</span> <span class=\"toctext\">Symptomatic therapy</span></a></li>\n<li class=\"toclevel-2 tocsection-13\"><a href=\"#Palliative_therapy\"><span class=\"tocnumber\">5.2</span> <span class=\"toctext\">Palliative therapy</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-14\"><a href=\"#Surgery\"><span class=\"tocnumber\">5.2.1</span> <span class=\"toctext\">Surgery</span></a></li>\n<li class=\"toclevel-3 tocsection-15\"><a href=\"#Radiotherapy\"><span class=\"tocnumber\">5.2.2</span> <span class=\"toctext\">Radiotherapy</span></a></li>\n<li class=\"toclevel-3 tocsection-16\"><a href=\"#Chemotherapy\"><span class=\"tocnumber\">5.2.3</span> <span class=\"toctext\">Chemotherapy</span></a></li>\n<li class=\"toclevel-3 tocsection-17\"><a href=\"#Other_modalities\"><span class=\"tocnumber\">5.2.4</span> <span class=\"toctext\">Other modalities</span></a></li>\n</ul>\n</li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-18\"><a href=\"#Prognosis\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Prognosis</span></a></li>\n<li class=\"toclevel-1 tocsection-19\"><a href=\"#Epidemiology\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Epidemiology</span></a></li>\n<li class=\"toclevel-1 tocsection-20\"><a href=\"#History\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-21\"><a href=\"#Research\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">Research</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-22\"><a href=\"#MicroRNA\"><span class=\"tocnumber\">9.1</span> <span class=\"toctext\">MicroRNA</span></a></li>\n<li class=\"toclevel-2 tocsection-23\"><a href=\"#Gene_therapy\"><span class=\"tocnumber\">9.2</span> <span class=\"toctext\">Gene therapy</span></a></li>\n<li class=\"toclevel-2 tocsection-24\"><a href=\"#Virotherapy\"><span class=\"tocnumber\">9.3</span> <span class=\"toctext\">Virotherapy</span></a></li>\n<li class=\"toclevel-2 tocsection-25\"><a href=\"#Intranasal_drug_delivery\"><span class=\"tocnumber\">9.4</span> <span class=\"toctext\">Intranasal drug delivery</span></a></li>\n<li class=\"toclevel-2 tocsection-26\"><a href=\"#Risk_factors_2\"><span class=\"tocnumber\">9.5</span> <span class=\"toctext\">Risk factors</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-27\"><a href=\"#See_also\"><span class=\"tocnumber\">10</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-28\"><a href=\"#References\"><span class=\"tocnumber\">11</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-29\"><a href=\"#External_links\"><span class=\"tocnumber\">12</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n</div>\n<h2><span class=\"mw-headline\" id=\"Signs_and_symptoms\">Signs and symptoms</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=1\" title=\"Edit section: Signs and symptoms\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Common symptoms include <a href=\"/wiki/Seizure\" class=\"mw-redirect\" title=\"Seizure\">seizure</a>, <a href=\"/wiki/Headache\" title=\"Headache\">headaches</a>, <a href=\"/wiki/Nausea\" title=\"Nausea\">nausea</a> and <a href=\"/wiki/Vomiting\" title=\"Vomiting\">vomiting</a>, <a href=\"/wiki/Memory_loss\" class=\"mw-redirect\" title=\"Memory loss\">memory loss</a>, changes to personality, mood or concentration; and localized neurological problems.<sup id=\"cite_ref-Al2015_12-0\" class=\"reference\"><a href=\"#cite_note-Al2015-12\">&#91;12&#93;</a></sup>\n</p><p>The kind of symptoms produced depends more on the location of the tumor than on its pathological properties. The tumor can start producing symptoms quickly, but occasionally is an <a href=\"/wiki/Asymptomatic_condition\" class=\"mw-redirect\" title=\"Asymptomatic condition\">asymptomatic condition</a> until it reaches an enormous size.\n</p>\n<h2><span class=\"mw-headline\" id=\"Risk_factors\">Risk factors</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=2\" title=\"Edit section: Risk factors\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The cause of most cases is unclear.<sup id=\"cite_ref-WCR2014,5.16_2-10\" class=\"reference\"><a href=\"#cite_note-WCR2014,5.16-2\">&#91;2&#93;</a></sup> About 5% develop from another type brain tumor known as a low-grade <a href=\"/wiki/Astrocytoma\" title=\"Astrocytoma\">astrocytoma</a>.<sup id=\"cite_ref-Al2015_12-1\" class=\"reference\"><a href=\"#cite_note-Al2015-12\">&#91;12&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Genetics\">Genetics</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=3\" title=\"Edit section: Genetics\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Uncommon risk factors include <a href=\"/wiki/Genetic_disorder\" title=\"Genetic disorder\">genetic disorders</a> such as <a href=\"/wiki/Neurofibromatosis\" title=\"Neurofibromatosis\">neurofibromatosis</a>, <a href=\"/wiki/Li%E2%80%93Fraumeni_syndrome\" title=\"Li\u2013Fraumeni syndrome\">Li\u2013Fraumeni syndrome</a>, <a href=\"/wiki/Tuberous_sclerosis\" title=\"Tuberous sclerosis\">tuberous sclerosis</a>, or <a href=\"/wiki/Mismatch_repair_cancer_syndrome\" title=\"Mismatch repair cancer syndrome\">Turcot syndrome</a>.<sup id=\"cite_ref-Al2015_12-2\" class=\"reference\"><a href=\"#cite_note-Al2015-12\">&#91;12&#93;</a></sup> Previous <a href=\"/wiki/Radiation_therapy\" title=\"Radiation therapy\">radiation therapy</a> is also a risk.<sup id=\"cite_ref-WCR2014,5.16_2-11\" class=\"reference\"><a href=\"#cite_note-WCR2014,5.16-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Gal2015_3-14\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup> For unknown reasons, GBM occurs more commonly in males.<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Environmental\">Environmental</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=4\" title=\"Edit section: Environmental\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Other associations include exposure to <a href=\"/wiki/Smoking\" title=\"Smoking\">smoking</a>, <a href=\"/wiki/Pesticide\" title=\"Pesticide\">pesticides</a>, and working in <a href=\"/wiki/Oil_refinery\" title=\"Oil refinery\">petroleum refining</a> or <a href=\"/wiki/Synthetic_rubber\" title=\"Synthetic rubber\">rubber manufacturing</a>.<sup id=\"cite_ref-Al2015_12-3\" class=\"reference\"><a href=\"#cite_note-Al2015-12\">&#91;12&#93;</a></sup>\n</p><p>Glioblastoma has been associated with the viruses <a href=\"/wiki/SV40\" title=\"SV40\">SV40</a>,<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup> <a href=\"/wiki/Human_herpesvirus_6\" title=\"Human herpesvirus 6\">HHV-6</a>,<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup><sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup> and <a href=\"/wiki/Cytomegalovirus\" title=\"Cytomegalovirus\">cytomegalovirus</a>.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Pathogenesis\">Pathogenesis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=5\" title=\"Edit section: Pathogenesis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The cellular origin of glioblastoma is unknown.  Because of the similarities in <a href=\"/wiki/Immunostaining\" title=\"Immunostaining\">immunostaining</a> of <a href=\"/wiki/Glial_cell\" class=\"mw-redirect\" title=\"Glial cell\">glial cells</a> and glioblastoma, it has long been assumed that gliomas such as glioblastoma originate from glial type cells.  However more recent studies suggest that <a href=\"/wiki/Astrocyte\" title=\"Astrocyte\">astrocytes</a>, <a href=\"/wiki/Oligodendrocyte\" title=\"Oligodendrocyte\">oligodendrocyte</a> progenitor cells and <a href=\"/wiki/Neural_stem_cell\" title=\"Neural stem cell\">neural stem cells</a> could also serve as the cell of origin.<sup id=\"cite_ref-Zong_2012_18-0\" class=\"reference\"><a href=\"#cite_note-Zong_2012-18\">&#91;18&#93;</a></sup><sup id=\"cite_ref-Zong_2015_19-0\" class=\"reference\"><a href=\"#cite_note-Zong_2015-19\">&#91;19&#93;</a></sup>\n</p><p>Glioblastoma multiforme tumors are characterized by the presence of small areas of <a href=\"/wiki/Necrosis\" title=\"Necrosis\">necrotizing</a> <a href=\"/wiki/Tissue_(biology)\" title=\"Tissue (biology)\">tissue</a> that are surrounded by <a href=\"/wiki/Anaplastic\" class=\"mw-redirect\" title=\"Anaplastic\">anaplastic</a> cells. This characteristic, as well as the presence of <a href=\"/wiki/Hyperplastic\" class=\"mw-redirect\" title=\"Hyperplastic\">hyperplastic</a> blood vessels, differentiates the tumor from Grade 3 <a href=\"/wiki/Astrocytomas\" class=\"mw-redirect\" title=\"Astrocytomas\">astrocytomas</a>, which do not have these features.\n</p><p>GBMs usually form in the cerebral white matter, grow quickly, and can become very large before producing symptoms. Fewer than 10% form more slowly following degeneration of <a href=\"/wiki/Fibrillary_astrocytoma\" title=\"Fibrillary astrocytoma\">low-grade astrocytoma</a> or <a href=\"/wiki/Anaplastic_astrocytoma\" title=\"Anaplastic astrocytoma\">anaplastic astrocytoma</a>. These are called secondary GBMs and are more common in younger patients (mean age 45 versus 62 years).<sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup> The tumor may extend into the meninges or <a href=\"/wiki/Ventricular_system\" title=\"Ventricular system\">ventricular</a> wall, leading to high protein content in the <a href=\"/wiki/Cerebrospinal_fluid\" title=\"Cerebrospinal fluid\">cerebrospinal fluid</a> (CSF) (&gt; 100&#160;mg/dL), as well as an occasional <a href=\"/wiki/Pleocytosis\" title=\"Pleocytosis\">pleocytosis</a> of 10 to 100 cells, mostly <a href=\"/wiki/Lymphocyte\" title=\"Lymphocyte\">lymphocytes</a>. <a href=\"/wiki/Malignant\" class=\"mw-redirect\" title=\"Malignant\">Malignant</a> cells carried in the CSF may spread (rarely) to the <a href=\"/wiki/Spinal_cord\" title=\"Spinal cord\">spinal cord</a> or cause meningeal gliomatosis. However, <a href=\"/wiki/Metastasis\" title=\"Metastasis\">metastasis</a> of GBM beyond the <a href=\"/wiki/Central_nervous_system\" title=\"Central nervous system\">central nervous system</a> is extremely unusual. About 50% of GBMs occupy more than one lobe of a hemisphere or are bilateral. Tumors of this type usually arise from the <a href=\"/wiki/Cerebrum\" title=\"Cerebrum\">cerebrum</a> and may  exhibit the classic infiltration across the <a href=\"/wiki/Corpus_callosum\" title=\"Corpus callosum\">corpus callosum</a>, producing a butterfly (bilateral) <a href=\"/wiki/Glioma\" title=\"Glioma\">glioma</a>.\n</p><p>The tumor may take on a variety of appearances, depending on the amount of hemorrhage, <a href=\"/wiki/Necrosis\" title=\"Necrosis\">necrosis</a>, or its age. A CT scan will usually show an inhomogeneous mass with a hypodense center and a variable <a href=\"/wiki/Ring-enhancing_lesion\" title=\"Ring-enhancing lesion\">ring of enhancement</a> surrounded by <a href=\"/wiki/Edema\" title=\"Edema\">edema</a>. <a href=\"/wiki/Mass_effect_(medicine)\" title=\"Mass effect (medicine)\">Mass effect</a> from the tumor and edema may compress the ventricles and cause <a href=\"/wiki/Hydrocephalus\" title=\"Hydrocephalus\">hydrocephalus</a>.\n</p>\n<h3><span class=\"mw-headline\" id=\"Molecular_alterations\">Molecular alterations</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=6\" title=\"Edit section: Molecular alterations\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Four subtypes of glioblastoma have been identified:<sup id=\"cite_ref-Roel2010_21-0\" class=\"reference\"><a href=\"#cite_note-Roel2010-21\">&#91;21&#93;</a></sup>\n</p>\n<ul><li>Classical: Ninety-seven percent of tumors in the 'classical' subtype carry extra copies of the <a href=\"/wiki/Epidermal_growth_factor_receptor\" title=\"Epidermal growth factor receptor\">epidermal growth factor receptor</a> (EGFR) gene, and most have higher than normal expression of <a href=\"/wiki/Epidermal_growth_factor_receptor\" title=\"Epidermal growth factor receptor\">epidermal growth factor receptor</a> (EGFR), whereas the gene <a href=\"/wiki/TP53\" class=\"mw-redirect\" title=\"TP53\">TP53</a> (p53), which is often mutated in glioblastoma, is rarely mutated in this subtype.<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup> <a href=\"/wiki/Loss_of_heterozygosity\" title=\"Loss of heterozygosity\">Loss of heterozygosity</a> (LOH) in chromosome 10 is also frequently seen in the classical subtype alongside chromosome 7 amplification.<sup id=\"cite_ref-:0_23-0\" class=\"reference\"><a href=\"#cite_note-:0-23\">&#91;23&#93;</a></sup></li>\n<li>The Proneural subtype often has high rates of alterations in TP53 (p53), and in PDGFRA, the gene encoding a-type <a href=\"/wiki/Platelet-derived_growth_factor_receptor\" title=\"Platelet-derived growth factor receptor\">platelet-derived growth factor receptor</a>, and in IDH1, the gene encoding <a href=\"/wiki/Isocitrate_dehydrogenase\" title=\"Isocitrate dehydrogenase\">isocitrate dehydrogenase</a>-1.</li>\n<li>The Mesenchymal subtype is characterized by high rates of mutations or other alterations in NF1, the gene encoding <a href=\"/wiki/Neurofibromin_1\" title=\"Neurofibromin 1\">Neurofibromin 1</a> and fewer alterations in the EGFR gene and less expression of EGFR than other types.<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup></li>\n<li>The Neural subtype was typified by the expression of neuron markers such as <a href=\"/wiki/NEFL\" class=\"mw-redirect\" title=\"NEFL\">NEFL</a>, <a href=\"/wiki/Gamma-aminobutyric_acid_receptor_subunit_alpha-1\" title=\"Gamma-aminobutyric acid receptor subunit alpha-1\">GABRA1</a>, <a href=\"/wiki/Synaptotagmin\" title=\"Synaptotagmin\">SYT1</a> and <a href=\"/wiki/Chloride_potassium_symporter_5\" title=\"Chloride potassium symporter 5\">SLC12A5</a>, while often presenting themselves as normal cells upon pathological assessment.<sup id=\"cite_ref-Roel2010_21-1\" class=\"reference\"><a href=\"#cite_note-Roel2010-21\">&#91;21&#93;</a></sup><sup id=\"cite_ref-:0_23-1\" class=\"reference\"><a href=\"#cite_note-:0-23\">&#91;23&#93;</a></sup></li></ul>\n<p>Many other genetic alterations have been described in glioblastoma, and the majority of them are clustered in two pathways, the <a href=\"/wiki/Retinoblastoma_protein\" title=\"Retinoblastoma protein\">RB</a> and the <a href=\"/wiki/PI3K/AKT/mTOR_pathway\" title=\"PI3K/AKT/mTOR pathway\">PI3K/AKT</a>.<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup> Glioblastomas have alterations in 68\u201378% and 88% of these pathways, respectively.<sup id=\"cite_ref-Ble2012_5-2\" class=\"reference\"><a href=\"#cite_note-Ble2012-5\">&#91;5&#93;</a></sup>\n</p><p>Another important alteration is methylation of <a href=\"/wiki/O-6-methylguanine-DNA_methyltransferase\" title=\"O-6-methylguanine-DNA methyltransferase\">MGMT</a>, a \"suicide\" DNA repair enzyme. Methylation is described to impair DNA transcription and therefore, expression of the MGMT enzyme. Since an MGMT enzyme can repair only one DNA alkylation due to its suicide repair mechanism, reverse capacity is low and methylation of the <a href=\"/wiki/MGMT_promoter\" class=\"mw-redirect\" title=\"MGMT promoter\">MGMT gene promoter</a> greatly affects DNA-repair capacity.<sup id=\"cite_ref-ReferenceB_26-0\" class=\"reference\"><a href=\"#cite_note-ReferenceB-26\">&#91;26&#93;</a></sup><sup id=\"cite_ref-ReferenceC_27-0\" class=\"reference\"><a href=\"#cite_note-ReferenceC-27\">&#91;27&#93;</a></sup> Indeed, MGMT methylation is associated with an improved response to treatment with DNA-damaging chemotherapeutics, such as temozolomide.<sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Glioblastoma_stem-like_cells\">Glioblastoma stem-like cells</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=7\" title=\"Edit section: Glioblastoma stem-like cells\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Cancer cells with properties similar to stem cells have been found in glioblastomas (this may be a cause of their resistance to conventional treatments, and high recurrence rate).<sup id=\"cite_ref-29\" class=\"reference\"><a href=\"#cite_note-29\">&#91;29&#93;</a></sup> These so-called glioblastoma stem-like cells reside in a niche around arterioles, protecting these cells against therapy by maintaining a relatively hypoxic environment.<sup id=\"cite_ref-30\" class=\"reference\"><a href=\"#cite_note-30\">&#91;30&#93;</a></sup> A biomarker for cells in glioblastomas that exhibit <a href=\"/wiki/Cancer_stem_cell\" title=\"Cancer stem cell\">cancer stem cell</a> properties, the transcription factor <a href=\"/wiki/Hes3_signaling_axis\" title=\"Hes3 signaling axis\">Hes3</a>, has been shown to regulate their number when placed in culture.<sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Metabolism\">Metabolism</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=8\" title=\"Edit section: Metabolism\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The <i>IDH1</i> gene encodes for the enzyme <a href=\"/wiki/Isocitrate_dehydrogenase\" title=\"Isocitrate dehydrogenase\">isocitrate dehydrogenase</a> 1 and is frequently mutated in glioblastoma (primary GBM: 5%, secondary GBM &gt;80%).<sup id=\"cite_ref-ReferenceC_27-1\" class=\"reference\"><a href=\"#cite_note-ReferenceC-27\">&#91;27&#93;</a></sup> By producing very high concentrations of the \"oncometabolite\" D-2-hydroxyglutarate and dysregulating the function of the wild-type IDH1-enzyme it induces profound changes to the metabolism of <i>IDH1</i>-mutated glioblastoma, compared with <i>IDH1</i> wild-type glioblastoma or healthy astrocytes. Among others, it increases the glioblastoma cells' dependence on <a href=\"/wiki/Glutamine\" title=\"Glutamine\">glutamine</a> or <a href=\"/wiki/Glutamate\" class=\"mw-redirect\" title=\"Glutamate\">glutamate</a> as an energy source.<sup id=\"cite_ref-32\" class=\"reference\"><a href=\"#cite_note-32\">&#91;32&#93;</a></sup> It has been hypothesized that <i>IDH1</i>-mutated glioblastoma are in a very high demand for glutamate and use this amino acid and neurotransmitter as a chemotactic signal. Since healthy astrocytes excrete glutamate, <i>IDH1</i>-mutated glioblastoma cells do not favor dense tumor structures but instead migrate, invade and disperse into healthy parts of the brain where glutamate concentrations are higher. This may explain the invasive behaviour of these <i>IDH1</i>-mutated glioblastoma.<sup id=\"cite_ref-33\" class=\"reference\"><a href=\"#cite_note-33\">&#91;33&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Ion_channels\">Ion channels</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=9\" title=\"Edit section: Ion channels\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Furthermore, glioblastoma multiforme exhibits numerous alterations in genes that encode for ion channels, including upregulation of gBK potassium channels and ClC-3 chloride channels. It has been hypothesized that by upregulating these ion channels, glioblastoma tumor cells can facilitate increased ion movement over the cell membrane, thereby increasing H<sub>2</sub>O movement through osmosis, which aids glioblastoma cells in changing cellular volume very rapidly. This is helpful in their extremely aggressive invasive behavior, because quick adaptations in cellular volume can facilitate movement through the sinuous extracellular matrix of the brain.<sup id=\"cite_ref-34\" class=\"reference\"><a href=\"#cite_note-34\">&#91;34&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Diagnosis\">Diagnosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=10\" title=\"Edit section: Diagnosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:BrainCAConMark.png\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d7/BrainCAConMark.png/220px-BrainCAConMark.png\" width=\"220\" height=\"282\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d7/BrainCAConMark.png/330px-BrainCAConMark.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d7/BrainCAConMark.png/440px-BrainCAConMark.png 2x\" data-file-width=\"698\" data-file-height=\"895\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:BrainCAConMark.png\" class=\"internal\" title=\"Enlarge\"></a></div>GBM in the frontal right lobe as seen on CT scan</div></div></div>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Glioblastoma_-_MR_sagittal_with_contrast.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c0/Glioblastoma_-_MR_sagittal_with_contrast.jpg/220px-Glioblastoma_-_MR_sagittal_with_contrast.jpg\" width=\"220\" height=\"215\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c0/Glioblastoma_-_MR_sagittal_with_contrast.jpg/330px-Glioblastoma_-_MR_sagittal_with_contrast.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c0/Glioblastoma_-_MR_sagittal_with_contrast.jpg/440px-Glioblastoma_-_MR_sagittal_with_contrast.jpg 2x\" data-file-width=\"974\" data-file-height=\"954\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Glioblastoma_-_MR_sagittal_with_contrast.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Sagittal <a href=\"/wiki/MRI\" class=\"mw-redirect\" title=\"MRI\">MRI</a> with contrast of a glioblastoma WHO grade IV in a 15-year-old boy.</div></div></div>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Glioblastoma_(1).jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/ff/Glioblastoma_%281%29.jpg/220px-Glioblastoma_%281%29.jpg\" width=\"220\" height=\"166\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/ff/Glioblastoma_%281%29.jpg/330px-Glioblastoma_%281%29.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/ff/Glioblastoma_%281%29.jpg/440px-Glioblastoma_%281%29.jpg 2x\" data-file-width=\"600\" data-file-height=\"452\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Glioblastoma_(1).jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Glioblastoma (histology slide)</div></div></div>\n<p>When viewed with <a href=\"/wiki/MRI\" class=\"mw-redirect\" title=\"MRI\">MRI</a>, glioblastomas often appear as ring-enhancing lesions.  The appearance is not specific, however, as other lesions such as <a href=\"/wiki/Abscess\" title=\"Abscess\">abscess</a>, <a href=\"/wiki/Metastasis\" title=\"Metastasis\">metastasis</a>, <a href=\"/wiki/Tumefactive_multiple_sclerosis\" title=\"Tumefactive multiple sclerosis\">tumefactive multiple sclerosis</a>, and other entities may have a similar appearance.<sup id=\"cite_ref-35\" class=\"reference\"><a href=\"#cite_note-35\">&#91;35&#93;</a></sup> Definitive diagnosis of a suspected GBM on CT or MRI requires a <a href=\"/wiki/Stereotactic_biopsy\" title=\"Stereotactic biopsy\">stereotactic biopsy</a> or a <a href=\"/wiki/Craniotomy\" title=\"Craniotomy\">craniotomy</a> with tumor resection and pathologic confirmation.  Because the tumor grade is based upon the most malignant portion of the tumor, biopsy or subtotal tumor resection can result in undergrading of the lesion. Imaging of tumor blood flow using perfusion MRI and measuring tumor metabolite concentration with <a href=\"/wiki/In_vivo_magnetic_resonance_spectroscopy\" title=\"In vivo magnetic resonance spectroscopy\">MR spectroscopy</a> may add value to standard MRI in select cases by showing increased relative cerebral blood volume and increased choline peak respectively, but pathology remains the gold standard for diagnosis and molecular characterization.\n</p><p>It is important to distinguish primary glioblastoma from secondary glioblastoma. These tumors occur spontaneously (<i>de novo</i>) or have progressed from a lower-grade glioma, respectively.<sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup> Primary glioblastomas have a worse prognosis, different tumor biology and may have a different response to therapy, which makes this a critical evaluation to determine patient prognosis and therapy.<sup id=\"cite_ref-ReferenceB_26-1\" class=\"reference\"><a href=\"#cite_note-ReferenceB-26\">&#91;26&#93;</a></sup> Over 80% of secondary glioblastoma carries a mutation in <i>IDH1</i>, whereas this mutation is rare in primary glioblastoma (5\u201310%). Thus, <i>IDH1</i> mutations are a useful tool to distinguish primary and secondary glioblastomas  since histopathologically they are very similar and the distinction without molecular biomarkers is unreliable.<sup id=\"cite_ref-37\" class=\"reference\"><a href=\"#cite_note-37\">&#91;37&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Treatment\">Treatment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=11\" title=\"Edit section: Treatment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>It is very difficult to treat glioblastoma due to several complicating factors:<sup id=\"cite_ref-pmid12672279_38-0\" class=\"reference\"><a href=\"#cite_note-pmid12672279-38\">&#91;38&#93;</a></sup>\n</p>\n<ul><li>The tumor cells are very resistant to conventional therapies.</li>\n<li>The brain is susceptible to damage from conventional therapy.</li>\n<li>The brain has a very limited capacity to repair itself.</li>\n<li>Many drugs cannot cross the <a href=\"/wiki/Blood%E2%80%93brain_barrier\" title=\"Blood\u2013brain barrier\">blood\u2013brain barrier</a> to act on the tumor.</li></ul>\n<p>Treatment of primary brain tumors and brain metastases consists of both symptomatic\nand palliative therapies.\n</p>\n<h3><span class=\"mw-headline\" id=\"Symptomatic_therapy\">Symptomatic therapy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=12\" title=\"Edit section: Symptomatic therapy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Supportive treatment focuses on relieving symptoms and improving the patient\u2019s\nneurologic function. The primary supportive agents are <a href=\"/wiki/Anticonvulsant\" title=\"Anticonvulsant\">anticonvulsants</a> and\n<a href=\"/wiki/Corticosteroid\" title=\"Corticosteroid\">corticosteroids</a>.\n</p>\n<ul><li>Historically, around 90% of patients with glioblastoma underwent anticonvulsant treatment, although it has been estimated that only approximately 40% of patients required this treatment. Recently, it has been recommended that neurosurgeons not administer anticonvulsants prophylactically, and should wait until a seizure occurs before prescribing this medication.<sup id=\"cite_ref-39\" class=\"reference\"><a href=\"#cite_note-39\">&#91;39&#93;</a></sup> Those receiving <a href=\"/wiki/Phenytoin\" title=\"Phenytoin\">phenytoin</a> concurrent with radiation may have serious skin reactions such as <a href=\"/wiki/Erythema_multiforme\" title=\"Erythema multiforme\">erythema multiforme</a> and <a href=\"/wiki/Stevens%E2%80%93Johnson_syndrome\" title=\"Stevens\u2013Johnson syndrome\">Stevens\u2013Johnson syndrome</a>.</li>\n<li>Corticosteroids, usually <a href=\"/wiki/Dexamethasone\" title=\"Dexamethasone\">dexamethasone</a> given 4 to 8&#160;mg every 4 to 6 h, can reduce peritumoral edema (through rearrangement of the blood\u2013brain barrier), diminishing mass effect and lowering intracranial pressure, with a decrease in headache or drowsiness.</li></ul>\n<h3><span class=\"mw-headline\" id=\"Palliative_therapy\">Palliative therapy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=13\" title=\"Edit section: Palliative therapy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Palliative treatment usually is conducted to improve quality of life and to achieve a longer survival time. It includes surgery, radiation therapy, and chemotherapy. A maximally feasible resection with maximal tumor-free margins is usually performed along with external beam <a href=\"/wiki/Radiation\" title=\"Radiation\">radiation</a> and <a href=\"/wiki/Chemotherapy\" title=\"Chemotherapy\">chemotherapy</a>.  Gross total resection of tumor is associated with a better prognosis.\n</p>\n<h4><span class=\"mw-headline\" id=\"Surgery\">Surgery</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=14\" title=\"Edit section: Surgery\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Surgery is the first stage of treatment of glioblastoma. An average GBM tumor contains 10<sup>11</sup> cells, which is on average reduced to 10<sup>9</sup> cells after surgery (a reduction of 99%).\nBenefits of surgery include resection for a pathological diagnosis, alleviation of symptoms related to mass effect, and potentially removing disease before secondary resistance to radiotherapy and chemotherapy occurs.\n</p><p>The greater the extent of tumor removal, the better. Removal of 98% or more of the tumor has been associated with a significantly longer healthier time than if less than 98% of the tumor is removed in retrospective analyses.<sup id=\"cite_ref-40\" class=\"reference\"><a href=\"#cite_note-40\">&#91;40&#93;</a></sup> The chances of near-complete initial removal of the tumor may be increased if the surgery is guided by a fluorescent dye known as <a href=\"/wiki/5-aminolevulinic_acid\" class=\"mw-redirect\" title=\"5-aminolevulinic acid\">5-aminolevulinic acid</a>.<sup id=\"cite_ref-41\" class=\"reference\"><a href=\"#cite_note-41\">&#91;41&#93;</a></sup> GBM cells are widely infiltrative through the brain at diagnosis, and so despite a \"total resection\" of all obvious tumor, most people with GBM later develop recurrent tumors either near the original site or at more distant locations within the brain. Other modalities, typically radiation and chemotherapy, are used after surgery in an effort to suppress and slow recurrent disease.\n</p>\n<h4><span class=\"mw-headline\" id=\"Radiotherapy\">Radiotherapy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=15\" title=\"Edit section: Radiotherapy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Subsequent to surgery, radiotherapy becomes the mainstay of treatment for people with glioblastoma. It is typically performed along with giving <a href=\"/wiki/Temozolomide\" title=\"Temozolomide\">temozolomide</a> (TMZ).<sup id=\"cite_ref-RTG1_7-1\" class=\"reference\"><a href=\"#cite_note-RTG1-7\">&#91;7&#93;</a></sup> A pivotal clinical trial carried out in the early 1970s showed that among 303 GBM patients randomized to radiation or nonradiation therapy, those who received radiation had a median survival more than double those who did not.<sup id=\"cite_ref-42\" class=\"reference\"><a href=\"#cite_note-42\">&#91;42&#93;</a></sup> Subsequent clinical research has attempted to build on the backbone of surgery followed by radiation. On average, <a href=\"/wiki/Radiotherapy\" class=\"mw-redirect\" title=\"Radiotherapy\">radiotherapy</a> after surgery can reduce the tumor size to 10<sup>7</sup> cells. Whole-brain radiotherapy does not improve when compared to the more precise and targeted three-dimensional conformal radiotherapy.<sup id=\"cite_ref-43\" class=\"reference\"><a href=\"#cite_note-43\">&#91;43&#93;</a></sup> A total radiation dose of 60\u201365 Gy has been found to be optimal for treatment.<sup id=\"cite_ref-44\" class=\"reference\"><a href=\"#cite_note-44\">&#91;44&#93;</a></sup>\n</p><p>GBM tumors are well known to contain zones of tissue exhibiting <a href=\"/wiki/Hypoxia_(medical)\" title=\"Hypoxia (medical)\">hypoxia</a> which are highly resistant to radiotherapy.  Various approaches to chemotherapy radiosensitizers have been pursued with limited success as of  2016<sup class=\"plainlinks noexcerpt noprint asof-tag update\" style=\"display:none;\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Glioblastoma&amp;action=edit\">&#91;update&#93;</a></sup>. As of  2010<sup class=\"plainlinks noexcerpt noprint asof-tag update\" style=\"display:none;\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Glioblastoma&amp;action=edit\">&#91;update&#93;</a></sup> newer research approaches included preclinical and clinical investigations into the use of an <a href=\"/wiki/Oxygen_diffusion-enhancing_compound\" title=\"Oxygen diffusion-enhancing compound\">oxygen diffusion-enhancing compound</a> such as <a href=\"/wiki/Trans_sodium_crocetinate\" class=\"mw-redirect\" title=\"Trans sodium crocetinate\">trans sodium crocetinate</a> (TSC) as <a href=\"/wiki/Radiosensitizer\" title=\"Radiosensitizer\">radiosensitizers</a>,<sup id=\"cite_ref-45\" class=\"reference\"><a href=\"#cite_note-45\">&#91;45&#93;</a></sup> and as of  2015<sup class=\"plainlinks noexcerpt noprint asof-tag update\" style=\"display:none;\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Glioblastoma&amp;action=edit\">&#91;update&#93;</a></sup> a clinical trial was underway.<sup id=\"cite_ref-46\" class=\"reference\"><a href=\"#cite_note-46\">&#91;46&#93;</a></sup>\n</p><p><a href=\"/wiki/Boron_neutron_capture_therapy\" class=\"mw-redirect\" title=\"Boron neutron capture therapy\">Boron neutron capture therapy</a> has been tested as an alternative treatment for glioblastoma multiforme but is not in common use.\n</p>\n<h4><span class=\"mw-headline\" id=\"Chemotherapy\">Chemotherapy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=16\" title=\"Edit section: Chemotherapy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Most studies show no benefit from the addition of chemotherapy. However, a large clinical trial of 575 participants randomized to standard radiation versus radiation plus <a href=\"/wiki/Temozolomide\" title=\"Temozolomide\">temozolomide</a> chemotherapy showed that the group receiving temozolomide survived a median of 14.6 months as opposed to 12.1 months for the group receiving radiation alone.<sup id=\"cite_ref-RTG1_7-2\" class=\"reference\"><a href=\"#cite_note-RTG1-7\">&#91;7&#93;</a></sup><sup id=\"cite_ref-47\" class=\"reference\"><a href=\"#cite_note-47\">&#91;47&#93;</a></sup> This treatment regime is now standard for most cases of glioblastoma where the person is not enrolled in a <a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">clinical trial</a>.<sup id=\"cite_ref-48\" class=\"reference\"><a href=\"#cite_note-48\">&#91;48&#93;</a></sup><sup id=\"cite_ref-49\" class=\"reference\"><a href=\"#cite_note-49\">&#91;49&#93;</a></sup> Temozolomide seems to work by sensitizing the tumor cells to radiation.<sup id=\"cite_ref-50\" class=\"reference\"><a href=\"#cite_note-50\">&#91;50&#93;</a></sup>\n</p><p>High doses of temozolomide in high-grade gliomas yield low toxicity, but the results are comparable to the standard doses.<sup id=\"cite_ref-51\" class=\"reference\"><a href=\"#cite_note-51\">&#91;51&#93;</a></sup>\n</p><p><a href=\"/wiki/Antiangiogenic_therapy\" class=\"mw-redirect\" title=\"Antiangiogenic therapy\">Antiangiogenic therapy</a> with medications such as <a href=\"/wiki/Bevacizumab\" title=\"Bevacizumab\">bevacizumab</a> control symptoms but do not affect overall survival.<sup id=\"cite_ref-52\" class=\"reference\"><a href=\"#cite_note-52\">&#91;52&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Other_modalities\">Other modalities</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=17\" title=\"Edit section: Other modalities\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p><a href=\"/wiki/Alternating_electric_field_therapy\" title=\"Alternating electric field therapy\">Alternating electric field therapy</a> is an FDA-approved therapy for newly diagnosed<sup id=\"cite_ref-53\" class=\"reference\"><a href=\"#cite_note-53\">&#91;53&#93;</a></sup> and recurrent glioblastoma.<sup id=\"cite_ref-NovoTTF_FDA_approval_54-0\" class=\"reference\"><a href=\"#cite_note-NovoTTF_FDA_approval-54\">&#91;54&#93;</a></sup> In 2015, initial results from a phase-three randomized clinical trial of alternating electric field therapy plus temozolomide in newly diagnosed glioblastoma reported a three-month improvement in progression-free survival, and a five-month improvement in overall survival compared to temozolomide therapy alone,<sup id=\"cite_ref-Stupp2015_55-0\" class=\"reference\"><a href=\"#cite_note-Stupp2015-55\">&#91;55&#93;</a></sup><sup id=\"cite_ref-Sampson2015_56-0\" class=\"reference\"><a href=\"#cite_note-Sampson2015-56\">&#91;56&#93;</a></sup> representing the first large trial in a decade to show a survival improvement in this setting.<sup id=\"cite_ref-Sampson2015_56-1\" class=\"reference\"><a href=\"#cite_note-Sampson2015-56\">&#91;56&#93;</a></sup> Despite these results, the efficacy of this approach remains controversial among medical experts.<sup id=\"cite_ref-57\" class=\"reference\"><a href=\"#cite_note-57\">&#91;57&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Prognosis\">Prognosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=18\" title=\"Edit section: Prognosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The most common length of survival following diagnosis is 12 to 15 months, with fewer than 3% to 5% of people surviving longer than five years.<sup id=\"cite_ref-WCR2014,5.16_2-12\" class=\"reference\"><a href=\"#cite_note-WCR2014,5.16-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Gal2015_3-15\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup> Without treatment survival is typically 3 months.<sup id=\"cite_ref-Sch2007_9-1\" class=\"reference\"><a href=\"#cite_note-Sch2007-9\">&#91;9&#93;</a></sup>\n</p><p>Increasing age (&gt; 60 years of age) carries a worse prognostic risk. Death is usually due to widespread tumor infiltration with <a href=\"/wiki/Cerebral_edema\" title=\"Cerebral edema\">cerebral edema</a> and increased <a href=\"/wiki/Intracranial_pressure\" title=\"Intracranial pressure\">intracranial pressure</a>.<sup id=\"cite_ref-doi101093brainawm204_58-0\" class=\"reference\"><a href=\"#cite_note-doi101093brainawm204-58\">&#91;58&#93;</a></sup>\n</p><p>A good initial <a href=\"/wiki/Karnofsky_score\" class=\"mw-redirect\" title=\"Karnofsky score\">Karnofsky Performance Score</a> (KPS) and <a href=\"/wiki/O-6-methylguanine-DNA_methyltransferase\" title=\"O-6-methylguanine-DNA methyltransferase\">MGMT</a> <a href=\"/wiki/Methylation\" title=\"Methylation\">methylation</a> are associated with longer survival.<sup id=\"cite_ref-doi101093brainawm204_58-1\" class=\"reference\"><a href=\"#cite_note-doi101093brainawm204-58\">&#91;58&#93;</a></sup> A DNA test can be conducted on glioblastomas to determine whether or not the <a href=\"/wiki/Promoter_(biology)\" class=\"mw-redirect\" title=\"Promoter (biology)\">promoter</a> of the <i>MGMT</i> <a href=\"/wiki/Gene\" title=\"Gene\">gene</a> is <a href=\"/wiki/Methylated\" class=\"mw-redirect\" title=\"Methylated\">methylated</a>. Patients with a methylated MGMT promoter have longer survival than those with an unmethylated MGMT promoter, due in part to increased sensitivity to temozolomide.<sup id=\"cite_ref-59\" class=\"reference\"><a href=\"#cite_note-59\">&#91;59&#93;</a></sup> This DNA characteristic is intrinsic to the patient and currently cannot be altered externally. Another positive prognostic marker for glioblastoma patients is mutation of the <i><a href=\"/wiki/IDH1\" title=\"IDH1\">IDH1</a></i> gene,<sup id=\"cite_ref-Ble2012_5-3\" class=\"reference\"><a href=\"#cite_note-Ble2012-5\">&#91;5&#93;</a></sup> which can be tested by DNA-based methods or by immunohistochemistry using an antibody against the most common mutation, namely IDH1-R132H.<sup id=\"cite_ref-P2_60-0\" class=\"reference\"><a href=\"#cite_note-P2-60\">&#91;60&#93;</a></sup>\n</p><p>More prognostic power can be obtained by combining the mutational status of <i>IDH1</i> and the methylation status of <i>MGMT</i> into a two-gene predictor. Patients with both <i>IDH1</i> mutations and <i>MGMT</i> methylation have the longest survival, patients with an <i>IDH1</i> mutation or <i>MGMT</i> methylation an intermediate survival and patients without either genetic event have the shortest survival.<sup id=\"cite_ref-61\" class=\"reference\"><a href=\"#cite_note-61\">&#91;61&#93;</a></sup>\n</p><p>Long-term benefits have also been associated with those patients who receive surgery, radiotherapy, and temozolomide chemotherapy.<sup id=\"cite_ref-doi101093brainawm204_58-2\" class=\"reference\"><a href=\"#cite_note-doi101093brainawm204-58\">&#91;58&#93;</a></sup> However, much remains unknown about why some patients survive longer with glioblastoma. Age of under 50 is linked to longer survival in glioblastoma multiforme, as is 98%+ resection and use of temozolomide chemotherapy and better Karnofsky performance scores. A recent study confirms that younger age is associated with a much better prognosis, with a small fraction of patients under 40 years of age achieving a population-based cure. The population-based cure is thought to occur when a population's risk of death returns to that of the normal population, and in GBM, this is thought to occur after 10 years.<sup id=\"cite_ref-62\" class=\"reference\"><a href=\"#cite_note-62\">&#91;62&#93;</a></sup>\n</p><p>UCLA Neuro-Oncology publishes real-time survival data for patients with this diagnosis.<sup id=\"cite_ref-63\" class=\"reference\"><a href=\"#cite_note-63\">&#91;63&#93;</a></sup> They are the only institution in the <a href=\"/wiki/United_States\" title=\"United States\">United States</a> that shows how their patients are performing. They also show a listing of chemotherapy agents used to treat GBM tumors. Despite a poor prognosis, there is a small number of survivors who have been GBM free for more than 10\u201320 years.\n</p><p>According to a 2003 study, glioblastoma multiforme prognosis can be divided into three subgroups dependent on KPS, the age of the patient, and treatment.<sup id=\"cite_ref-64\" class=\"reference\"><a href=\"#cite_note-64\">&#91;64&#93;</a></sup>\n</p>\n<table class=\"wikitable\" style=\"margin: 1em auto 1em auto\">\n<tbody><tr>\n<th>Recursive partitioning analysis<br />(RPA) class</th>\n<th>Definition</th>\n<th>Historical Median Survival Time</th>\n<th>Historical 1-Year Survival</th>\n<th>Historical 3-Year Survival</th>\n<th>Historical 5-Year Survival\n</th></tr>\n<tr>\n<td style=\"text-align:center;\">III</td>\n<td>Age &lt; 50, <a href=\"/wiki/Karnofsky_score\" class=\"mw-redirect\" title=\"Karnofsky score\">KPS</a> \u2265 90</td>\n<td style=\"text-align:center;\">17.1 months</td>\n<td style=\"text-align:center;\">70%</td>\n<td style=\"text-align:center;\">20%</td>\n<td style=\"text-align:center;\">14%\n</td></tr>\n<tr>\n<td rowspan=\"2\" style=\"text-align:center;\">IV</td>\n<td>Age &lt; 50, KPS &lt; 90</td>\n<td rowspan=\"2\" style=\"text-align:center;\">11.2 months</td>\n<td rowspan=\"2\" style=\"text-align:center;\">46%</td>\n<td rowspan=\"2\" style=\"text-align:center;\">7%</td>\n<td rowspan=\"2\" style=\"text-align:center;\">4%\n</td></tr>\n<tr>\n<td>Age \u2265 50, KPS \u2265 70, surgical removal with good neurologic function\n</td></tr>\n<tr>\n<td rowspan=\"3\" style=\"text-align:center;\">V + VI</td>\n<td>Age \u2265 50, KPS \u2265 70, surgical removal with poor neurologic function</td>\n<td rowspan=\"3\" style=\"text-align:center;\">7.5 months</td>\n<td rowspan=\"3\" style=\"text-align:center;\">28%</td>\n<td rowspan=\"3\" style=\"text-align:center;\">1%</td>\n<td rowspan=\"3\" style=\"text-align:center;\">0%\n</td></tr>\n<tr>\n<td>Age \u2265 50, KPS \u2265 70, no surgical removal\n</td></tr>\n<tr>\n<td>Age \u2265 50, KPS &lt; 70\n</td></tr></tbody></table>\n<h2><span class=\"mw-headline\" id=\"Epidemiology\">Epidemiology</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=19\" title=\"Edit section: Epidemiology\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>About 3 per 100,000 people develop the disease a year.<sup id=\"cite_ref-Gal2015_3-16\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup> It most often begins around 64 years of age and occurs more commonly in males than females.<sup id=\"cite_ref-WCR2014,5.16_2-13\" class=\"reference\"><a href=\"#cite_note-WCR2014,5.16-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Gal2015_3-17\" class=\"reference\"><a href=\"#cite_note-Gal2015-3\">&#91;3&#93;</a></sup> It is the second most common <a href=\"/wiki/Central_nervous_system\" title=\"Central nervous system\">central nervous system</a> cancer after <a href=\"/wiki/Meningioma\" title=\"Meningioma\">meningioma</a>.<sup id=\"cite_ref-Mc2016_10-1\" class=\"reference\"><a href=\"#cite_note-Mc2016-10\">&#91;10&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=20\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The term glioblastoma multiforme was introduced in 1926 by <a href=\"/wiki/Percival_Bailey\" title=\"Percival Bailey\">Percival Bailey</a> and <a href=\"/wiki/Harvey_Cushing\" title=\"Harvey Cushing\">Harvey Cushing</a>, based on the idea that the tumor originates from primitive precursors of <a href=\"/wiki/Glial_cell\" class=\"mw-redirect\" title=\"Glial cell\">glial cells</a> (<a href=\"/wiki/Glioblast\" title=\"Glioblast\">glioblasts</a>), and the highly variable appearance due to the presence of necrosis, hemorrhage and cysts (multiform).<sup id=\"cite_ref-65\" class=\"reference\"><a href=\"#cite_note-65\">&#91;65&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Research\">Research</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=21\" title=\"Edit section: Research\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"MicroRNA\">MicroRNA</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=22\" title=\"Edit section: MicroRNA\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>As of 2012, RNA interference, usually microRNA, was under investigation in tissue culture, pathology specimens and in preclinical animal models of glioblastoma.<sup id=\"cite_ref-66\" class=\"reference\"><a href=\"#cite_note-66\">&#91;66&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Gene_therapy\">Gene therapy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=23\" title=\"Edit section: Gene therapy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Gene_therapy\" title=\"Gene therapy\">Gene therapy</a> has been explored as a method to treat glioblastoma and while animal models and early phase clinical trials have been successful, as of 2017, all gene therapy drugs that had been tested in phase III clinical trials for glioblastoma had failed.<sup id=\"cite_ref-67\" class=\"reference\"><a href=\"#cite_note-67\">&#91;67&#93;</a></sup><sup id=\"cite_ref-68\" class=\"reference\"><a href=\"#cite_note-68\">&#91;68&#93;</a></sup><sup id=\"cite_ref-69\" class=\"reference\"><a href=\"#cite_note-69\">&#91;69&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Virotherapy\">Virotherapy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=24\" title=\"Edit section: Virotherapy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>A promising new direction of research (since 2017) is the use of the Zika virus which has shown promise in specifically targeting glioma stem cells while leaving adult brain cells unaffected. <sup id=\"cite_ref-70\" class=\"reference\"><a href=\"#cite_note-70\">&#91;70&#93;</a></sup><sup id=\"cite_ref-71\" class=\"reference\"><a href=\"#cite_note-71\">&#91;71&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Intranasal_drug_delivery\">Intranasal drug delivery</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=25\" title=\"Edit section: Intranasal drug delivery\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Direct nose-to-brain drug delivery is being explored as a means to achieve higher, and hopefully more effective, drug concentrations in the brain.<sup id=\"cite_ref-ReferenceA_72-0\" class=\"reference\"><a href=\"#cite_note-ReferenceA-72\">&#91;72&#93;</a></sup><sup id=\"cite_ref-73\" class=\"reference\"><a href=\"#cite_note-73\">&#91;73&#93;</a></sup> A clinical phase I/II study with glioblastoma patients in Brazil investigated the natural compound <a href=\"/wiki/Perillyl_alcohol\" title=\"Perillyl alcohol\">perillyl alcohol</a> for intranasal delivery as an <a href=\"/wiki/Aerosol\" title=\"Aerosol\">aerosol</a>. The results were encouraging<sup id=\"cite_ref-ReferenceA_72-1\" class=\"reference\"><a href=\"#cite_note-ReferenceA-72\">&#91;72&#93;</a></sup><sup id=\"cite_ref-74\" class=\"reference\"><a href=\"#cite_note-74\">&#91;74&#93;</a></sup><sup id=\"cite_ref-75\" class=\"reference\"><a href=\"#cite_note-75\">&#91;75&#93;</a></sup> and, as of 2016, a similar trial has been initiated in the United States.<sup id=\"cite_ref-76\" class=\"reference\"><a href=\"#cite_note-76\">&#91;76&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Risk_factors_2\">Risk factors</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=26\" title=\"Edit section: Risk factors\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Research has been done to see if <a href=\"/wiki/Curing_(food_preservation)\" title=\"Curing (food preservation)\">consumption of cured meat</a> is a risk factor. No risk had been confirmed as of 2013.<sup id=\"cite_ref-77\" class=\"reference\"><a href=\"#cite_note-77\">&#91;77&#93;</a></sup>  Similarly, exposure to radiation during <a href=\"/wiki/Medical_imaging\" title=\"Medical imaging\">medical imaging</a>, <a href=\"/wiki/Formaldehyde\" title=\"Formaldehyde\">formaldehyde</a>, and residential <a href=\"/wiki/Electromagnetic_field\" title=\"Electromagnetic field\">electromagnetic fields</a>, such as from cell phones and electrical wiring within homes, have been studied as risk factors. As of 2015, they had not been shown to cause GBM.<sup id=\"cite_ref-Al2015_12-4\" class=\"reference\"><a href=\"#cite_note-Al2015-12\">&#91;12&#93;</a></sup><sup id=\"cite_ref-78\" class=\"reference\"><a href=\"#cite_note-78\">&#91;78&#93;</a></sup><sup id=\"cite_ref-79\" class=\"reference\"><a href=\"#cite_note-79\">&#91;79&#93;</a></sup> However, a meta-analysis published in 2007, found a correlation between increased incidence of GBM and use of a cell phone for longer than 10 years, especially among those who always held the phone on one side of their head.<sup id=\"cite_ref-Al2015_12-5\" class=\"reference\"><a href=\"#cite_note-Al2015-12\">&#91;12&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=27\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/List_of_people_with_brain_tumors\" title=\"List of people with brain tumors\">List of people with brain tumors</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=28\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-Young2015-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Young2015_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Young2015_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Young2015_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Young2015_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Young2015_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Young2015_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Young2015_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Young2015_1-7\"><sup><i><b>h</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Young, RM; Jamshidi, A; Davis, G; Sherman, JH (June 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4481356\">\"Current trends in the surgical management and treatment of adult glioblastoma\"</a>. <i>Annals of Translational Medicine</i>. <b>3</b> (9): 121. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3978/j.issn.2305-5839.2015.05.10\">10.3978/j.issn.2305-5839.2015.05.10</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4481356\">4481356</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26207249\">26207249</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Translational+Medicine&amp;rft.atitle=Current+trends+in+the+surgical+management+and+treatment+of+adult+glioblastoma.&amp;rft.volume=3&amp;rft.issue=9&amp;rft.pages=121&amp;rft.date=2015-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4481356&amp;rft_id=info%3Apmid%2F26207249&amp;rft_id=info%3Adoi%2F10.3978%2Fj.issn.2305-5839.2015.05.10&amp;rft.aulast=Young&amp;rft.aufirst=RM&amp;rft.au=Jamshidi%2C+A&amp;rft.au=Davis%2C+G&amp;rft.au=Sherman%2C+JH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4481356&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-WCR2014,5.16-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-WCR2014,5.16_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-WCR2014,5.16_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-WCR2014,5.16_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-WCR2014,5.16_2-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-WCR2014,5.16_2-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-WCR2014,5.16_2-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-WCR2014,5.16_2-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-WCR2014,5.16_2-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-WCR2014,5.16_2-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-WCR2014,5.16_2-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-WCR2014,5.16_2-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-WCR2014,5.16_2-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-WCR2014,5.16_2-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-WCR2014,5.16_2-13\"><sup><i><b>n</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">\"Chapter 5.16\". <i>World Cancer Report 2014</i>. World Health Organization. 2014. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9283204298\" title=\"Special:BookSources/9283204298\">9283204298</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+5.16&amp;rft.btitle=World+Cancer+Report+2014&amp;rft.pub=World+Health+Organization&amp;rft.date=2014&amp;rft.isbn=9283204298&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Gal2015-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Gal2015_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Gal2015_3-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Gal2015_3-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Gal2015_3-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Gal2015_3-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Gal2015_3-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Gal2015_3-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Gal2015_3-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-Gal2015_3-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-Gal2015_3-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-Gal2015_3-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-Gal2015_3-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-Gal2015_3-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-Gal2015_3-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-Gal2015_3-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-Gal2015_3-15\"><sup><i><b>p</b></i></sup></a> <a href=\"#cite_ref-Gal2015_3-16\"><sup><i><b>q</b></i></sup></a> <a href=\"#cite_ref-Gal2015_3-17\"><sup><i><b>r</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gallego, O (August 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4530825\">\"Nonsurgical treatment of recurrent glioblastoma\"</a>. <i>Current oncology (Toronto, Ont.)</i>. <b>22</b> (4): e273\u201381. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3747/co.22.2436\">10.3747/co.22.2436</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4530825\">4530825</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26300678\">26300678</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+oncology+%28Toronto%2C+Ont.%29&amp;rft.atitle=Nonsurgical+treatment+of+recurrent+glioblastoma.&amp;rft.volume=22&amp;rft.issue=4&amp;rft.pages=e273-81&amp;rft.date=2015-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4530825&amp;rft_id=info%3Apmid%2F26300678&amp;rft_id=info%3Adoi%2F10.3747%2Fco.22.2436&amp;rft.aulast=Gallego&amp;rft.aufirst=O&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4530825&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Hart2013-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Hart2013_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Hart2013_4-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hart, MG; Garside, R; Rogers, G; Stein, K; Grant, R (30 April 2013). \"Temozolomide for high grade glioma\". <i>The Cochrane Database of Systematic Reviews</i>. <b>4</b>: CD007415. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD007415.pub2\">10.1002/14651858.CD007415.pub2</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23633341\">23633341</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Temozolomide+for+high+grade+glioma.&amp;rft.volume=4&amp;rft.pages=CD007415&amp;rft.date=2013-04-30&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD007415.pub2&amp;rft_id=info%3Apmid%2F23633341&amp;rft.aulast=Hart&amp;rft.aufirst=MG&amp;rft.au=Garside%2C+R&amp;rft.au=Rogers%2C+G&amp;rft.au=Stein%2C+K&amp;rft.au=Grant%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Ble2012-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Ble2012_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Ble2012_5-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Ble2012_5-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Ble2012_5-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bleeker, Fonnet E.; Molenaar, Remco J.; Leenstra, Sieger (2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3337398\">\"Recent advances in the molecular understanding of glioblastoma\"</a>. <i>Journal of Neuro-Oncology</i>. <b>108</b> (1): 11\u201327. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s11060-011-0793-0\">10.1007/s11060-011-0793-0</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3337398\">3337398</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22270850\">22270850</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neuro-Oncology&amp;rft.atitle=Recent+advances+in+the+molecular+understanding+of+glioblastoma&amp;rft.volume=108&amp;rft.issue=1&amp;rft.pages=11-27&amp;rft.date=2012&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3337398&amp;rft_id=info%3Apmid%2F22270850&amp;rft_id=info%3Adoi%2F10.1007%2Fs11060-011-0793-0&amp;rft.aulast=Bleeker&amp;rft.aufirst=Fonnet+E.&amp;rft.au=Molenaar%2C+Remco+J.&amp;rft.au=Leenstra%2C+Sieger&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3337398&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-WCR2014,3.8-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-WCR2014,3.8_6-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">\"Chapter 3.8\". <i>World Cancer Report 2014</i>. World Health Organization. 2014. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9283204298\" title=\"Special:BookSources/9283204298\">9283204298</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+3.8&amp;rft.btitle=World+Cancer+Report+2014&amp;rft.pub=World+Health+Organization&amp;rft.date=2014&amp;rft.isbn=9283204298&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-RTG1-7\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-RTG1_7-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-RTG1_7-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-RTG1_7-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Khosla, D (February 2016). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4740000\">\"Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma\"</a>. <i>Annals of translational medicine</i>. <b>4</b> (3): 54. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3978/j.issn.2305-5839.2016.01.25\">10.3978/j.issn.2305-5839.2016.01.25</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4740000\">4740000</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26904576\">26904576</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+translational+medicine&amp;rft.atitle=Concurrent+therapy+to+enhance+radiotherapeutic+outcomes+in+glioblastoma.&amp;rft.volume=4&amp;rft.issue=3&amp;rft.pages=54&amp;rft.date=2016-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4740000&amp;rft_id=info%3Apmid%2F26904576&amp;rft_id=info%3Adoi%2F10.3978%2Fj.issn.2305-5839.2016.01.25&amp;rft.aulast=Khosla&amp;rft.aufirst=D&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4740000&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Van Meir, E. G.; Hadjipanayis, C. G.; Norden, A. D.; Shu, H. K.; Wen, P. Y.; Olson, J. J. (2010). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2888474\">\"Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma\"</a>. <i>CA: A Cancer Journal for Clinicians</i>. <b>60</b> (3): 166\u201393. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3322/caac.20069\">10.3322/caac.20069</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2888474\">2888474</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20445000\">20445000</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CA%3A+A+Cancer+Journal+for+Clinicians&amp;rft.atitle=Exciting+New+Advances+in+Neuro-Oncology%3A+The+Avenue+to+a+Cure+for+Malignant+Glioma&amp;rft.volume=60&amp;rft.issue=3&amp;rft.pages=166-93&amp;rft.date=2010&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2888474&amp;rft_id=info%3Apmid%2F20445000&amp;rft_id=info%3Adoi%2F10.3322%2Fcaac.20069&amp;rft.aulast=Van+Meir&amp;rft.aufirst=E.+G.&amp;rft.au=Hadjipanayis%2C+C.+G.&amp;rft.au=Norden%2C+A.+D.&amp;rft.au=Shu%2C+H.+K.&amp;rft.au=Wen%2C+P.+Y.&amp;rft.au=Olson%2C+J.+J.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2888474&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Sch2007-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Sch2007_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Sch2007_9-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Schapira, Anthony H.V. (2007). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.ca/books?id=EwajBQAAQBAJ&amp;pg=PA1336\"><i>Neurology and clinical neuroscience</i></a>. Philadelphia: Mosby Elsevier. p.&#160;1336. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9780323070539\" title=\"Special:BookSources/9780323070539\">9780323070539</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170729005047/https://books.google.ca/books?id=EwajBQAAQBAJ&amp;pg=PA1336\">Archived</a> from the original on 2017-07-29.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Neurology+and+clinical+neuroscience&amp;rft.place=Philadelphia&amp;rft.pages=1336&amp;rft.pub=Mosby+Elsevier&amp;rft.date=2007&amp;rft.isbn=9780323070539&amp;rft.aulast=Schapira&amp;rft.aufirst=Anthony+H.V.&amp;rft_id=https%3A%2F%2Fbooks.google.ca%2Fbooks%3Fid%3DEwajBQAAQBAJ%26pg%3DPA1336&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Mc2016-10\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Mc2016_10-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Mc2016_10-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">McNeill, Katharine A. <a rel=\"nofollow\" class=\"external text\" href=\"http://linkinghub.elsevier.com/retrieve/pii/S0733861916300366\">\"Epidemiology of Brain Tumors\"</a>. <i>Neurologic Clinics</i>. <b>34</b> (4): 981\u201398. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ncl.2016.06.014\">10.1016/j.ncl.2016.06.014</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurologic+Clinics&amp;rft.atitle=Epidemiology+of+Brain+Tumors&amp;rft.volume=34&amp;rft.issue=4&amp;rft.pages=981-98&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ncl.2016.06.014&amp;rft.aulast=McNeill&amp;rft.aufirst=Katharine+A.&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0733861916300366&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.cancer.gov/types/brain/research/immunotherapy-glioblastoma\">\"With Immunotherapy, Glimmers of Progress against Glioblastoma\"</a>. <i>National Cancer Institute</i>. 9 December 2015. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20151224103950/http://www.cancer.gov/types/brain/research/immunotherapy-glioblastoma\">Archived</a> from the original on 24 December 2015<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 December</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Cancer+Institute&amp;rft.atitle=With+Immunotherapy%2C+Glimmers+of+Progress+against+Glioblastoma&amp;rft.date=2015-12-09&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Ftypes%2Fbrain%2Fresearch%2Fimmunotherapy-glioblastoma&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Al2015-12\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Al2015_12-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Al2015_12-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Al2015_12-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Al2015_12-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Al2015_12-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Al2015_12-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Alifieris, C; Trafalis, DT (August 2015). \"Glioblastoma multiforme: Pathogenesis and treatment\". <i>Pharmacology &amp; Therapeutics</i>. <b>152</b>: 63\u201382. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.pharmthera.2015.05.005\">10.1016/j.pharmthera.2015.05.005</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25944528\">25944528</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacology+%26+Therapeutics&amp;rft.atitle=Glioblastoma+multiforme%3A+Pathogenesis+and+treatment.&amp;rft.volume=152&amp;rft.pages=63-82&amp;rft.date=2015-08&amp;rft_id=info%3Adoi%2F10.1016%2Fj.pharmthera.2015.05.005&amp;rft_id=info%3Apmid%2F25944528&amp;rft.aulast=Alifieris&amp;rft.aufirst=C&amp;rft.au=Trafalis%2C+DT&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ohgaki, Hiroko; Kleihues, Paul (2005). \"Population-Based Studies on Incidence, Survival Rates, and Genetic Alterations in Astrocytic and Oligodendroglial Gliomas\". <i>Journal of Neuropathology &amp; Experimental Neurology</i>. <b>64</b> (6): 479\u201389. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15977639\">15977639</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neuropathology+%26+Experimental+Neurology&amp;rft.atitle=Population-Based+Studies+on+Incidence%2C+Survival+Rates%2C+and+Genetic+Alterations+in+Astrocytic+and+Oligodendroglial+Gliomas&amp;rft.volume=64&amp;rft.issue=6&amp;rft.pages=479-89&amp;rft.date=2005&amp;rft_id=info%3Apmid%2F15977639&amp;rft.aulast=Ohgaki&amp;rft.aufirst=Hiroko&amp;rft.au=Kleihues%2C+Paul&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Vilchez, Regis A; Kozinetz, Claudia A; Arrington, Amy S; Madden, Charles R; Butel, Janet S (2003). \"Simian virus 40 in human cancers\". <i>The American Journal of Medicine</i>. <b>114</b> (8): 675\u201384. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0002-9343%2803%2900087-1\">10.1016/S0002-9343(03)00087-1</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12798456\">12798456</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Medicine&amp;rft.atitle=Simian+virus+40+in+human+cancers&amp;rft.volume=114&amp;rft.issue=8&amp;rft.pages=675-84&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1016%2FS0002-9343%2803%2900087-1&amp;rft_id=info%3Apmid%2F12798456&amp;rft.aulast=Vilchez&amp;rft.aufirst=Regis+A&amp;rft.au=Kozinetz%2C+Claudia+A&amp;rft.au=Arrington%2C+Amy+S&amp;rft.au=Madden%2C+Charles+R&amp;rft.au=Butel%2C+Janet+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Crawford, JR; Santi, MR; Thorarinsdottir, HK; Cornelison, R; Rushing, EJ; Zhang, H; Yao, K; Jacobson, S; MacDonald, TJ (2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2749001\">\"Detection of human herpesvirus-6 variants in pediatric brain tumors: Association of viral antigen in low grade gliomas\"</a>. <i>Journal of Clinical Virology</i>. <b>46</b> (1): 37\u201342. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.jcv.2009.05.011\">10.1016/j.jcv.2009.05.011</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2749001\">2749001</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19505845\">19505845</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Virology&amp;rft.atitle=Detection+of+human+herpesvirus-6+variants+in+pediatric+brain+tumors%3A+Association+of+viral+antigen+in+low+grade+gliomas&amp;rft.volume=46&amp;rft.issue=1&amp;rft.pages=37-42&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2749001&amp;rft_id=info%3Apmid%2F19505845&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jcv.2009.05.011&amp;rft.aulast=Crawford&amp;rft.aufirst=JR&amp;rft.au=Santi%2C+MR&amp;rft.au=Thorarinsdottir%2C+HK&amp;rft.au=Cornelison%2C+R&amp;rft.au=Rushing%2C+EJ&amp;rft.au=Zhang%2C+H&amp;rft.au=Yao%2C+K&amp;rft.au=Jacobson%2C+S&amp;rft.au=MacDonald%2C+TJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2749001&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chi, J.; Gu, B.; Zhang, C.; Peng, G.; Zhou, F.; Chen, Y.; Zhang, G.; Guo, Y.;  et al. (2012). \"Human Herpesvirus 6 Latent Infection in Patients with Glioma\". <i>Journal of Infectious Diseases</i>. <b>206</b> (9): 1394\u201398. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/infdis/jis513\">10.1093/infdis/jis513</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22962688\">22962688</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Infectious+Diseases&amp;rft.atitle=Human+Herpesvirus+6+Latent+Infection+in+Patients+with+Glioma&amp;rft.volume=206&amp;rft.issue=9&amp;rft.pages=1394-98&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.1093%2Finfdis%2Fjis513&amp;rft_id=info%3Apmid%2F22962688&amp;rft.aulast=Chi&amp;rft.aufirst=J.&amp;rft.au=Gu%2C+B.&amp;rft.au=Zhang%2C+C.&amp;rft.au=Peng%2C+G.&amp;rft.au=Zhou%2C+F.&amp;rft.au=Chen%2C+Y.&amp;rft.au=Zhang%2C+G.&amp;rft.au=Guo%2C+Y.&amp;rft.au=Guo%2C+D.&amp;rft.au=Qin%2C+J.&amp;rft.au=Wang%2C+J.&amp;rft.au=Li%2C+L.&amp;rft.au=Wang%2C+F.&amp;rft.au=Liu%2C+G.&amp;rft.au=Xie%2C+F.&amp;rft.au=Feng%2C+D.&amp;rft.au=Zhou%2C+H.&amp;rft.au=Huang%2C+X.&amp;rft.au=Lu%2C+S.&amp;rft.au=Liu%2C+Y.&amp;rft.au=Hu%2C+W.&amp;rft.au=Yao%2C+K.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">McFaline-Figueroa, JR; Wen, PY (February 2017). \"The Viral Connection to Glioblastoma\". <i>Current infectious disease reports</i>. <b>19</b> (2): 5. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s11908-017-0563-z\">10.1007/s11908-017-0563-z</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28233187\">28233187</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+infectious+disease+reports&amp;rft.atitle=The+Viral+Connection+to+Glioblastoma.&amp;rft.volume=19&amp;rft.issue=2&amp;rft.pages=5&amp;rft.date=2017-02&amp;rft_id=info%3Adoi%2F10.1007%2Fs11908-017-0563-z&amp;rft_id=info%3Apmid%2F28233187&amp;rft.aulast=McFaline-Figueroa&amp;rft.aufirst=JR&amp;rft.au=Wen%2C+PY&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Zong_2012-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Zong_2012_18-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zong H, Verhaak RG, Canoll P (May 2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3368274\">\"The cellular origin for malignant glioma and prospects for clinical advancements\"</a>. <i>Expert Review of Molecular Diagnostics</i>. <b>12</b> (4): 383\u201394. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1586/erm.12.30\">10.1586/erm.12.30</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3368274\">3368274</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22616703\">22616703</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Review+of+Molecular+Diagnostics&amp;rft.atitle=The+cellular+origin+for+malignant+glioma+and+prospects+for+clinical+advancements&amp;rft.volume=12&amp;rft.issue=4&amp;rft.pages=383-94&amp;rft.date=2012-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3368274&amp;rft_id=info%3Apmid%2F22616703&amp;rft_id=info%3Adoi%2F10.1586%2Ferm.12.30&amp;rft.aulast=Zong&amp;rft.aufirst=H&amp;rft.au=Verhaak%2C+RG&amp;rft.au=Canoll%2C+P&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3368274&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Zong_2015-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Zong_2015_19-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zong H, Parada LF, Baker SJ (January 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4448618\">\"Cell of origin for malignant gliomas and its implication in therapeutic development\"</a>. <i>Cold Spring Harbor Perspectives in Biology</i>. <b>7</b> (5): a020610. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1101/cshperspect.a020610\">10.1101/cshperspect.a020610</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4448618\">4448618</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25635044\">25635044</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cold+Spring+Harbor+Perspectives+in+Biology&amp;rft.atitle=Cell+of+origin+for+malignant+gliomas+and+its+implication+in+therapeutic+development&amp;rft.volume=7&amp;rft.issue=5&amp;rft.pages=a020610&amp;rft.date=2015-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4448618&amp;rft_id=info%3Apmid%2F25635044&amp;rft_id=info%3Adoi%2F10.1101%2Fcshperspect.a020610&amp;rft.aulast=Zong&amp;rft.aufirst=H&amp;rft.au=Parada%2C+LF&amp;rft.au=Baker%2C+SJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4448618&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ohgaki, Hiroko; Kleihues, Paul (2009). \"Genetic alterations and signaling pathways in the evolution of gliomas\". <i>Cancer Science</i>. <b>100</b> (12): 2235\u201341. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1349-7006.2009.01308.x\">10.1111/j.1349-7006.2009.01308.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19737147\">19737147</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Science&amp;rft.atitle=Genetic+alterations+and+signaling+pathways+in+the+evolution+of+gliomas&amp;rft.volume=100&amp;rft.issue=12&amp;rft.pages=2235-41&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1349-7006.2009.01308.x&amp;rft_id=info%3Apmid%2F19737147&amp;rft.aulast=Ohgaki&amp;rft.aufirst=Hiroko&amp;rft.au=Kleihues%2C+Paul&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Roel2010-21\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Roel2010_21-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Roel2010_21-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Verhaak, Roel G. W.; Hoadley, Katherine A.; Purdom, Elizabeth; Wang, Victoria; Qi, Yuan; Wilkerson, Matthew D.; Miller, C. Ryan; Ding, Li;  et al. (January 2010). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2818769\">\"Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in <i>PDGFRA</i>, <i>IDH1</i>, <i>EGFR</i>, and <i>NF1</i>\"</a>. <i>Cancer Cell</i>. <b>17</b> (1): 98\u2013110. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ccr.2009.12.020\">10.1016/j.ccr.2009.12.020</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2818769\">2818769</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20129251\">20129251</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Cell&amp;rft.atitle=Integrated+Genomic+Analysis+Identifies+Clinically+Relevant+Subtypes+of+Glioblastoma+Characterized+by+Abnormalities+in+PDGFRA%2C+IDH1%2C+EGFR%2C+and+NF1&amp;rft.volume=17&amp;rft.issue=1&amp;rft.pages=98-110&amp;rft.date=2010-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2818769&amp;rft_id=info%3Apmid%2F20129251&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ccr.2009.12.020&amp;rft.aulast=Verhaak&amp;rft.aufirst=Roel+G.+W.&amp;rft.au=Hoadley%2C+Katherine+A.&amp;rft.au=Purdom%2C+Elizabeth&amp;rft.au=Wang%2C+Victoria&amp;rft.au=Qi%2C+Yuan&amp;rft.au=Wilkerson%2C+Matthew+D.&amp;rft.au=Miller%2C+C.+Ryan&amp;rft.au=Ding%2C+Li&amp;rft.au=Golub%2C+Todd&amp;rft.au=Mesirov%2C+Jill+P.&amp;rft.au=Alexe%2C+Gabriele&amp;rft.au=Lawrence%2C+Michael&amp;rft.au=O%27Kelly%2C+Michael&amp;rft.au=Tamayo%2C+Pablo&amp;rft.au=Weir%2C+Barbara+A.&amp;rft.au=Gabriel%2C+Stacey&amp;rft.au=Winckler%2C+Wendy&amp;rft.au=Gupta%2C+Supriya&amp;rft.au=Jakkula%2C+Lakshmi&amp;rft.au=Feiler%2C+Heidi+S.&amp;rft.au=Hodgson%2C+J.+Graeme&amp;rft.au=James%2C+C.+David&amp;rft.au=Sarkaria%2C+Jann+N.&amp;rft.au=Brennan%2C+Cameron&amp;rft.au=Kahn%2C+Ari&amp;rft.au=Spellman%2C+Paul+T.&amp;rft.au=Wilson%2C+Richard+K.&amp;rft.au=Speed%2C+Terence+P.&amp;rft.au=Gray%2C+Joe+W.&amp;rft.au=Meyerson%2C+Matthew&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2818769&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hayden, Erika Check (2010). \"Genomics boosts brain-cancer work\". <i>Nature</i>. <b>463</b> (7279): 278. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/463278a\">10.1038/463278a</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20090720\">20090720</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Genomics+boosts+brain-cancer+work&amp;rft.volume=463&amp;rft.issue=7279&amp;rft.pages=278&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1038%2F463278a&amp;rft_id=info%3Apmid%2F20090720&amp;rft.aulast=Hayden&amp;rft.aufirst=Erika+Check&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:0-23\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:0_23-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:0_23-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sasmita, Andrew Octavian; Wong, Ying Pei; Ling, Anna Pick Kiong (2018-02-01). \"Biomarkers and therapeutic advances in glioblastoma multiforme\". <i>Asia-Pacific Journal of Clinical Oncology</i>. <b>14</b> (1): 40\u201351. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/ajco.12756\">10.1111/ajco.12756</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28840962\">28840962</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Asia-Pacific+Journal+of+Clinical+Oncology&amp;rft.atitle=Biomarkers+and+therapeutic+advances+in+glioblastoma+multiforme&amp;rft.volume=14&amp;rft.issue=1&amp;rft.pages=40-51&amp;rft.date=2018-02-01&amp;rft_id=info%3Adoi%2F10.1111%2Fajco.12756&amp;rft_id=info%3Apmid%2F28840962&amp;rft.aulast=Sasmita&amp;rft.aufirst=Andrew+Octavian&amp;rft.au=Wong%2C+Ying+Pei&amp;rft.au=Ling%2C+Anna+Pick+Kiong&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span style=\"position:relative; top: -2px;\"><a href=\"/wiki/Open_access\" title=\"open access publication \u2013 free to read\"><img alt=\"open access publication \u2013 free to read\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/9px-Open_Access_logo_PLoS_transparent.svg.png\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/14px-Open_Access_logo_PLoS_transparent.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/18px-Open_Access_logo_PLoS_transparent.svg.png 2x\" data-file-width=\"640\" data-file-height=\"1000\" /></a></span></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kuehn, Bridget M. (2010). \"Genomics Illuminates a Deadly Brain Cancer\". <i>JAMA</i>. <b>303</b> (10): 925\u201327. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.2010.236\">10.1001/jama.2010.236</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20215599\">20215599</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Genomics+Illuminates+a+Deadly+Brain+Cancer&amp;rft.volume=303&amp;rft.issue=10&amp;rft.pages=925-27&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2010.236&amp;rft_id=info%3Apmid%2F20215599&amp;rft.aulast=Kuehn&amp;rft.aufirst=Bridget+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bleeker, FE; Lamba, S; Zanon, C; Molenaar, RJ; Hulsebos, TJ; Troost, D; van Tilborg, AA; Vandertop, WP; Leenstra, S; van Noorden, CJ; Bardelli, A (26 September 2014). \"Mutational profiling of kinases in glioblastoma\". <i>BMC Cancer</i>. <b>14</b> (1): 718. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1186/1471-2407-14-718\">10.1186/1471-2407-14-718</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25256166\">25256166</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Cancer&amp;rft.atitle=Mutational+profiling+of+kinases+in+glioblastoma.&amp;rft.volume=14&amp;rft.issue=1&amp;rft.pages=718&amp;rft.date=2014-09-26&amp;rft_id=info%3Adoi%2F10.1186%2F1471-2407-14-718&amp;rft_id=info%3Apmid%2F25256166&amp;rft.aulast=Bleeker&amp;rft.aufirst=FE&amp;rft.au=Lamba%2C+S&amp;rft.au=Zanon%2C+C&amp;rft.au=Molenaar%2C+RJ&amp;rft.au=Hulsebos%2C+TJ&amp;rft.au=Troost%2C+D&amp;rft.au=van+Tilborg%2C+AA&amp;rft.au=Vandertop%2C+WP&amp;rft.au=Leenstra%2C+S&amp;rft.au=van+Noorden%2C+CJ&amp;rft.au=Bardelli%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ReferenceB-26\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ReferenceB_26-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ReferenceB_26-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Molenaar, RJ; Verbaan, D; Lamba, S; Zanon, C; Jeuken, JW; Boots-Sprenger, SH; Wesseling, P; Hulsebos, TJ; Troost, D; van Tilborg, AA; Leenstra, S; Vandertop, WP; Bardelli, A; van Noorden, CJ; Bleeker, FE (September 2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4136888\">\"The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone\"</a>. <i>Neuro-oncology</i>. <b>16</b> (9): 1263\u201373. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/neuonc/nou005\">10.1093/neuonc/nou005</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4136888\">4136888</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24510240\">24510240</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuro-oncology&amp;rft.atitle=The+combination+of+IDH1+mutations+and+MGMT+methylation+status+predicts+survival+in+glioblastoma+better+than+either+IDH1+or+MGMT+alone.&amp;rft.volume=16&amp;rft.issue=9&amp;rft.pages=1263-73&amp;rft.date=2014-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4136888&amp;rft_id=info%3Apmid%2F24510240&amp;rft_id=info%3Adoi%2F10.1093%2Fneuonc%2Fnou005&amp;rft.aulast=Molenaar&amp;rft.aufirst=RJ&amp;rft.au=Verbaan%2C+D&amp;rft.au=Lamba%2C+S&amp;rft.au=Zanon%2C+C&amp;rft.au=Jeuken%2C+JW&amp;rft.au=Boots-Sprenger%2C+SH&amp;rft.au=Wesseling%2C+P&amp;rft.au=Hulsebos%2C+TJ&amp;rft.au=Troost%2C+D&amp;rft.au=van+Tilborg%2C+AA&amp;rft.au=Leenstra%2C+S&amp;rft.au=Vandertop%2C+WP&amp;rft.au=Bardelli%2C+A&amp;rft.au=van+Noorden%2C+CJ&amp;rft.au=Bleeker%2C+FE&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4136888&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ReferenceC-27\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ReferenceC_27-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ReferenceC_27-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Molenaar, RJ; Radivoyevitch, T; Maciejewski, JP; van Noorden, CJ; Bleeker, FE (28 May 2014). \"The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation\". <i>Biochimica et Biophysica Acta</i>. <b>1846</b> (2): 326\u201341. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbcan.2014.05.004\">10.1016/j.bbcan.2014.05.004</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24880135\">24880135</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochimica+et+Biophysica+Acta&amp;rft.atitle=The+driver+and+passenger+effects+of+isocitrate+dehydrogenase+1+and+2+mutations+in+oncogenesis+and+survival+prolongation.&amp;rft.volume=1846&amp;rft.issue=2&amp;rft.pages=326-41&amp;rft.date=2014-05-28&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbcan.2014.05.004&amp;rft_id=info%3Apmid%2F24880135&amp;rft.aulast=Molenaar&amp;rft.aufirst=RJ&amp;rft.au=Radivoyevitch%2C+T&amp;rft.au=Maciejewski%2C+JP&amp;rft.au=van+Noorden%2C+CJ&amp;rft.au=Bleeker%2C+FE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hegi, Monika E.; Diserens, Annie-Claire; Gorlia, Thierry; Hamou, Marie-France; De Tribolet, Nicolas; Weller, Michael; Kros, Johan M.; Hainfellner, Johannes A.;  et al. (2005). \"<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma\". <i>New England Journal of Medicine</i>. <b>352</b> (10): 997\u20131003. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMoa043331\">10.1056/NEJMoa043331</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15758010\">15758010</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=MGMT+Gene+Silencing+and+Benefit+from+Temozolomide+in+Glioblastoma&amp;rft.volume=352&amp;rft.issue=10&amp;rft.pages=997-1003&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa043331&amp;rft_id=info%3Apmid%2F15758010&amp;rft.aulast=Hegi&amp;rft.aufirst=Monika+E.&amp;rft.au=Diserens%2C+Annie-Claire&amp;rft.au=Gorlia%2C+Thierry&amp;rft.au=Hamou%2C+Marie-France&amp;rft.au=De+Tribolet%2C+Nicolas&amp;rft.au=Weller%2C+Michael&amp;rft.au=Kros%2C+Johan+M.&amp;rft.au=Hainfellner%2C+Johannes+A.&amp;rft.au=Mason%2C+Warren&amp;rft.au=Mariani%2C+Luigi&amp;rft.au=Bromberg%2C+Jacoline+E.C.&amp;rft.au=Hau%2C+Peter&amp;rft.au=Mirimanoff%2C+Ren%C3%A9+O.&amp;rft.au=Cairncross%2C+J.+Gregory&amp;rft.au=Janzer%2C+Robert+C.&amp;rft.au=Stupp%2C+Roger&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-29\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Murat, A.; Migliavacca, E.; Gorlia, T.; Lambiv, W. L.; Shay, T.; Hamou, M.-F.; De Tribolet, N.; Regli, L.;  et al. (2008). \"Stem Cell-Related 'Self-Renewal' Signature and High Epidermal Growth Factor Receptor Expression Associated with Resistance to Concomitant Chemoradiotherapy in Glioblastoma\". <i>Journal of Clinical Oncology</i>. <b>26</b> (18): 3015\u201324. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1200/JCO.2007.15.7164\">10.1200/JCO.2007.15.7164</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18565887\">18565887</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Oncology&amp;rft.atitle=Stem+Cell-Related+%27Self-Renewal%27+Signature+and+High+Epidermal+Growth+Factor+Receptor+Expression+Associated+with+Resistance+to+Concomitant+Chemoradiotherapy+in+Glioblastoma&amp;rft.volume=26&amp;rft.issue=18&amp;rft.pages=3015-24&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2007.15.7164&amp;rft_id=info%3Apmid%2F18565887&amp;rft.aulast=Murat&amp;rft.aufirst=A.&amp;rft.au=Migliavacca%2C+E.&amp;rft.au=Gorlia%2C+T.&amp;rft.au=Lambiv%2C+W.+L.&amp;rft.au=Shay%2C+T.&amp;rft.au=Hamou%2C+M.-F.&amp;rft.au=De+Tribolet%2C+N.&amp;rft.au=Regli%2C+L.&amp;rft.au=Wick%2C+W.&amp;rft.au=Kouwenhoven%2C+M.+C.M.&amp;rft.au=Hainfellner%2C+J.+A.&amp;rft.au=Heppner%2C+F.+L.&amp;rft.au=Dietrich%2C+P.-Y.&amp;rft.au=Zimmer%2C+Y.&amp;rft.au=Cairncross%2C+J.+G.&amp;rft.au=Janzer%2C+R.-C.&amp;rft.au=Domany%2C+E.&amp;rft.au=Delorenzi%2C+M.&amp;rft.au=Stupp%2C+R.&amp;rft.au=Hegi%2C+M.+E.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-30\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hira, Vashendriya V. V.; Ploegmakers, Kimberley J.; Grevers, Frederieke; Verbov\u0161ek, Ur\u0161ka; Silvestre-Roig, Carlos; Aronica, Eleonora; Tigchelaar, Wikky; Turn\u0161ek, Tamara Lah; Molenaar, Remco J. (2015-07-01). <a rel=\"nofollow\" class=\"external text\" href=\"http://jhc.sagepub.com/content/63/7/481\">\"CD133+ and Nestin+ Glioma Stem-Like Cells Reside Around CD31+ Arterioles in Niches that Express SDF-1\u03b1, CXCR4, Osteopontin and Cathepsin K\"</a>. <i>Journal of Histochemistry &amp; Cytochemistry</i>. <b>63</b> (7): 481\u201393. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1369/0022155415581689\">10.1369/0022155415581689</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0022-1554\">0022-1554</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25809793\">25809793</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20160109014011/http://jhc.sagepub.com/content/63/7/481\">Archived</a> from the original on 2016-01-09.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Histochemistry+%26+Cytochemistry&amp;rft.atitle=CD133%2B+and+Nestin%2B+Glioma+Stem-Like+Cells+Reside+Around+CD31%2B+Arterioles+in+Niches+that+Express+SDF-1%CE%B1%2C+CXCR4%2C+Osteopontin+and+Cathepsin+K&amp;rft.volume=63&amp;rft.issue=7&amp;rft.pages=481-93&amp;rft.date=2015-07-01&amp;rft.issn=0022-1554&amp;rft_id=info%3Apmid%2F25809793&amp;rft_id=info%3Adoi%2F10.1369%2F0022155415581689&amp;rft.aulast=Hira&amp;rft.aufirst=Vashendriya+V.+V.&amp;rft.au=Ploegmakers%2C+Kimberley+J.&amp;rft.au=Grevers%2C+Frederieke&amp;rft.au=Verbov%C5%A1ek%2C+Ur%C5%A1ka&amp;rft.au=Silvestre-Roig%2C+Carlos&amp;rft.au=Aronica%2C+Eleonora&amp;rft.au=Tigchelaar%2C+Wikky&amp;rft.au=Turn%C5%A1ek%2C+Tamara+Lah&amp;rft.au=Molenaar%2C+Remco+J.&amp;rft_id=http%3A%2F%2Fjhc.sagepub.com%2Fcontent%2F63%2F7%2F481&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Park, Deric M.; Jung, Jinkyu; Masjkur, Jimmy; Makrogkikas, Stylianos; Ebermann, Doreen; Saha, Sarama; Rogliano, Roberta; Paolillo, Nicoletta; Pacioni, Simone; McKay, Ron D.; Poser, Steve; Androutsellis-Theotokis, Andreas (2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3566603\">\"Hes3 regulates cell number in cultures from glioblastoma multiforme with stem cell characteristics\"</a>. <i>Scientific Reports</i>. <b>3</b>: 1095. <a href=\"/wiki/Bibcode\" title=\"Bibcode\">Bibcode</a>:<a rel=\"nofollow\" class=\"external text\" href=\"http://adsabs.harvard.edu/abs/2013NatSR...3E1095P\">2013NatSR...3E1095P</a>. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/srep01095\">10.1038/srep01095</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3566603\">3566603</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23393614\">23393614</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Scientific+Reports&amp;rft.atitle=Hes3+regulates+cell+number+in+cultures+from+glioblastoma+multiforme+with+stem+cell+characteristics&amp;rft.volume=3&amp;rft.pages=1095&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3566603&amp;rft_id=info%3Apmid%2F23393614&amp;rft_id=info%3Adoi%2F10.1038%2Fsrep01095&amp;rft_id=info%3Abibcode%2F2013NatSR...3E1095P&amp;rft.aulast=Park&amp;rft.aufirst=Deric+M.&amp;rft.au=Jung%2C+Jinkyu&amp;rft.au=Masjkur%2C+Jimmy&amp;rft.au=Makrogkikas%2C+Stylianos&amp;rft.au=Ebermann%2C+Doreen&amp;rft.au=Saha%2C+Sarama&amp;rft.au=Rogliano%2C+Roberta&amp;rft.au=Paolillo%2C+Nicoletta&amp;rft.au=Pacioni%2C+Simone&amp;rft.au=McKay%2C+Ron+D.&amp;rft.au=Poser%2C+Steve&amp;rft.au=Androutsellis-Theotokis%2C+Andreas&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3566603&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-32\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">van Lith, SA; Navis, AC; Verrijp, K; Niclou, SP; Bjerkvig, R; Wesseling, P; Tops, B; Molenaar, R; van Noorden, CJ; Leenders, WP (August 2014). \"Glutamate as chemotactic fuel for diffuse glioma cells: are they glutamate suckers?\". <i>Biochimica et Biophysica Acta</i>. <b>1846</b> (1): 66\u201374. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbcan.2014.04.004\">10.1016/j.bbcan.2014.04.004</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24747768\">24747768</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochimica+et+Biophysica+Acta&amp;rft.atitle=Glutamate+as+chemotactic+fuel+for+diffuse+glioma+cells%3A+are+they+glutamate+suckers%3F&amp;rft.volume=1846&amp;rft.issue=1&amp;rft.pages=66-74&amp;rft.date=2014-08&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbcan.2014.04.004&amp;rft_id=info%3Apmid%2F24747768&amp;rft.aulast=van+Lith&amp;rft.aufirst=SA&amp;rft.au=Navis%2C+AC&amp;rft.au=Verrijp%2C+K&amp;rft.au=Niclou%2C+SP&amp;rft.au=Bjerkvig%2C+R&amp;rft.au=Wesseling%2C+P&amp;rft.au=Tops%2C+B&amp;rft.au=Molenaar%2C+R&amp;rft.au=van+Noorden%2C+CJ&amp;rft.au=Leenders%2C+WP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-33\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">van Lith, SA; Molenaar, R; van Noorden, CJ; Leenders, WP (December 2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4232089\">\"Tumor cells in search for glutamate: an alternative explanation for increased invasiveness of IDH1 mutant gliomas\"</a>. <i>Neuro-oncology</i>. <b>16</b> (12): 1669\u201370. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/neuonc/nou152\">10.1093/neuonc/nou152</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4232089\">4232089</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25074540\">25074540</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuro-oncology&amp;rft.atitle=Tumor+cells+in+search+for+glutamate%3A+an+alternative+explanation+for+increased+invasiveness+of+IDH1+mutant+gliomas.&amp;rft.volume=16&amp;rft.issue=12&amp;rft.pages=1669-70&amp;rft.date=2014-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4232089&amp;rft_id=info%3Apmid%2F25074540&amp;rft_id=info%3Adoi%2F10.1093%2Fneuonc%2Fnou152&amp;rft.aulast=van+Lith&amp;rft.aufirst=SA&amp;rft.au=Molenaar%2C+R&amp;rft.au=van+Noorden%2C+CJ&amp;rft.au=Leenders%2C+WP&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4232089&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-34\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Molenaar, Remco J. (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3263536\">\"Ion Channels in Glioblastoma\"</a>. <i>ISRN Neurology</i>. <b>2011</b>: 1\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.5402/2011/590249\">10.5402/2011/590249</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3263536\">3263536</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22389824\">22389824</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=ISRN+Neurology&amp;rft.atitle=Ion+Channels+in+Glioblastoma&amp;rft.volume=2011&amp;rft.pages=1-7&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3263536&amp;rft_id=info%3Apmid%2F22389824&amp;rft_id=info%3Adoi%2F10.5402%2F2011%2F590249&amp;rft.aulast=Molenaar&amp;rft.aufirst=Remco+J.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3263536&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-35\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Smirniotopoulos, J. G.; Murphy, F. M.; Rushing, E. J.; Rees, J. H.; Schroeder, J. W. (2007). \"From the Archives of the AFIP: Patterns of Contrast Enhancement in the Brain and Meninges\". <i>Radiographics</i>. <b>27</b> (2): 525\u201351. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1148/rg.272065155\">10.1148/rg.272065155</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17374867\">17374867</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Radiographics&amp;rft.atitle=From+the+Archives+of+the+AFIP%3A+Patterns+of+Contrast+Enhancement+in+the+Brain+and+Meninges&amp;rft.volume=27&amp;rft.issue=2&amp;rft.pages=525-51&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1148%2Frg.272065155&amp;rft_id=info%3Apmid%2F17374867&amp;rft.aulast=Smirniotopoulos&amp;rft.aufirst=J.+G.&amp;rft.au=Murphy%2C+F.+M.&amp;rft.au=Rushing%2C+E.+J.&amp;rft.au=Rees%2C+J.+H.&amp;rft.au=Schroeder%2C+J.+W.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bleeker, FE; Molenaar, RJ; Leenstra, S (May 2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3337398\">\"Recent advances in the molecular understanding of glioblastoma\"</a>. <i>Journal of Neuro-Oncology</i>. <b>108</b> (1): 11\u201327. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s11060-011-0793-0\">10.1007/s11060-011-0793-0</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3337398\">3337398</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22270850\">22270850</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neuro-Oncology&amp;rft.atitle=Recent+advances+in+the+molecular+understanding+of+glioblastoma.&amp;rft.volume=108&amp;rft.issue=1&amp;rft.pages=11-27&amp;rft.date=2012-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3337398&amp;rft_id=info%3Apmid%2F22270850&amp;rft_id=info%3Adoi%2F10.1007%2Fs11060-011-0793-0&amp;rft.aulast=Bleeker&amp;rft.aufirst=FE&amp;rft.au=Molenaar%2C+RJ&amp;rft.au=Leenstra%2C+S&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3337398&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-37\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Molenaar, RJ; Radivoyevitch, T; Maciejewski, JP; van Noorden, CJ; Bleeker, FE (Dec 2014). \"The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation\". <i>Biochim Biophys Acta</i>. <b>1846</b> (2): 326\u201341. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbcan.2014.05.004\">10.1016/j.bbcan.2014.05.004</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24880135\">24880135</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochim+Biophys+Acta&amp;rft.atitle=The+driver+and+passenger+effects+of+isocitrate+dehydrogenase+1+and+2+mutations+in+oncogenesis+and+survival+prolongation.&amp;rft.volume=1846&amp;rft.issue=2&amp;rft.pages=326-41&amp;rft.date=2014-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbcan.2014.05.004&amp;rft_id=info%3Apmid%2F24880135&amp;rft.aulast=Molenaar&amp;rft.aufirst=RJ&amp;rft.au=Radivoyevitch%2C+T&amp;rft.au=Maciejewski%2C+JP&amp;rft.au=van+Noorden%2C+CJ&amp;rft.au=Bleeker%2C+FE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid12672279-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12672279_38-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lawson, H. Christopher; Sampath, Prakash; Bohan, Eileen; Park, Michael C.; Hussain, Namath; Olivi, Alessandro; Weingart, Jon; Kleinberg, Lawrence; Brem, Henry (2006). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4086528\">\"Interstitial chemotherapy for malignant gliomas: The Johns Hopkins experience\"</a>. <i>Journal of Neuro-Oncology</i>. <b>83</b> (1): 61\u201370. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s11060-006-9303-1\">10.1007/s11060-006-9303-1</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4086528\">4086528</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17171441\">17171441</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neuro-Oncology&amp;rft.atitle=Interstitial+chemotherapy+for+malignant+gliomas%3A+The+Johns+Hopkins+experience&amp;rft.volume=83&amp;rft.issue=1&amp;rft.pages=61-70&amp;rft.date=2006&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4086528&amp;rft_id=info%3Apmid%2F17171441&amp;rft_id=info%3Adoi%2F10.1007%2Fs11060-006-9303-1&amp;rft.aulast=Lawson&amp;rft.aufirst=H.+Christopher&amp;rft.au=Sampath%2C+Prakash&amp;rft.au=Bohan%2C+Eileen&amp;rft.au=Park%2C+Michael+C.&amp;rft.au=Hussain%2C+Namath&amp;rft.au=Olivi%2C+Alessandro&amp;rft.au=Weingart%2C+Jon&amp;rft.au=Kleinberg%2C+Lawrence&amp;rft.au=Brem%2C+Henry&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4086528&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-39\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Stevens, Glen H. J. (2006). \"Antiepileptic therapy in patients with central nervous system malignancies\". <i>Current Neurology and Neuroscience Reports</i>. <b>6</b> (4): 311\u201318. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s11910-006-0024-9\">10.1007/s11910-006-0024-9</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16822352\">16822352</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Neurology+and+Neuroscience+Reports&amp;rft.atitle=Antiepileptic+therapy+in+patients+with+central+nervous+system+malignancies&amp;rft.volume=6&amp;rft.issue=4&amp;rft.pages=311-18&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1007%2Fs11910-006-0024-9&amp;rft_id=info%3Apmid%2F16822352&amp;rft.aulast=Stevens&amp;rft.aufirst=Glen+H.+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-40\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lacroix, Michel; Abi-Said, Dima; Fourney, Daryl R.; Gokaslan, Ziya L.; Shi, Weiming; Demonte, Franco; Lang, Frederick F.; McCutcheon, Ian E.;  et al. (2001). \"A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival\". <i>Journal of Neurosurgery</i>. <b>95</b> (2): 190\u201398. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3171/jns.2001.95.2.0190\">10.3171/jns.2001.95.2.0190</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11780887\">11780887</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurosurgery&amp;rft.atitle=A+multivariate+analysis+of+416+patients+with+glioblastoma+multiforme%3A+Prognosis%2C+extent+of+resection%2C+and+survival&amp;rft.volume=95&amp;rft.issue=2&amp;rft.pages=190-98&amp;rft.date=2001&amp;rft_id=info%3Adoi%2F10.3171%2Fjns.2001.95.2.0190&amp;rft_id=info%3Apmid%2F11780887&amp;rft.aulast=Lacroix&amp;rft.aufirst=Michel&amp;rft.au=Abi-Said%2C+Dima&amp;rft.au=Fourney%2C+Daryl+R.&amp;rft.au=Gokaslan%2C+Ziya+L.&amp;rft.au=Shi%2C+Weiming&amp;rft.au=Demonte%2C+Franco&amp;rft.au=Lang%2C+Frederick+F.&amp;rft.au=McCutcheon%2C+Ian+E.&amp;rft.au=Hassenbusch%2C+Samuel+J.&amp;rft.au=Holland%2C+Eric&amp;rft.au=Hess%2C+Kenneth&amp;rft.au=Michael%2C+Christopher&amp;rft.au=Miller%2C+Daniel&amp;rft.au=Sawaya%2C+Raymond&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-41\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Stummer, Walter; Pichlmeier, Uwe; Meinel, Thomas; Wiestler, Otmar Dieter; Zanella, Friedhelm; Reulen, Hans-J\u00fcrgen; Ala-Glioma Study, Group (2006). \"Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial\". <i>The Lancet Oncology</i>. <b>7</b> (5): 392\u2013401. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S1470-2045%2806%2970665-9\">10.1016/S1470-2045(06)70665-9</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16648043\">16648043</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet+Oncology&amp;rft.atitle=Fluorescence-guided+surgery+with+5-aminolevulinic+acid+for+resection+of+malignant+glioma%3A+A+randomised+controlled+multicentre+phase+III+trial&amp;rft.volume=7&amp;rft.issue=5&amp;rft.pages=392-401&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1016%2FS1470-2045%2806%2970665-9&amp;rft_id=info%3Apmid%2F16648043&amp;rft.aulast=Stummer&amp;rft.aufirst=Walter&amp;rft.au=Pichlmeier%2C+Uwe&amp;rft.au=Meinel%2C+Thomas&amp;rft.au=Wiestler%2C+Otmar+Dieter&amp;rft.au=Zanella%2C+Friedhelm&amp;rft.au=Reulen%2C+Hans-J%C3%BCrgen&amp;rft.au=Ala-Glioma+Study%2C+Group&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-42\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Walker, Michael D.; Alexander, Eben; Hunt, William E.; MacCarty, Collin S.; Mahaley, M. Stephen; Mealey, John; Norrell, Horace A.; Owens, Guy;  et al. (1978). \"Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas\". <i>Journal of Neurosurgery</i>. <b>49</b> (3): 333\u201343. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3171/jns.1978.49.3.0333\">10.3171/jns.1978.49.3.0333</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/355604\">355604</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurosurgery&amp;rft.atitle=Evaluation+of+BCNU+and%2For+radiotherapy+in+the+treatment+of+anaplastic+gliomas&amp;rft.volume=49&amp;rft.issue=3&amp;rft.pages=333-43&amp;rft.date=1978&amp;rft_id=info%3Adoi%2F10.3171%2Fjns.1978.49.3.0333&amp;rft_id=info%3Apmid%2F355604&amp;rft.aulast=Walker&amp;rft.aufirst=Michael+D.&amp;rft.au=Alexander%2C+Eben&amp;rft.au=Hunt%2C+William+E.&amp;rft.au=MacCarty%2C+Collin+S.&amp;rft.au=Mahaley%2C+M.+Stephen&amp;rft.au=Mealey%2C+John&amp;rft.au=Norrell%2C+Horace+A.&amp;rft.au=Owens%2C+Guy&amp;rft.au=Ransohoff%2C+Joseph&amp;rft.au=Wilson%2C+Charles+B.&amp;rft.au=Gehan%2C+Edmund+A.&amp;rft.au=Strike%2C+Thomas+A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-43\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-43\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Showalter, Timothy N.; Andrel, Jocelyn; Andrews, David W.; Curran, Walter J.; Daskalakis, Constantine; Werner-Wasik, Maria (2007). \"Multifocal Glioblastoma Multiforme: Prognostic Factors and Patterns of Progression\". <i>International Journal of Radiation Oncology \u2022 Biology \u2022 Physics</i>. <b>69</b> (3): 820\u201324. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ijrobp.2007.03.045\">10.1016/j.ijrobp.2007.03.045</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17499453\">17499453</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Radiation+Oncology+%E2%80%A2+Biology+%E2%80%A2+Physics&amp;rft.atitle=Multifocal+Glioblastoma+Multiforme%3A+Prognostic+Factors+and+Patterns+of+Progression&amp;rft.volume=69&amp;rft.issue=3&amp;rft.pages=820-24&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ijrobp.2007.03.045&amp;rft_id=info%3Apmid%2F17499453&amp;rft.aulast=Showalter&amp;rft.aufirst=Timothy+N.&amp;rft.au=Andrel%2C+Jocelyn&amp;rft.au=Andrews%2C+David+W.&amp;rft.au=Curran%2C+Walter+J.&amp;rft.au=Daskalakis%2C+Constantine&amp;rft.au=Werner-Wasik%2C+Maria&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-44\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fulton, DS; Urtasun, RC; Scott-Brown, I; Johnson, ES; Mielke, B; Curry, B; Huyser-Wierenga, D; Hanson, J; Feldstein, M (1992). \"Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study\". <i>Journal of Neuro-Oncology</i>. <b>14</b> (1): 63\u201372. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/BF00170946\">10.1007/BF00170946</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/1335044\">1335044</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neuro-Oncology&amp;rft.atitle=Increasing+radiation+dose+intensity+using+hyperfractionation+in+patients+with+malignant+glioma.+Final+report+of+a+prospective+phase+I-II+dose+response+study&amp;rft.volume=14&amp;rft.issue=1&amp;rft.pages=63-72&amp;rft.date=1992&amp;rft_id=info%3Adoi%2F10.1007%2FBF00170946&amp;rft_id=info%3Apmid%2F1335044&amp;rft.aulast=Fulton&amp;rft.aufirst=DS&amp;rft.au=Urtasun%2C+RC&amp;rft.au=Scott-Brown%2C+I&amp;rft.au=Johnson%2C+ES&amp;rft.au=Mielke%2C+B&amp;rft.au=Curry%2C+B&amp;rft.au=Huyser-Wierenga%2C+D&amp;rft.au=Hanson%2C+J&amp;rft.au=Feldstein%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-45\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-45\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sheehan, Jason P; Shaffrey, Mark E; Gupta, Brinda; Larner, James; Rich, Jeremy N; Park, Deric M (2010). \"Improving the radiosensitivity of radioresistant and hypoxic glioblastoma\". <i>Future Oncology</i>. <b>6</b> (10): 1591\u2013601. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2217/fon.10.123\">10.2217/fon.10.123</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21062158\">21062158</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Future+Oncology&amp;rft.atitle=Improving+the+radiosensitivity+of+radioresistant+and+hypoxic+glioblastoma&amp;rft.volume=6&amp;rft.issue=10&amp;rft.pages=1591-601&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.2217%2Ffon.10.123&amp;rft_id=info%3Apmid%2F21062158&amp;rft.aulast=Sheehan&amp;rft.aufirst=Jason+P&amp;rft.au=Shaffrey%2C+Mark+E&amp;rft.au=Gupta%2C+Brinda&amp;rft.au=Larner%2C+James&amp;rft.au=Rich%2C+Jeremy+N&amp;rft.au=Park%2C+Deric+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-46\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-46\">^</a></b></span> <span class=\"reference-text\">\nClinical trial number <i><a rel=\"nofollow\" class=\"external text\" href=\"https://www.clinicaltrials.gov/show/NCT01465347\">NCT01465347</a></i> for \"Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) With Concomitant Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM)\" at <a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a>, accessed 2016-02-01</span>\n</li>\n<li id=\"cite_note-47\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-47\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Stupp, Roger; Mason, Warren P.; Van Den Bent, Martin J.; Weller, Michael; Fisher, Barbara; Taphoorn, Martin J.B.; Belanger, Karl; Brandes, Alba A.;  et al. (2005). \"Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma\". <i>New England Journal of Medicine</i>. <b>352</b> (10): 987\u201396. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMoa043330\">10.1056/NEJMoa043330</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15758009\">15758009</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=Radiotherapy+plus+Concomitant+and+Adjuvant+Temozolomide+for+Glioblastoma&amp;rft.volume=352&amp;rft.issue=10&amp;rft.pages=987-96&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa043330&amp;rft_id=info%3Apmid%2F15758009&amp;rft.aulast=Stupp&amp;rft.aufirst=Roger&amp;rft.au=Mason%2C+Warren+P.&amp;rft.au=Van+Den+Bent%2C+Martin+J.&amp;rft.au=Weller%2C+Michael&amp;rft.au=Fisher%2C+Barbara&amp;rft.au=Taphoorn%2C+Martin+J.B.&amp;rft.au=Belanger%2C+Karl&amp;rft.au=Brandes%2C+Alba+A.&amp;rft.au=Marosi%2C+Christine&amp;rft.au=Bogdahn%2C+Ulrich&amp;rft.au=Curschmann%2C+J%C3%BCrgen&amp;rft.au=Janzer%2C+Robert+C.&amp;rft.au=Ludwin%2C+Samuel+K.&amp;rft.au=Gorlia%2C+Thierry&amp;rft.au=Allgeier%2C+Anouk&amp;rft.au=Lacombe%2C+Denis&amp;rft.au=Cairncross%2C+J.+Gregory&amp;rft.au=Eisenhauer%2C+Elizabeth&amp;rft.au=Mirimanoff%2C+Ren%C3%A9+O.&amp;rft.au=European+Organisation+for+Research+Treatment+of+Cancer+Brain+Tumor+Radiotherapy+Groups&amp;rft.au=National+Cancer+Institute+of+Canada+Clinical+Trials+Group&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-48\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mason, Warren P.; Mirimanoff, Ren\u00e9 O.; Stupp, Roger (2006). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=mDhxMg5UXvIC&amp;pg=PA37\">\"Radiotherapy with Concurrent and Adjuvant Temozolomide: A New Standard of Care for Glioblastoma Multiforme\"</a>. <i>Progress in Neurotherapeutics and Neuropsychopharmacology</i>. <b>1</b> (1): 37\u201352. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1017/S1748232105000054\">10.1017/S1748232105000054</a>. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-521-86253-0\" title=\"Special:BookSources/978-0-521-86253-0\">978-0-521-86253-0</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150317021325/http://books.google.com/books?id=mDhxMg5UXvIC&amp;pg=PA37\">Archived</a> from the original on 2015-03-17.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Progress+in+Neurotherapeutics+and+Neuropsychopharmacology&amp;rft.atitle=Radiotherapy+with+Concurrent+and+Adjuvant+Temozolomide%3A+A+New+Standard+of+Care+for+Glioblastoma+Multiforme&amp;rft.volume=1&amp;rft.issue=1&amp;rft.pages=37-52&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1017%2FS1748232105000054&amp;rft.isbn=978-0-521-86253-0&amp;rft.aulast=Mason&amp;rft.aufirst=Warren+P.&amp;rft.au=Mirimanoff%2C+Ren%C3%A9+O.&amp;rft.au=Stupp%2C+Roger&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DmDhxMg5UXvIC%26pg%3DPA37&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-49\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-49\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20070815232444/http://www.cancer.gov/clinicaltrials/results/glioblastoma0604\">\"Temozolomide Plus Radiation Helps Brain Cancer \u2013 National Cancer Institute\"</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.cancer.gov/clinicaltrials/results/glioblastoma0604\">the original</a> on August 15, 2007<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-09-15</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Temozolomide+Plus+Radiation+Helps+Brain+Cancer+%E2%80%93+National+Cancer+Institute&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fclinicaltrials%2Fresults%2Fglioblastoma0604&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-50\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-50\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chamberlain, Marc C.; Glantz, Michael J.; Chalmers, Lisa; Horn, Alixis; Sloan, Andrew E. (2006). \"Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma\". <i>Journal of Neuro-Oncology</i>. <b>82</b> (1): 81\u201383. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s11060-006-9241-y\">10.1007/s11060-006-9241-y</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16944309\">16944309</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neuro-Oncology&amp;rft.atitle=Early+necrosis+following+concurrent+Temodar+and+radiotherapy+in+patients+with+glioblastoma&amp;rft.volume=82&amp;rft.issue=1&amp;rft.pages=81-83&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1007%2Fs11060-006-9241-y&amp;rft_id=info%3Apmid%2F16944309&amp;rft.aulast=Chamberlain&amp;rft.aufirst=Marc+C.&amp;rft.au=Glantz%2C+Michael+J.&amp;rft.au=Chalmers%2C+Lisa&amp;rft.au=Horn%2C+Alixis&amp;rft.au=Sloan%2C+Andrew+E.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-51\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Dall\u2019Oglio, Stefano; d\u2019Amico, Anna; Pioli, Fabio; Gabbani, Milena; Pasini, Felice; Passarin, Maria Grazia; Talacchi, Andrea; Turazzi, Sergio; Maluta, Sergio (2008). \"Dose-intensity temozolomide after concurrent chemoradiotherapy in operated high-grade gliomas\". <i>Journal of Neuro-Oncology</i>. <b>90</b> (3): 315\u201319. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s11060-008-9663-9\">10.1007/s11060-008-9663-9</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18688571\">18688571</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neuro-Oncology&amp;rft.atitle=Dose-intensity+temozolomide+after+concurrent+chemoradiotherapy+in+operated+high-grade+gliomas&amp;rft.volume=90&amp;rft.issue=3&amp;rft.pages=315-19&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1007%2Fs11060-008-9663-9&amp;rft_id=info%3Apmid%2F18688571&amp;rft.aulast=Dall%E2%80%99Oglio&amp;rft.aufirst=Stefano&amp;rft.au=d%E2%80%99Amico%2C+Anna&amp;rft.au=Pioli%2C+Fabio&amp;rft.au=Gabbani%2C+Milena&amp;rft.au=Pasini%2C+Felice&amp;rft.au=Passarin%2C+Maria+Grazia&amp;rft.au=Talacchi%2C+Andrea&amp;rft.au=Turazzi%2C+Sergio&amp;rft.au=Maluta%2C+Sergio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-52\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-52\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Khasraw, M; Ameratunga, MS; Grant, R; Wheeler, H; Pavlakis, N (Sep 22, 2014). \"Antiangiogenic therapy for high-grade glioma\". <i>The Cochrane Database of Systematic Reviews</i>. <b>9</b>: CD008218. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD008218.pub3\">10.1002/14651858.CD008218.pub3</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25242542\">25242542</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Antiangiogenic+therapy+for+high-grade+glioma.&amp;rft.volume=9&amp;rft.pages=CD008218&amp;rft.date=2014-09-22&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008218.pub3&amp;rft_id=info%3Apmid%2F25242542&amp;rft.aulast=Khasraw&amp;rft.aufirst=M&amp;rft.au=Ameratunga%2C+MS&amp;rft.au=Grant%2C+R&amp;rft.au=Wheeler%2C+H&amp;rft.au=Pavlakis%2C+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-53\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-53\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm465744.htm\">\"FDA approves expanded indication for medical device to treat a form of brain cancer\"</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20160323083354/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm465744.htm\">Archived</a> from the original on 23 March 2016<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">19 March</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+approves+expanded+indication+for+medical+device+to+treat+a+form+of+brain+cancer&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm465744.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-NovoTTF_FDA_approval-54\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-NovoTTF_FDA_approval_54-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.accessdata.fda.gov/cdrh_docs/pdf10/p100034a.pdf\">\"FDA approval letter&#160;\u2013 NovoTTF-100A System\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>www.fda.gov</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150922095543/http://www.accessdata.fda.gov/cdrh_docs/pdf10/p100034a.pdf\">Archived</a> <span style=\"font-size:85%;\">(PDF)</span> from the original on 22 September 2015<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">26 December</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.fda.gov&amp;rft.atitle=FDA+approval+letter+%E2%80%93+NovoTTF-100A+System&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fcdrh_docs%2Fpdf10%2Fp100034a.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Stupp2015-55\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Stupp2015_55-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Stupp, R;  et al. (15 December 2015). \"Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma\". <i>JAMA</i>. <b>314</b> (23): 2535\u201343. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.2015.16669\">10.1001/jama.2015.16669</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26670971\">26670971</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Maintenance+Therapy+With+Tumor-Treating+Fields+Plus+Temozolomide+vs+Temozolomide+Alone+for+Glioblastoma&amp;rft.volume=314&amp;rft.issue=23&amp;rft.pages=2535-43&amp;rft.date=2015-12-15&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2015.16669&amp;rft_id=info%3Apmid%2F26670971&amp;rft.aulast=Stupp&amp;rft.aufirst=R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Sampson2015-56\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Sampson2015_56-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Sampson2015_56-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sampson, John H. (15 December 2015). \"Alternating Electric Fields for the Treatment of Glioblastoma\". <i>JAMA</i>. <b>314</b> (23): 2511. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.2015.16701\">10.1001/jama.2015.16701</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Alternating+Electric+Fields+for+the+Treatment+of+Glioblastoma&amp;rft.volume=314&amp;rft.issue=23&amp;rft.pages=2511&amp;rft.date=2015-12-15&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2015.16701&amp;rft.aulast=Sampson&amp;rft.aufirst=John+H.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-57\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-57\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wick, Wolfgang (25 February 2016). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4767251\">\"TTFields: where does all the skepticism come from?\"</a>. <i>Neuro-Oncology</i>. <b>18</b> (3): 303\u201305. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/neuonc/now012\">10.1093/neuonc/now012</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4767251\">4767251</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuro-Oncology&amp;rft.atitle=TTFields%3A+where+does+all+the+skepticism+come+from%3F&amp;rft.volume=18&amp;rft.issue=3&amp;rft.pages=303-05&amp;rft.date=2016-02-25&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4767251&amp;rft_id=info%3Adoi%2F10.1093%2Fneuonc%2Fnow012&amp;rft.aulast=Wick&amp;rft.aufirst=Wolfgang&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4767251&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-doi101093brainawm204-58\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-doi101093brainawm204_58-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-doi101093brainawm204_58-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-doi101093brainawm204_58-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Krex, D.; Klink, B.; Hartmann, C.; Von Deimling, A.; Pietsch, T.; Simon, M.; Sabel, M.; Steinbach, J. P.;  et al. (2007). \"Long-term survival with glioblastoma multiforme\". <i>Brain</i>. <b>130</b> (10): 2596\u2013606. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/brain/awm204\">10.1093/brain/awm204</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17785346\">17785346</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain&amp;rft.atitle=Long-term+survival+with+glioblastoma+multiforme&amp;rft.volume=130&amp;rft.issue=10&amp;rft.pages=2596-606&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1093%2Fbrain%2Fawm204&amp;rft_id=info%3Apmid%2F17785346&amp;rft.aulast=Krex&amp;rft.aufirst=D.&amp;rft.au=Klink%2C+B.&amp;rft.au=Hartmann%2C+C.&amp;rft.au=Von+Deimling%2C+A.&amp;rft.au=Pietsch%2C+T.&amp;rft.au=Simon%2C+M.&amp;rft.au=Sabel%2C+M.&amp;rft.au=Steinbach%2C+J.+P.&amp;rft.au=Heese%2C+O.&amp;rft.au=Reifenberger%2C+G.&amp;rft.au=Weller%2C+M.&amp;rft.au=Schackert%2C+G.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-59\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-59\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Martinez, Ramon; Schackert, Gabriele; Yaya-Tur, Ricard; Rojas-Marcos, I\u00f1igo; Herman, James G.; Esteller, Manel (2006). \"Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme\". <i>Journal of Neuro-Oncology</i>. <b>83</b> (1): 91\u20133. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s11060-006-9292-0\">10.1007/s11060-006-9292-0</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17164975\">17164975</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neuro-Oncology&amp;rft.atitle=Frequent+hypermethylation+of+the+DNA+repair+gene+MGMT+in+long-term+survivors+of+glioblastoma+multiforme&amp;rft.volume=83&amp;rft.issue=1&amp;rft.pages=91-3&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1007%2Fs11060-006-9292-0&amp;rft_id=info%3Apmid%2F17164975&amp;rft.aulast=Martinez&amp;rft.aufirst=Ramon&amp;rft.au=Schackert%2C+Gabriele&amp;rft.au=Yaya-Tur%2C+Ricard&amp;rft.au=Rojas-Marcos%2C+I%C3%B1igo&amp;rft.au=Herman%2C+James+G.&amp;rft.au=Esteller%2C+Manel&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-P2-60\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-P2_60-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\"><a href=\"/wiki/Matthias_Preusser\" title=\"Matthias Preusser\">M. Preusser</a>, A. W\u00f6hrer, S. Stary, R. H\u00f6ftberger, B. Streubel, J. A. Hainfellner (Aug 2011). \"Value and limitations of immunohistochemistry and gene sequencing for detection of the IDH1-R132H mutation in diffuse glioma biopsy specimens\". <i>J Neuropathol Exp Neurol</i>. <b>70</b> (8): 715\u2013723. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/NEN.0b013e31822713f0\">10.1097/NEN.0b013e31822713f0</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Neuropathol+Exp+Neurol&amp;rft.atitle=Value+and+limitations+of+immunohistochemistry+and+gene+sequencing+for+detection+of+the+IDH1-R132H+mutation+in+diffuse+glioma+biopsy+specimens.&amp;rft.volume=70&amp;rft.issue=8&amp;rft.pages=715-723&amp;rft.date=2011-08&amp;rft_id=info%3Adoi%2F10.1097%2FNEN.0b013e31822713f0&amp;rft.au=M.+Preusser%2C+A.+W%C3%B6hrer%2C+S.+Stary%2C+R.+H%C3%B6ftberger%2C+B.+Streubel%2C+J.+A.+Hainfellner&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Multiple names: authors list (<a href=\"/wiki/Category:CS1_maint:_Multiple_names:_authors_list\" title=\"Category:CS1 maint: Multiple names: authors list\">link</a>) </span></span>\n</li>\n<li id=\"cite_note-61\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-61\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Molenaar, Remco J. (2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4136888\">\"The combination of <i>IDH1</i> mutations and <i>MGMT</i> methylation status predicts survival in glioblastoma better than either <i>IDH1</i> or <i>MGMT</i> alone\"</a>. <i>Neuro-Oncology</i>. <b>16</b> (9): 1263\u20131273. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/neuonc/nou005\">10.1093/neuonc/nou005</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4136888\">4136888</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24510240\">24510240</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuro-Oncology&amp;rft.atitle=The+combination+of+IDH1+mutations+and+MGMT+methylation+status+predicts+survival+in+glioblastoma+better+than+either+IDH1+or+MGMT+alone&amp;rft.volume=16&amp;rft.issue=9&amp;rft.pages=1263-1273&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4136888&amp;rft_id=info%3Apmid%2F24510240&amp;rft_id=info%3Adoi%2F10.1093%2Fneuonc%2Fnou005&amp;rft.aulast=Molenaar&amp;rft.aufirst=Remco+J.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4136888&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-62\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-62\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Smoll, Nicolas R.; Schaller, Karl; Gautschi, Oliver P. (2012). \"The Cure Fraction of Glioblastoma Multiforme\". <i>Neuroepidemiology</i>. <b>39</b> (1): 63\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1159/000339319\">10.1159/000339319</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22776797\">22776797</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuroepidemiology&amp;rft.atitle=The+Cure+Fraction+of+Glioblastoma+Multiforme&amp;rft.volume=39&amp;rft.issue=1&amp;rft.pages=63-9&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.1159%2F000339319&amp;rft_id=info%3Apmid%2F22776797&amp;rft.aulast=Smoll&amp;rft.aufirst=Nicolas+R.&amp;rft.au=Schaller%2C+Karl&amp;rft.au=Gautschi%2C+Oliver+P.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-63\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-63\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.neurooncology.ucla.edu/Performance/GlioblastomaMultiforme.aspx\">University of California, Los Angeles Neuro-Oncology&#160;: How Our Patients Perform&#160;: Glioblastoma Multiforme [GBM&#93;</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20120609070823/http://www.neurooncology.ucla.edu/Performance/GlioblastomaMultiforme.aspx\">Archived</a> 2012-06-09 at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>.. Neurooncology.ucla.edu. Retrieved on 2010-10-19.</span>\n</li>\n<li id=\"cite_note-64\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-64\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Shaw, E.G; Seiferheld, W; Scott, C; Coughlin, C; Leibel, S; Curran, W; Mehta, M (2003). \"Reexamining the radiation therapy oncology group (RTOG) recursive partitioning analysis (RPA) for glioblastoma multiforme (GBM) patients\". <i>International Journal of Radiation Oncology*Biology*Physics</i>. <b>57</b> (2): S135\u20136. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0360-3016%2803%2900843-5\">10.1016/S0360-3016(03)00843-5</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Radiation+Oncology%2ABiology%2APhysics&amp;rft.atitle=Reexamining+the+radiation+therapy+oncology+group+%28RTOG%29+recursive+partitioning+analysis+%28RPA%29+for+glioblastoma+multiforme+%28GBM%29+patients&amp;rft.volume=57&amp;rft.issue=2&amp;rft.pages=S135-6&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1016%2FS0360-3016%2803%2900843-5&amp;rft.aulast=Shaw&amp;rft.aufirst=E.G&amp;rft.au=Seiferheld%2C+W&amp;rft.au=Scott%2C+C&amp;rft.au=Coughlin%2C+C&amp;rft.au=Leibel%2C+S&amp;rft.au=Curran%2C+W&amp;rft.au=Mehta%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-65\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-65\">^</a></b></span> <span class=\"reference-text\">Bailey &amp; Cushing: <i>Tumors of the Glioma Group</i>. JB Lippincott, Philadelphia, 1926.<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\"><span title=\"This citation requires a reference to the specific page or range of pages in which the material appears. (August 2013)\">page&#160;needed</span></a></i>&#93;</sup></span>\n</li>\n<li id=\"cite_note-66\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-66\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">M\u00f8ller, Heidi G.; Rasmussen, Andreas P.; Andersen, Hjalte H.; Johnsen, Kasper B.; Henriksen, Michael; Duroux, Meg (2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3538124\">\"A Systematic Review of MicroRNA in Glioblastoma Multiforme: Micro-modulators in the Mesenchymal Mode of Migration and Invasion\"</a>. <i>Molecular Neurobiology</i>. <b>47</b> (1): 131\u201344. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s12035-012-8349-7\">10.1007/s12035-012-8349-7</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3538124\">3538124</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23054677\">23054677</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Molecular+Neurobiology&amp;rft.atitle=A+Systematic+Review+of+MicroRNA+in+Glioblastoma+Multiforme%3A+Micro-modulators+in+the+Mesenchymal+Mode+of+Migration+and+Invasion&amp;rft.volume=47&amp;rft.issue=1&amp;rft.pages=131-44&amp;rft.date=2012&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3538124&amp;rft_id=info%3Apmid%2F23054677&amp;rft_id=info%3Adoi%2F10.1007%2Fs12035-012-8349-7&amp;rft.aulast=M%C3%B8ller&amp;rft.aufirst=Heidi+G.&amp;rft.au=Rasmussen%2C+Andreas+P.&amp;rft.au=Andersen%2C+Hjalte+H.&amp;rft.au=Johnsen%2C+Kasper+B.&amp;rft.au=Henriksen%2C+Michael&amp;rft.au=Duroux%2C+Meg&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3538124&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-67\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-67\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rajesh, Y; Pal, I; Banik, P; Chakraborty, S; Borkar, SA; Dey, G; Mukherjee, A; Mandal, M (May 2017). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5457688\">\"Insights into molecular therapy of glioma: current challenges and next generation blueprint\"</a>. <i>Acta pharmacologica Sinica</i>. <b>38</b> (5): 591\u2013613. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/aps.2016.167\">10.1038/aps.2016.167</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5457688\">5457688</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28317871\">28317871</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+pharmacologica+Sinica&amp;rft.atitle=Insights+into+molecular+therapy+of+glioma%3A+current+challenges+and+next+generation+blueprint.&amp;rft.volume=38&amp;rft.issue=5&amp;rft.pages=591-613&amp;rft.date=2017-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5457688&amp;rft_id=info%3Apmid%2F28317871&amp;rft_id=info%3Adoi%2F10.1038%2Faps.2016.167&amp;rft.aulast=Rajesh&amp;rft.aufirst=Y&amp;rft.au=Pal%2C+I&amp;rft.au=Banik%2C+P&amp;rft.au=Chakraborty%2C+S&amp;rft.au=Borkar%2C+SA&amp;rft.au=Dey%2C+G&amp;rft.au=Mukherjee%2C+A&amp;rft.au=Mandal%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5457688&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-68\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-68\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Tobias, A; Ahmed, A; Moon, KS; Lesniak, MS (February 2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3543505\">\"The art of gene therapy for glioma: a review of the challenging road to the bedside\"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>84</b> (2): 213\u201322. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1136/jnnp-2012-302946\">10.1136/jnnp-2012-302946</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3543505\">3543505</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22993449\">22993449</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=The+art+of+gene+therapy+for+glioma%3A+a+review+of+the+challenging+road+to+the+bedside.&amp;rft.volume=84&amp;rft.issue=2&amp;rft.pages=213-22&amp;rft.date=2013-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3543505&amp;rft_id=info%3Apmid%2F22993449&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp-2012-302946&amp;rft.aulast=Tobias&amp;rft.aufirst=A&amp;rft.au=Ahmed%2C+A&amp;rft.au=Moon%2C+KS&amp;rft.au=Lesniak%2C+MS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3543505&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-69\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-69\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fulci, Giulia; Chiocca, E Antonio (2007). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2819130\">\"The status of gene therapy for brain tumors\"</a>. <i>Expert Opinion on Biological Therapy</i>. <b>7</b> (2): 197\u2013208. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1517/14712598.7.2.197\">10.1517/14712598.7.2.197</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2819130\">2819130</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17250458\">17250458</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Opinion+on+Biological+Therapy&amp;rft.atitle=The+status+of+gene+therapy+for+brain+tumors&amp;rft.volume=7&amp;rft.issue=2&amp;rft.pages=197-208&amp;rft.date=2007&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2819130&amp;rft_id=info%3Apmid%2F17250458&amp;rft_id=info%3Adoi%2F10.1517%2F14712598.7.2.197&amp;rft.aulast=Fulci&amp;rft.aufirst=Giulia&amp;rft.au=Chiocca%2C+E+Antonio&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2819130&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-70\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-70\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zhu, Z,  et al. (2017). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5626408\">\"Zika virus has oncolytic activity against glioblastoma stem cells\"</a>. <i>J.Exp. Medicine</i>. 214(10) (1): 2843\u20132857. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1084/jem.2017109\">10.1084/jem.2017109</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5626408\">5626408</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28874392\">28874392</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.Exp.+Medicine&amp;rft.atitle=Zika+virus+has+oncolytic+activity+against+glioblastoma+stem+cells&amp;rft.volume=214%2810%29&amp;rft.issue=1&amp;rft.pages=2843-2857&amp;rft.date=2017&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5626408&amp;rft_id=info%3Apmid%2F28874392&amp;rft_id=info%3Adoi%2F10.1084%2Fjem.2017109&amp;rft.au=Zhu&amp;rft.au=Z&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5626408&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-71\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-71\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gewin, Virginia (2017). \"Turning point: Tumour tactician\". <i>Nature</i>. <b>546</b>: 693. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nj7660-693a\">10.1038/nj7660-693a</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Turning+point%3A+Tumour+tactician&amp;rft.volume=546&amp;rft.pages=693&amp;rft.date=2017&amp;rft_id=info%3Adoi%2F10.1038%2Fnj7660-693a&amp;rft.au=Gewin&amp;rft.au=Virginia&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ReferenceA-72\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ReferenceA_72-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_72-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Matthias van Woensel; Nathalie Wauthoz; R\u00e9mi Rosi\u00e8re; Karim Amighi; V\u00e9ronique Mathieu; Florence Lefranc; Stefaan W. van Gool; Steven de Vleeschouwer (2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3795377\">\"Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?\"</a>. <i>Cancers (Basel)</i>. <b>5</b> (3): 1020\u201348. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3390/cancers5031020\">10.3390/cancers5031020</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3795377\">3795377</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24202332\">24202332</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancers+%28Basel%29&amp;rft.atitle=Formulations+for+Intranasal+Delivery+of+Pharmacological+Agents+to+Combat+Brain+Disease%3A+A+New+Opportunity+to+Tackle+GBM%3F&amp;rft.volume=5&amp;rft.issue=3&amp;rft.pages=1020-48&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3795377&amp;rft_id=info%3Apmid%2F24202332&amp;rft_id=info%3Adoi%2F10.3390%2Fcancers5031020&amp;rft.au=Matthias+van+Woensel&amp;rft.au=Nathalie+Wauthoz&amp;rft.au=R%C3%A9mi+Rosi%C3%A8re&amp;rft.au=Karim+Amighi&amp;rft.au=V%C3%A9ronique+Mathieu&amp;rft.au=Florence+Lefranc&amp;rft.au=Stefaan+W.+van+Gool&amp;rft.au=Steven+de+Vleeschouwer&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3795377&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-73\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-73\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pardeshi CV, Belgamwar VS (2013). \"Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting\". <i>Expert Opinion in Drug Delivery</i>. <b>10</b> (7): 957\u201372. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1517/17425247.2013.790887\">10.1517/17425247.2013.790887</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23586809\">23586809</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Opinion+in+Drug+Delivery&amp;rft.atitle=Direct+nose+to+brain+drug+delivery+via+integrated+nerve+pathways+bypassing+the+blood-brain+barrier%3A+an+excellent+platform+for+brain+targeting&amp;rft.volume=10&amp;rft.issue=7&amp;rft.pages=957-72&amp;rft.date=2013&amp;rft_id=info%3Adoi%2F10.1517%2F17425247.2013.790887&amp;rft_id=info%3Apmid%2F23586809&amp;rft.aulast=Pardeshi&amp;rft.aufirst=CV&amp;rft.au=Belgamwar%2C+VS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-74\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-74\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Peterson A, Bansal A, Hofman F, Chen TC, Zada G (2014). \"A systematic review of inhaled intranasal therapy for central nervous system neoplasms: an emerging therapeutic option\". <i>Journal of Neurooncology</i>. <b>116</b> (3): 437\u201346. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s11060-013-1346-5\">10.1007/s11060-013-1346-5</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24398618\">24398618</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurooncology&amp;rft.atitle=A+systematic+review+of+inhaled+intranasal+therapy+for+central+nervous+system+neoplasms%3A+an+emerging+therapeutic+option&amp;rft.volume=116&amp;rft.issue=3&amp;rft.pages=437-46&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.1007%2Fs11060-013-1346-5&amp;rft_id=info%3Apmid%2F24398618&amp;rft.aulast=Peterson&amp;rft.aufirst=A&amp;rft.au=Bansal%2C+A&amp;rft.au=Hofman%2C+F&amp;rft.au=Chen%2C+TC&amp;rft.au=Zada%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-75\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-75\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chen TC, Da Fonseca CO, Sch\u00f6nthal AH (2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4497427\">\"Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy\"</a>. <i>American Journal of Cancer Research</i>. <b>5</b> (5): 1580\u201393. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4497427\">4497427</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26175929\">26175929</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Cancer+Research&amp;rft.atitle=Preclinical+development+and+clinical+use+of+perillyl+alcohol+for+chemoprevention+and+cancer+therapy&amp;rft.volume=5&amp;rft.issue=5&amp;rft.pages=1580-93&amp;rft.date=2015&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4497427&amp;rft_id=info%3Apmid%2F26175929&amp;rft.aulast=Chen&amp;rft.aufirst=TC&amp;rft.au=Da+Fonseca%2C+CO&amp;rft.au=Sch%C3%B6nthal%2C+AH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4497427&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-76\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-76\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT02704858\">\"Archived copy\"</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170120055208/https://clinicaltrials.gov/ct2/show/NCT02704858\">Archived</a> from the original on 2017-01-20<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2016-05-05</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02704858&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-77\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-77\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wheeler, Lamar; Huncharek, Michael; Kupelnick, Bruce (2003). \"Dietary Cured Meat and the Risk of Adult Glioma: A Meta-Analysis of Nine Observational Studies\". <i>Journal of Environmental Pathology, Toxicology and Oncology</i>. <b>22</b> (2): 129\u201337. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1615/JEnvPathToxOncol.v22.i2.60\">10.1615/JEnvPathToxOncol.v22.i2.60</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14533876\">14533876</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Environmental+Pathology%2C+Toxicology+and+Oncology&amp;rft.atitle=Dietary+Cured+Meat+and+the+Risk+of+Adult+Glioma%3A+A+Meta-Analysis+of+Nine+Observational+Studies&amp;rft.volume=22&amp;rft.issue=2&amp;rft.pages=129-37&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1615%2FJEnvPathToxOncol.v22.i2.60&amp;rft_id=info%3Apmid%2F14533876&amp;rft.aulast=Wheeler&amp;rft.aufirst=Lamar&amp;rft.au=Huncharek%2C+Michael&amp;rft.au=Kupelnick%2C+Bruce&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-78\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-78\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kan, Peter; Simonsen, Sara E.; Lyon, Joseph L.; Kestle, John R. W. (2007). \"Cellular phone use and brain tumor: A meta-analysis\". <i>Journal of Neuro-Oncology</i>. <b>86</b> (1): 71\u201378. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s11060-007-9432-1\">10.1007/s11060-007-9432-1</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17619826\">17619826</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neuro-Oncology&amp;rft.atitle=Cellular+phone+use+and+brain+tumor%3A+A+meta-analysis&amp;rft.volume=86&amp;rft.issue=1&amp;rft.pages=71-78&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1007%2Fs11060-007-9432-1&amp;rft_id=info%3Apmid%2F17619826&amp;rft.aulast=Kan&amp;rft.aufirst=Peter&amp;rft.au=Simonsen%2C+Sara+E.&amp;rft.au=Lyon%2C+Joseph+L.&amp;rft.au=Kestle%2C+John+R.+W.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-79\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-79\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hardell, Lennart; Carlberg, Michael; Hansson Mild, Kjell (2009). \"Epidemiological evidence for an association between use of wireless phones and tumor diseases\". <i>Pathophysiology</i>. <b>16</b> (2\u20133): 113\u201322. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.pathophys.2009.01.003\">10.1016/j.pathophys.2009.01.003</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19268551\">19268551</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pathophysiology&amp;rft.atitle=Epidemiological+evidence+for+an+association+between+use+of+wireless+phones+and+tumor+diseases&amp;rft.volume=16&amp;rft.issue=2%E2%80%933&amp;rft.pages=113-22&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1016%2Fj.pathophys.2009.01.003&amp;rft_id=info%3Apmid%2F19268551&amp;rft.aulast=Hardell&amp;rft.aufirst=Lennart&amp;rft.au=Carlberg%2C+Michael&amp;rft.au=Hansson+Mild%2C+Kjell&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlioblastoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Glioblastoma&amp;action=edit&amp;section=29\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"infobox\" style=\"width:22em;width:100%; margin:0 0 0.5em 0;\"><tbody><tr><th scope=\"row\">Classification</th><td style=\"text-align:left;\">\n<div style=\"position:relative; float:right; font-size:0.8em;\"><a href=\"https://www.wikidata.org/wiki/Q282142\" class=\"extiw\" title=\"d:Q282142\">D</a></div><div class=\"hlist hlist-separated\" style=\"text-align:left;\"><ul><li><b><a href=\"/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems\" title=\"International Statistical Classification of Diseases and Related Health Problems\">ICD</a>-<a href=\"/wiki/ICD-10\" title=\"ICD-10\">10</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://apps.who.int/classifications/icd10/browse/2016/en#/C71\">C71</a></li><li><b><a href=\"/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems\" title=\"International Statistical Classification of Diseases and Related Health Problems\">ICD</a>-<a href=\"/wiki/List_of_ICD-9_codes\" title=\"List of ICD-9 codes\">9-CM</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.icd9data.com/getICD9Code.ashx?icd9=191\">191</a></li><li><b><a href=\"/wiki/International_Classification_of_Diseases_for_Oncology\" title=\"International Classification of Diseases for Oncology\">ICD-O</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"https://progenetix.org/subsets/?term_id=icdom:9440_3\">M9440/3</a></li><li><b><a href=\"/wiki/OMIM\" class=\"mw-redirect\" title=\"OMIM\">OMIM</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"https://omim.org/entry/137800\">137800</a></li><li><b><a href=\"/wiki/Medical_Subject_Headings\" title=\"Medical Subject Headings\">MeSH</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D005909\">D005909</a></li><li><b><a href=\"/wiki/Diseases_Database\" title=\"Diseases Database\">DiseasesDB</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.diseasesdatabase.com/ddb29448.htm\">29448</a></li></ul></div></td></tr><tr><th scope=\"row\">External resources</th><td style=\"text-align:left;\">\n<div class=\"hlist hlist-separated\" style=\"text-align:left;\"><ul><li><b><a href=\"/wiki/EMedicine\" title=\"EMedicine\">eMedicine</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.emedicine.com/neuro/topic147.htm\">neuro/147</a> <a rel=\"nofollow\" class=\"external text\" href=\"http://www.emedicine.com/med/topic2692.htm#\">med/2692</a></li></ul></div></td></tr></tbody></table>\n<table role=\"presentation\" class=\"mbox-small plainlinks sistersitebox\" style=\"background-color:#f9f9f9;border:1px solid #aaa;color:#000\">\n<tbody><tr>\n<td class=\"mbox-image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png\" width=\"30\" height=\"40\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x\" data-file-width=\"1024\" data-file-height=\"1376\" /></td>\n<td class=\"mbox-text plainlist\">Wikimedia Commons has media related to <i><b><a href=\"https://commons.wikimedia.org/wiki/Category:Glioblastoma_multiforme\" class=\"extiw\" title=\"commons:Category:Glioblastoma multiforme\">Glioblastoma multiforme</a></b></i>.</td></tr></tbody></table>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.abta.org/understanding-brain-tumors/types-of-tumors/glioblastoma.html\">Information about Glioblastoma Multiforme (GBM)</a> from the American Brain Tumor Association</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20111214210812/http://rad.usuhs.edu/rad/handouts/jsmirnio/Astrocytoma_2008_March%20HO.pdf\">AFIP Course Syllabus</a>&#160;\u2013 Astrocytoma WHO Grading Lecture Handout</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20111214214044/http://rad.usuhs.edu/medpix/parent.php3?mode=image_finder&amp;srchstr=glioblastoma&amp;srch_type=all\">Image Database</a>&#160;\u2013 MR &amp; CT of Glioblastoma</li></ul>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Nervous_tissue_tumors/NS_neoplasm/Neuroectodermal_tumor_(ICD-O_9350\u20139589)_(C70\u2013C72,_D32\u2013D33,_191\u2013192/225)\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Nervous_system_tumors\" title=\"Template:Nervous system tumors\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Nervous_system_tumors\" title=\"Template talk:Nervous system tumors\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Nervous_system_tumors&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Nervous_tissue_tumors/NS_neoplasm/Neuroectodermal_tumor_(ICD-O_9350\u20139589)_(C70\u2013C72,_D32\u2013D33,_191\u2013192/225)\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Nervous_tissue\" title=\"Nervous tissue\">Nervous tissue</a> <a href=\"/wiki/Neoplasm\" title=\"Neoplasm\">tumors</a>/<a href=\"/wiki/Nervous_system_neoplasm\" title=\"Nervous system neoplasm\">NS neoplasm</a>/<a href=\"/wiki/Neuroectodermal_tumor\" title=\"Neuroectodermal tumor\">Neuroectodermal tumor</a> (<a href=\"/wiki/International_Classification_of_Diseases_for_Oncology\" title=\"International Classification of Diseases for Oncology\">ICD-O</a> 9350\u20139589) (<a href=\"/wiki/ICD-10_Chapter_II:_Neoplasms#(C69\u2013C72)_Malignant_neoplasms,_eye,_brain_and_central_nervous_system\" title=\"ICD-10 Chapter II: Neoplasms\">C70\u2013C72, D32\u2013D33</a>, <a href=\"/wiki/List_of_ICD-9_codes_140%E2%80%93239:_neoplasms#Malignant_neoplasm_of_other_and_unspecified_sites_(190\u2013199)\" title=\"List of ICD-9 codes 140\u2013239: neoplasms\">191\u2013192/225</a>)</div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Endocrine_gland_neoplasm\" title=\"Endocrine gland neoplasm\">Endocrine</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><span style=\"font-weight:normal;\"><i><a href=\"/wiki/WHO_classification_of_the_tumors_of_the_central_nervous_system#6._Tumours_of_the_sellar_region\" class=\"mw-redirect\" title=\"WHO classification of the tumors of the central nervous system\">Sellar</a>:</i></span></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Craniopharyngioma\" title=\"Craniopharyngioma\">Craniopharyngioma</a></li>\n<li><a href=\"/wiki/Pituicytoma\" title=\"Pituicytoma\">Pituicytoma</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><span style=\"font-weight:normal;\"><i>Other:</i></span></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Pinealoma\" title=\"Pinealoma\">Pinealoma</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Central_nervous_system\" title=\"Central nervous system\">CNS</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/WHO_classification_of_the_tumors_of_the_central_nervous_system#1._Tumours_of_neuroepithelial_tissue\" class=\"mw-redirect\" title=\"WHO classification of the tumors of the central nervous system\">Neuroepithelial</a><br />(<a href=\"/wiki/Brain_tumor\" title=\"Brain tumor\">brain tumors</a>,<br /><a href=\"/wiki/Spinal_tumor\" title=\"Spinal tumor\">spinal tumors</a>)</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Glioma\" title=\"Glioma\">Glioma</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Astrocyte\" title=\"Astrocyte\">Astrocyte</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Astrocytoma\" title=\"Astrocytoma\">Astrocytoma</a>\n<ul><li><a href=\"/wiki/Pilocytic_astrocytoma\" title=\"Pilocytic astrocytoma\">Pilocytic astrocytoma</a></li>\n<li><a href=\"/wiki/Pleomorphic_xanthoastrocytoma\" title=\"Pleomorphic xanthoastrocytoma\">Pleomorphic xanthoastrocytoma</a></li>\n<li><a href=\"/wiki/Subependymal_giant_cell_astrocytoma\" title=\"Subependymal giant cell astrocytoma\">Subependymal giant cell astrocytoma</a></li>\n<li><a href=\"/wiki/Fibrillary_astrocytoma\" title=\"Fibrillary astrocytoma\">Fibrillary astrocytoma</a></li>\n<li><a href=\"/wiki/Anaplastic_astrocytoma\" title=\"Anaplastic astrocytoma\">Anaplastic astrocytoma</a></li>\n<li><a href=\"/wiki/Glioblastoma_multiforme\" class=\"mw-redirect\" title=\"Glioblastoma multiforme\">Glioblastoma multiforme</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Oligodendrocyte\" title=\"Oligodendrocyte\">Oligodendrocyte</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Oligodendroglioma\" title=\"Oligodendroglioma\">Oligodendroglioma</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Ependyma\" title=\"Ependyma\">Ependyma</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Ependymoma\" title=\"Ependymoma\">Ependymoma</a></li>\n<li><a href=\"/wiki/Subependymoma\" title=\"Subependymoma\">Subependymoma</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Choroid_plexus\" title=\"Choroid plexus\">Choroid plexus</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Choroid_plexus_tumor\" title=\"Choroid plexus tumor\">Choroid plexus tumor</a>\n<ul><li><a href=\"/wiki/Choroid_plexus_papilloma\" title=\"Choroid plexus papilloma\">Choroid plexus papilloma</a></li>\n<li><a href=\"/wiki/Choroid_plexus_carcinoma\" title=\"Choroid plexus carcinoma\">Choroid plexus carcinoma</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Multiple/unknown</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Oligoastrocytoma\" title=\"Oligoastrocytoma\">Oligoastrocytoma</a></li>\n<li><a href=\"/wiki/Gliomatosis_cerebri\" title=\"Gliomatosis cerebri\">Gliomatosis cerebri</a></li>\n<li><a href=\"/wiki/Gliosarcoma\" title=\"Gliosarcoma\">Gliosarcoma</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Mature<br /><a href=\"/wiki/Neuron\" title=\"Neuron\">neuron</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Ganglioneuroma\" title=\"Ganglioneuroma\">Ganglioneuroma</a>: <a href=\"/wiki/Ganglioglioma\" title=\"Ganglioglioma\">Ganglioglioma</a></li>\n<li><a href=\"/wiki/Retinoblastoma\" title=\"Retinoblastoma\">Retinoblastoma</a></li>\n<li><a href=\"/wiki/Neurocytoma\" title=\"Neurocytoma\">Neurocytoma</a></li>\n<li><a href=\"/wiki/Dysembryoplastic_neuroepithelial_tumour\" title=\"Dysembryoplastic neuroepithelial tumour\">Dysembryoplastic neuroepithelial tumour</a></li>\n<li><a href=\"/wiki/Lhermitte%E2%80%93Duclos_disease\" title=\"Lhermitte\u2013Duclos disease\">Lhermitte\u2013Duclos disease</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Primitive_neuroectodermal_tumor\" title=\"Primitive neuroectodermal tumor\">PNET</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Neuroblastoma\" title=\"Neuroblastoma\">Neuroblastoma</a>\n<ul><li><a href=\"/wiki/Esthesioneuroblastoma\" title=\"Esthesioneuroblastoma\">Esthesioneuroblastoma</a></li>\n<li><a href=\"/wiki/Ganglioneuroblastoma\" title=\"Ganglioneuroblastoma\">Ganglioneuroblastoma</a></li></ul></li>\n<li><a href=\"/wiki/Medulloblastoma\" title=\"Medulloblastoma\">Medulloblastoma</a></li>\n<li><a href=\"/wiki/Atypical_teratoid_rhabdoid_tumor\" title=\"Atypical teratoid rhabdoid tumor\">Atypical teratoid rhabdoid tumor</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Primitive</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Medulloepithelioma\" title=\"Medulloepithelioma\">Medulloepithelioma</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Meningeal<br />(<a href=\"/wiki/Meninges\" title=\"Meninges\">Meninges</a>)</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Meningioma\" title=\"Meningioma\">Meningioma</a></li>\n<li><a href=\"/wiki/Hemangiopericytoma\" title=\"Hemangiopericytoma\">Hemangiopericytoma</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/WHO_classification_of_the_tumors_of_the_central_nervous_system#4._Tumors_of_the_haematopoietic_system\" class=\"mw-redirect\" title=\"WHO classification of the tumors of the central nervous system\">Hematopoietic</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Primary_central_nervous_system_lymphoma\" title=\"Primary central nervous system lymphoma\">Primary central nervous system lymphoma</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Peripheral_nervous_system\" title=\"Peripheral nervous system\">PNS</a>: <a href=\"/wiki/Nerve_sheath_tumor\" title=\"Nerve sheath tumor\">NST</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i><a href=\"/wiki/WHO_classification_of_the_tumors_of_the_central_nervous_system#2._Tumours_of_cranial_and_paraspinal_nerves\" class=\"mw-redirect\" title=\"WHO classification of the tumors of the central nervous system\">Cranial and paraspinal nerves</a>:</i> <a href=\"/wiki/Neurofibroma\" title=\"Neurofibroma\">Neurofibroma</a>\n<ul><li><a href=\"/wiki/Neurofibromatosis\" title=\"Neurofibromatosis\">Neurofibromatosis</a></li></ul></li>\n<li><a href=\"/wiki/Neurilemmoma\" class=\"mw-redirect\" title=\"Neurilemmoma\">Neurilemmoma</a>/<a href=\"/wiki/Schwannoma\" title=\"Schwannoma\">Schwannoma</a>\n<ul><li><a href=\"/wiki/Vestibular_schwannoma\" title=\"Vestibular schwannoma\">Acoustic neuroma</a></li></ul></li>\n<li><a href=\"/wiki/Malignant_peripheral_nerve_sheath_tumor\" title=\"Malignant peripheral nerve sheath tumor\">Malignant peripheral nerve sheath tumor</a></li></ul>\n</div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\" style=\"background: transparent; padding: 0px;\"><div><i>Note: Not all brain tumors are of nervous tissue, and not all nervous tissue tumors are in the brain (see <a href=\"/wiki/Brain_metastasis\" title=\"Brain metastasis\">brain metastasis</a>).</i><br /></div></td></tr></tbody></table></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q282142&amp;#124;Edit_this_at_Wikidata\" style=\"padding:3px\"><table class=\"nowraplinks hlist navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th id=\"Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q282142&amp;#124;Edit_this_at_Wikidata\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Help:Authority_control\" title=\"Help:Authority control\">Authority control</a> <a href=\"https://www.wikidata.org/wiki/Q282142\" title=\"Edit this at Wikidata\"><img alt=\"Edit this at Wikidata\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/10px-Blue_pencil.svg.png\" width=\"10\" height=\"10\" style=\"vertical-align: text-top\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/15px-Blue_pencil.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/20px-Blue_pencil.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><span class=\"nowrap\"><a href=\"/wiki/Integrated_Authority_File\" title=\"Integrated Authority File\">GND</a>: <span class=\"uid\"><a rel=\"nofollow\" class=\"external text\" href=\"https://d-nb.info/gnd/4157617-2\">4157617-2</a></span></span></li></ul>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2170\nCached time: 20180921220240\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 1.088 seconds\nReal time usage: 1.204 seconds\nPreprocessor visited node count: 6399/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 254801/2097152 bytes\nTemplate argument size: 4778/2097152 bytes\nHighest expansion depth: 12/40\nExpensive parser function count: 5/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 142978/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.566/10.000 seconds\nLua memory usage: 6.19 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  997.909      1 -total\n 70.31%  701.612      1 Template:Reflist\n 46.85%  467.532     68 Template:Cite_journal\n 10.88%  108.571      2 Template:Infobox\n  8.75%   87.318      1 Template:Infobox_medical_condition_(new)\n  4.28%   42.710      1 Template:Medical_resources\n  4.27%   42.642      1 Template:Page_needed\n  3.87%   38.639      1 Template:Fix\n  3.26%   32.515      5 Template:Navbox\n  2.50%   24.919      1 Template:Authority_control\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:1023575-0!canonical and timestamp 20180921220239 and revision id 860473497\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D9%88%D8%B1%D9%85_%D8%A3%D8%B1%D9%88%D9%85%D9%8A_%D8%AF%D8%A8%D9%82%D9%8A_%D9%85%D8%AA%D8%B9%D8%AF%D8%AF_%D8%A7%D9%84%D8%A3%D8%B4%D9%83%D8%A7%D9%84","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u0648\u0631\u0645 \u0623\u0631\u0648\u0645\u064a \u062f\u0628\u0642\u064a \u0645\u062a\u0639\u062f\u062f \u0627\u0644\u0623\u0634\u0643\u0627\u0644"},{"lang":"ca","url":"https://ca.wikipedia.org/wiki/Glioblastoma_multiforme","langname":"Catalan","autonym":"catal\u00e0","*":"Glioblastoma multiforme"},{"lang":"cs","url":"https://cs.wikipedia.org/wiki/Glioblastoma_multiforme","langname":"Czech","autonym":"\u010de\u0161tina","*":"Glioblastoma multiforme"},{"lang":"de","url":"https://de.wikipedia.org/wiki/Glioblastom","langname":"German","autonym":"Deutsch","*":"Glioblastom"},{"lang":"et","url":"https://et.wikipedia.org/wiki/Glioblastoom","langname":"Estonian","autonym":"eesti","*":"Glioblastoom"},{"lang":"el","url":"https://el.wikipedia.org/wiki/%CE%A0%CE%BF%CE%BB%CF%8D%CE%BC%CE%BF%CF%81%CF%86%CE%BF_%CE%B3%CE%BB%CE%BF%CE%B9%CE%BF%CE%B2%CE%BB%CE%AC%CF%83%CF%84%CF%89%CE%BC%CE%B1","langname":"Greek","autonym":"\u0395\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ac","*":"\u03a0\u03bf\u03bb\u03cd\u03bc\u03bf\u03c1\u03c6\u03bf \u03b3\u03bb\u03bf\u03b9\u03bf\u03b2\u03bb\u03ac\u03c3\u03c4\u03c9\u03bc\u03b1"},{"lang":"es","url":"https://es.wikipedia.org/wiki/Glioblastoma","langname":"Spanish","autonym":"espa\u00f1ol","*":"Glioblastoma"},{"lang":"fa","url":"https://fa.wikipedia.org/wiki/%DA%AF%D9%84%DB%8C%D9%88%D8%A8%D9%84%D8%A7%D8%B3%D8%AA%D9%88%D9%85%D8%A7","langname":"Persian","autonym":"\u0641\u0627\u0631\u0633\u06cc","*":"\u06af\u0644\u06cc\u0648\u0628\u0644\u0627\u0633\u062a\u0648\u0645\u0627"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Glioblastome_multiforme","langname":"French","autonym":"fran\u00e7ais","*":"Glioblastome multiforme"},{"lang":"ko","url":"https://ko.wikipedia.org/wiki/%EA%B5%90%EB%AA%A8%EC%84%B8%ED%8F%AC%EC%A2%85","langname":"Korean","autonym":"\ud55c\uad6d\uc5b4","*":"\uad50\ubaa8\uc138\ud3ec\uc885"},{"lang":"hy","url":"https://hy.wikipedia.org/wiki/%D4%B3%D5%AC%D5%AB%D5%B8%D5%A2%D5%AC%D5%A1%D5%BD%D5%BF%D5%B8%D5%B4%D5%A1","langname":"Armenian","autonym":"\u0570\u0561\u0575\u0565\u0580\u0565\u0576","*":"\u0533\u056c\u056b\u0578\u0562\u056c\u0561\u057d\u057f\u0578\u0574\u0561"},{"lang":"it","url":"https://it.wikipedia.org/wiki/Glioblastoma","langname":"Italian","autonym":"italiano","*":"Glioblastoma"},{"lang":"he","url":"https://he.wikipedia.org/wiki/%D7%92%D7%9C%D7%99%D7%95%D7%91%D7%9C%D7%A1%D7%98%D7%95%D7%9E%D7%94_%D7%9E%D7%95%D7%9C%D7%98%D7%99%D7%A4%D7%95%D7%A8%D7%9E%D7%94","langname":"Hebrew","autonym":"\u05e2\u05d1\u05e8\u05d9\u05ea","*":"\u05d2\u05dc\u05d9\u05d5\u05d1\u05dc\u05e1\u05d8\u05d5\u05de\u05d4 \u05de\u05d5\u05dc\u05d8\u05d9\u05e4\u05d5\u05e8\u05de\u05d4"},{"lang":"la","url":"https://la.wikipedia.org/wiki/Glioblastoma_multiforme","langname":"Latin","autonym":"Latina","*":"Glioblastoma multiforme"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E8%86%A0%E8%8A%BD%E8%85%AB","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u81a0\u82bd\u816b"},{"lang":"no","url":"https://no.wikipedia.org/wiki/Glioblastoma_multiforme","langname":"Norwegian","autonym":"norsk","*":"Glioblastoma multiforme"},{"lang":"or","url":"https://or.wikipedia.org/wiki/%E0%AC%97%E0%AD%8D%E0%AC%B2%E0%AC%BE%E0%AD%9F%E0%AD%8B%E0%AC%AC%E0%AD%8D%E0%AC%B2%E0%AC%BE%E0%AC%B8%E0%AD%8D%E0%AC%9F%E0%AD%8B%E0%AC%AE%E0%AC%BE_%E0%AC%AE%E0%AC%B2%E0%AD%8D%E0%AC%9F%E0%AC%BF%E0%AC%AB%E0%AC%B0%E0%AD%8D%E0%AC%AE","langname":"Odia","autonym":"\u0b13\u0b21\u0b3c\u0b3f\u0b06","*":"\u0b17\u0b4d\u0b32\u0b3e\u0b5f\u0b4b\u0b2c\u0b4d\u0b32\u0b3e\u0b38\u0b4d\u0b1f\u0b4b\u0b2e\u0b3e \u0b2e\u0b32\u0b4d\u0b1f\u0b3f\u0b2b\u0b30\u0b4d\u0b2e"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Glejak_wielopostaciowy","langname":"Polish","autonym":"polski","*":"Glejak wielopostaciowy"},{"lang":"pt","url":"https://pt.wikipedia.org/wiki/Glioblastoma_multiforme","langname":"Portuguese","autonym":"portugu\u00eas","*":"Glioblastoma multiforme"},{"lang":"ru","url":"https://ru.wikipedia.org/wiki/%D0%93%D0%BB%D0%B8%D0%BE%D0%B1%D0%BB%D0%B0%D1%81%D1%82%D0%BE%D0%BC%D0%B0","langname":"Russian","autonym":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439","*":"\u0413\u043b\u0438\u043e\u0431\u043b\u0430\u0441\u0442\u043e\u043c\u0430"},{"lang":"simple","url":"https://simple.wikipedia.org/wiki/Glioblastoma_multiforme","langname":"Simple English","autonym":"Simple English","*":"Glioblastoma multiforme"},{"lang":"sl","url":"https://sl.wikipedia.org/wiki/Multiformni_glioblastom","langname":"Slovenian","autonym":"sloven\u0161\u010dina","*":"Multiformni glioblastom"},{"lang":"fi","url":"https://fi.wikipedia.org/wiki/Glioblastooma","langname":"Finnish","autonym":"suomi","*":"Glioblastooma"},{"lang":"sv","url":"https://sv.wikipedia.org/wiki/Glioblastom","langname":"Swedish","autonym":"svenska","*":"Glioblastom"},{"lang":"tr","url":"https://tr.wikipedia.org/wiki/Glioblastom","langname":"Turkish","autonym":"T\u00fcrk\u00e7e","*":"Glioblastom"},{"lang":"uk","url":"https://uk.wikipedia.org/wiki/%D0%93%D0%BB%D1%96%D0%BE%D0%B1%D0%BB%D0%B0%D1%81%D1%82%D0%BE%D0%BC%D0%B0","langname":"Ukrainian","autonym":"\u0443\u043a\u0440\u0430\u0457\u043d\u0441\u044c\u043a\u0430","*":"\u0413\u043b\u0456\u043e\u0431\u043b\u0430\u0441\u0442\u043e\u043c\u0430"},{"lang":"zh","url":"https://zh.wikipedia.org/wiki/%E8%83%B6%E8%B4%A8%E6%AF%8D%E7%BB%86%E8%83%9E%E7%98%A4","langname":"Chinese","autonym":"\u4e2d\u6587","*":"\u80f6\u8d28\u6bcd\u7ec6\u80de\u7624"}],"categories":[{"sortkey":"","hidden":"","*":"CS1_maint:_Multiple_names:_authors_list"},{"sortkey":"","hidden":"","*":"Webarchive_template_wayback_links"},{"sortkey":"","hidden":"","*":"Wikipedia_articles_needing_page_number_citations_from_August_2013"},{"sortkey":"","hidden":"","*":"Infobox_medical_condition_(new)"},{"sortkey":"","hidden":"","*":"Articles_containing_potentially_dated_statements_from_2016"},{"sortkey":"","hidden":"","*":"All_articles_containing_potentially_dated_statements"},{"sortkey":"","hidden":"","*":"Articles_containing_potentially_dated_statements_from_2010"},{"sortkey":"","hidden":"","*":"Articles_containing_potentially_dated_statements_from_2015"},{"sortkey":"","hidden":"","*":"Commons_category_with_local_link_different_than_on_Wikidata"},{"sortkey":"","hidden":"","*":"Wikipedia_articles_with_GND_identifiers"},{"sortkey":"","*":"Brain_tumor"},{"sortkey":"","hidden":"","*":"RTT"},{"sortkey":"","*":"Cancer"},{"sortkey":"","*":"Types_of_cancer"},{"sortkey":"","*":"Oncology"},{"sortkey":"","*":"Aging-associated_diseases"}],"links":[{"ns":14,"exists":"","*":"Category:Articles containing potentially dated statements from 2016"},{"ns":14,"exists":"","*":"Category:Articles containing potentially dated statements from 2010"},{"ns":14,"exists":"","*":"Category:Articles containing potentially dated statements from 2015"},{"ns":14,"exists":"","*":"Category:Wikipedia articles needing page number citations from August 2013"},{"ns":14,"exists":"","*":"Category:Wikipedia articles with GND identifiers"},{"ns":14,"exists":"","*":"Category:CS1 maint: Multiple names: authors list"},{"ns":0,"exists":"","*":"Open access"},{"ns":0,"exists":"","*":"5-aminolevulinic acid"},{"ns":0,"exists":"","*":"Abscess"},{"ns":0,"exists":"","*":"Aerosol"},{"ns":0,"exists":"","*":"Alternating electric field therapy"},{"ns":0,"exists":"","*":"Anaplastic"},{"ns":0,"exists":"","*":"Anaplastic astrocytoma"},{"ns":0,"exists":"","*":"Antiangiogenic therapy"},{"ns":0,"exists":"","*":"Anticonvulsant"},{"ns":0,"exists":"","*":"Astrocyte"},{"ns":0,"exists":"","*":"Astrocytoma"},{"ns":0,"exists":"","*":"Astrocytomas"},{"ns":0,"exists":"","*":"Asymptomatic condition"},{"ns":0,"exists":"","*":"Atypical teratoid rhabdoid tumor"},{"ns":0,"exists":"","*":"Bevacizumab"},{"ns":0,"exists":"","*":"Bibcode"},{"ns":0,"exists":"","*":"Blood\u2013brain barrier"},{"ns":0,"exists":"","*":"Boron neutron capture therapy"},{"ns":0,"exists":"","*":"Brain"},{"ns":0,"exists":"","*":"Brain metastasis"},{"ns":0,"exists":"","*":"Brain tumor"},{"ns":0,"exists":"","*":"CT scan"},{"ns":0,"exists":"","*":"Cancer"},{"ns":0,"exists":"","*":"Cancer stem cell"},{"ns":0,"exists":"","*":"Central nervous system"},{"ns":0,"exists":"","*":"Cerebral edema"},{"ns":0,"exists":"","*":"Cerebrospinal fluid"},{"ns":0,"exists":"","*":"Cerebrum"},{"ns":0,"exists":"","*":"Chemotherapy"},{"ns":0,"exists":"","*":"Chloride potassium symporter 5"},{"ns":0,"exists":"","*":"Choroid plexus"},{"ns":0,"exists":"","*":"Choroid plexus carcinoma"},{"ns":0,"exists":"","*":"Choroid plexus papilloma"},{"ns":0,"exists":"","*":"Choroid plexus tumor"},{"ns":0,"exists":"","*":"ClinicalTrials.gov"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Corpus callosum"},{"ns":0,"exists":"","*":"Corticosteroid"},{"ns":0,"exists":"","*":"Corticosteroids"},{"ns":0,"exists":"","*":"Craniopharyngioma"},{"ns":0,"exists":"","*":"Craniotomy"},{"ns":0,"exists":"","*":"Curing (food preservation)"},{"ns":0,"exists":"","*":"Cytomegalovirus"},{"ns":0,"exists":"","*":"Dexamethasone"},{"ns":0,"exists":"","*":"Diagnostic method"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Diseases Database"},{"ns":0,"exists":"","*":"Dysembryoplastic neuroepithelial tumour"},{"ns":0,"exists":"","*":"EMedicine"},{"ns":0,"exists":"","*":"Edema"},{"ns":0,"exists":"","*":"Electromagnetic field"},{"ns":0,"exists":"","*":"Endocrine gland neoplasm"},{"ns":0,"exists":"","*":"Ependyma"},{"ns":0,"exists":"","*":"Ependymoma"},{"ns":0,"exists":"","*":"Epidermal growth factor receptor"},{"ns":0,"exists":"","*":"Erythema multiforme"},{"ns":0,"exists":"","*":"Esthesioneuroblastoma"},{"ns":0,"exists":"","*":"Fibrillary astrocytoma"},{"ns":0,"exists":"","*":"Formaldehyde"},{"ns":0,"exists":"","*":"Gamma-aminobutyric acid receptor subunit alpha-1"},{"ns":0,"exists":"","*":"Ganglioglioma"},{"ns":0,"exists":"","*":"Ganglioneuroblastoma"},{"ns":0,"exists":"","*":"Ganglioneuroma"},{"ns":0,"exists":"","*":"Gene"},{"ns":0,"exists":"","*":"Gene therapy"},{"ns":0,"exists":"","*":"Genetic disorder"},{"ns":0,"exists":"","*":"Glial cell"},{"ns":0,"exists":"","*":"Glioblast"},{"ns":0,"exists":"","*":"Glioblastoma multiforme"},{"ns":0,"exists":"","*":"Glioma"},{"ns":0,"exists":"","*":"Gliomatosis cerebri"},{"ns":0,"exists":"","*":"Gliosarcoma"},{"ns":0,"exists":"","*":"Glutamate"},{"ns":0,"exists":"","*":"Glutamine"},{"ns":0,"exists":"","*":"Harvey Cushing"},{"ns":0,"exists":"","*":"Headache"},{"ns":0,"exists":"","*":"Hemangiopericytoma"},{"ns":0,"exists":"","*":"Hes3 signaling axis"},{"ns":0,"exists":"","*":"Human herpesvirus 6"},{"ns":0,"exists":"","*":"Hydrocephalus"},{"ns":0,"exists":"","*":"Hyperplastic"},{"ns":0,"exists":"","*":"Hypoxia (medical)"},{"ns":0,"exists":"","*":"ICD-10"},{"ns":0,"exists":"","*":"ICD-10 Chapter II: Neoplasms"},{"ns":0,"exists":"","*":"IDH1"},{"ns":0,"exists":"","*":"Immunostaining"},{"ns":0,"exists":"","*":"Immunotherapy"},{"ns":0,"exists":"","*":"In vivo magnetic resonance spectroscopy"},{"ns":0,"exists":"","*":"Integrated Authority File"},{"ns":0,"exists":"","*":"International Classification of Diseases for Oncology"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"International Standard Serial Number"},{"ns":0,"exists":"","*":"International Statistical Classification of Diseases and Related Health Problems"},{"ns":0,"exists":"","*":"Intracranial pressure"},{"ns":0,"exists":"","*":"Isocitrate dehydrogenase"},{"ns":0,"exists":"","*":"Karnofsky score"},{"ns":0,"exists":"","*":"Lhermitte\u2013Duclos disease"},{"ns":0,"exists":"","*":"Life expectancy"},{"ns":0,"exists":"","*":"List of ICD-9 codes"},{"ns":0,"exists":"","*":"List of ICD-9 codes 140\u2013239: neoplasms"},{"ns":0,"exists":"","*":"List of people with brain tumors"},{"ns":0,"exists":"","*":"Li\u2013Fraumeni syndrome"},{"ns":0,"exists":"","*":"Loss of heterozygosity"},{"ns":0,"exists":"","*":"Low-grade astrocytoma"},{"ns":0,"exists":"","*":"Lymphocyte"},{"ns":0,"exists":"","*":"MGMT promoter"},{"ns":0,"exists":"","*":"MRI"},{"ns":0,"exists":"","*":"MRI scan"},{"ns":0,"exists":"","*":"Malignant"},{"ns":0,"exists":"","*":"Malignant peripheral nerve sheath tumor"},{"ns":0,"exists":"","*":"Mass effect (medicine)"},{"ns":0,"exists":"","*":"Matthias Preusser"},{"ns":0,"exists":"","*":"Medical Subject Headings"},{"ns":0,"exists":"","*":"Medical imaging"},{"ns":0,"exists":"","*":"Medulloblastoma"},{"ns":0,"exists":"","*":"Medulloepithelioma"},{"ns":0,"exists":"","*":"Memory loss"},{"ns":0,"exists":"","*":"Meninges"},{"ns":0,"exists":"","*":"Meningioma"},{"ns":0,"exists":"","*":"Metastasis"},{"ns":0,"exists":"","*":"Methylated"},{"ns":0,"exists":"","*":"Methylation"},{"ns":0,"exists":"","*":"Mismatch repair cancer syndrome"},{"ns":0,"exists":"","*":"NEFL"},{"ns":0,"exists":"","*":"Nausea"},{"ns":0,"exists":"","*":"Necrosis"},{"ns":0,"exists":"","*":"Neoplasm"},{"ns":0,"exists":"","*":"Nerve sheath tumor"},{"ns":0,"exists":"","*":"Nervous system neoplasm"},{"ns":0,"exists":"","*":"Nervous tissue"},{"ns":0,"exists":"","*":"Neural stem cell"},{"ns":0,"exists":"","*":"Neurilemmoma"},{"ns":0,"exists":"","*":"Neuroblastoma"},{"ns":0,"exists":"","*":"Neurocytoma"},{"ns":0,"exists":"","*":"Neuroectodermal tumor"},{"ns":0,"exists":"","*":"Neurofibroma"},{"ns":0,"exists":"","*":"Neurofibromatosis"},{"ns":0,"exists":"","*":"Neurofibromin 1"},{"ns":0,"exists":"","*":"Neuron"},{"ns":0,"exists":"","*":"Neurosurgery"},{"ns":0,"exists":"","*":"O-6-methylguanine-DNA methyltransferase"},{"ns":0,"exists":"","*":"OMIM"},{"ns":0,"exists":"","*":"Oil refinery"},{"ns":0,"exists":"","*":"Oligoastrocytoma"},{"ns":0,"exists":"","*":"Oligodendrocyte"},{"ns":0,"exists":"","*":"Oligodendroglioma"},{"ns":0,"exists":"","*":"Oncology"},{"ns":0,"exists":"","*":"Oxygen diffusion-enhancing compound"},{"ns":0,"exists":"","*":"PI3K/AKT/mTOR pathway"},{"ns":0,"exists":"","*":"Percival Bailey"},{"ns":0,"exists":"","*":"Perillyl alcohol"},{"ns":0,"exists":"","*":"Peripheral nervous system"},{"ns":0,"exists":"","*":"Pesticide"},{"ns":0,"exists":"","*":"Phenytoin"},{"ns":0,"exists":"","*":"Pilocytic astrocytoma"},{"ns":0,"exists":"","*":"Pinealoma"},{"ns":0,"exists":"","*":"Pituicytoma"},{"ns":0,"exists":"","*":"Platelet-derived growth factor receptor"},{"ns":0,"exists":"","*":"Pleocytosis"},{"ns":0,"exists":"","*":"Pleomorphic xanthoastrocytoma"},{"ns":0,"exists":"","*":"Primary central nervous system lymphoma"},{"ns":0,"exists":"","*":"Primitive neuroectodermal tumor"},{"ns":0,"exists":"","*":"Promoter (biology)"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Radiation"},{"ns":0,"exists":"","*":"Radiation therapy"},{"ns":0,"exists":"","*":"Radiosensitizer"},{"ns":0,"exists":"","*":"Radiotherapy"},{"ns":0,"exists":"","*":"Retinoblastoma"},{"ns":0,"exists":"","*":"Retinoblastoma protein"},{"ns":0,"exists":"","*":"Ring-enhancing lesion"},{"ns":0,"exists":"","*":"Risk factor"},{"ns":0,"exists":"","*":"SV40"},{"ns":0,"exists":"","*":"Schwannoma"},{"ns":0,"exists":"","*":"Seizure"},{"ns":0,"exists":"","*":"Smoking"},{"ns":0,"exists":"","*":"Specialty (medicine)"},{"ns":0,"exists":"","*":"Spinal cord"},{"ns":0,"exists":"","*":"Spinal tumor"},{"ns":0,"exists":"","*":"Stereotactic biopsy"},{"ns":0,"exists":"","*":"Stevens\u2013Johnson syndrome"},{"ns":0,"exists":"","*":"Stroke"},{"ns":0,"exists":"","*":"Subependymal giant cell astrocytoma"},{"ns":0,"exists":"","*":"Subependymoma"},{"ns":0,"exists":"","*":"Surgery"},{"ns":0,"exists":"","*":"Synaptotagmin"},{"ns":0,"exists":"","*":"Synthetic rubber"},{"ns":0,"exists":"","*":"TP53"},{"ns":0,"exists":"","*":"Temozolomide"},{"ns":0,"exists":"","*":"Tissue (biology)"},{"ns":0,"exists":"","*":"Tissue biopsy"},{"ns":0,"exists":"","*":"Trans sodium crocetinate"},{"ns":0,"exists":"","*":"Tuberous sclerosis"},{"ns":0,"exists":"","*":"Tumefactive multiple sclerosis"},{"ns":0,"exists":"","*":"Unconsciousness"},{"ns":0,"exists":"","*":"United States"},{"ns":0,"exists":"","*":"Ventricular system"},{"ns":0,"exists":"","*":"Vestibular schwannoma"},{"ns":0,"exists":"","*":"Vomiting"},{"ns":0,"exists":"","*":"WHO classification of the tumors of the central nervous system"},{"ns":0,"exists":"","*":"Wayback Machine"},{"ns":10,"exists":"","*":"Template:Nervous system tumors"},{"ns":4,"exists":"","*":"Wikipedia:Citing sources"},{"ns":11,"exists":"","*":"Template talk:Nervous system tumors"},{"ns":12,"exists":"","*":"Help:Authority control"}],"templates":[{"ns":10,"exists":"","*":"Template:Infobox medical condition (new)"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:TOC limit"},{"ns":10,"exists":"","*":"Template:As of"},{"ns":10,"exists":"","*":"Template:DMCA"},{"ns":10,"exists":"","*":"Template:Dated maintenance category"},{"ns":10,"exists":"","*":"Template:FULLROOTPAGENAME"},{"ns":10,"exists":"","*":"Template:Ns has subpages"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Open access"},{"ns":10,"exists":"","*":"Template:ClinicalTrialsGov"},{"ns":10,"exists":"","*":"Template:Webarchive"},{"ns":10,"exists":"","*":"Template:Page needed"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Medical resources"},{"ns":10,"exists":"","*":"Template:Hlist"},{"ns":10,"exists":"","*":"Template:ICD10"},{"ns":10,"exists":"","*":"Template:ICD9"},{"ns":10,"exists":"","*":"Template:ICDO"},{"ns":10,"exists":"","*":"Template:EMedicine2"},{"ns":10,"exists":"","*":"Template:Str find"},{"ns":10,"exists":"","*":"Template:Commons category"},{"ns":10,"exists":"","*":"Template:Commons"},{"ns":10,"exists":"","*":"Template:Sister project"},{"ns":10,"exists":"","*":"Template:Side box"},{"ns":10,"exists":"","*":"Template:Nervous system tumors"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":10,"exists":"","*":"Template:Nobold"},{"ns":10,"exists":"","*":"Template:Authority control"},{"ns":10,"exists":"","*":"Template:EditAtWikidata"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:String2"},{"ns":828,"exists":"","*":"Module:WikidataIB/sandbox"},{"ns":828,"exists":"","*":"Module:Complex date"},{"ns":828,"exists":"","*":"Module:I18n/complex date"},{"ns":828,"exists":"","*":"Module:Ordinal"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Roman"},{"ns":828,"exists":"","*":"Module:ISOdate"},{"ns":828,"exists":"","*":"Module:DateI18n"},{"ns":828,"exists":"","*":"Module:I18n/date"},{"ns":828,"exists":"","*":"Module:Calendar"},{"ns":828,"exists":"","*":"Module:I18n"},{"ns":828,"*":"Module:WikidataIB/i18n"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Ns has subpages"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Webarchive"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Webarchive/data"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:Side box"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Authority control"},{"ns":828,"exists":"","*":"Module:ResolveEntityId"},{"ns":828,"exists":"","*":"Module:EditAtWikidata"}],"images":["Lock-green.svg","Open_Access_logo_PLoS_transparent.svg","Glioblastoma_-_MR_coronal_with_contrast.jpg","BrainCAConMark.png","Glioblastoma_-_MR_sagittal_with_contrast.jpg","Glioblastoma_(1).jpg","Commons-logo.svg","Blue_pencil.svg"],"externallinks":["//www.ncbi.nlm.nih.gov/pmc/articles/PMC4481356","//doi.org/10.3978/j.issn.2305-5839.2015.05.10","//www.ncbi.nlm.nih.gov/pubmed/26207249","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4530825","//doi.org/10.3747/co.22.2436","//www.ncbi.nlm.nih.gov/pubmed/26300678","//doi.org/10.1002/14651858.CD007415.pub2","//www.ncbi.nlm.nih.gov/pubmed/23633341","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3337398","//doi.org/10.1007/s11060-011-0793-0","//www.ncbi.nlm.nih.gov/pubmed/22270850","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4740000","//doi.org/10.3978/j.issn.2305-5839.2016.01.25","//www.ncbi.nlm.nih.gov/pubmed/26904576","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2888474","//doi.org/10.3322/caac.20069","//www.ncbi.nlm.nih.gov/pubmed/20445000","https://books.google.ca/books?id=EwajBQAAQBAJ&pg=PA1336","https://web.archive.org/web/20170729005047/https://books.google.ca/books?id=EwajBQAAQBAJ&pg=PA1336","http://linkinghub.elsevier.com/retrieve/pii/S0733861916300366","//doi.org/10.1016/j.ncl.2016.06.014","http://www.cancer.gov/types/brain/research/immunotherapy-glioblastoma","https://web.archive.org/web/20151224103950/http://www.cancer.gov/types/brain/research/immunotherapy-glioblastoma","//doi.org/10.1016/j.pharmthera.2015.05.005","//www.ncbi.nlm.nih.gov/pubmed/25944528","//www.ncbi.nlm.nih.gov/pubmed/15977639","//doi.org/10.1016/S0002-9343(03)00087-1","//www.ncbi.nlm.nih.gov/pubmed/12798456","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2749001","//doi.org/10.1016/j.jcv.2009.05.011","//www.ncbi.nlm.nih.gov/pubmed/19505845","//doi.org/10.1093/infdis/jis513","//www.ncbi.nlm.nih.gov/pubmed/22962688","//doi.org/10.1007/s11908-017-0563-z","//www.ncbi.nlm.nih.gov/pubmed/28233187","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3368274","//doi.org/10.1586/erm.12.30","//www.ncbi.nlm.nih.gov/pubmed/22616703","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4448618","//doi.org/10.1101/cshperspect.a020610","//www.ncbi.nlm.nih.gov/pubmed/25635044","//doi.org/10.1111/j.1349-7006.2009.01308.x","//www.ncbi.nlm.nih.gov/pubmed/19737147","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2818769","//doi.org/10.1016/j.ccr.2009.12.020","//www.ncbi.nlm.nih.gov/pubmed/20129251","//doi.org/10.1038/463278a","//www.ncbi.nlm.nih.gov/pubmed/20090720","//doi.org/10.1111/ajco.12756","//www.ncbi.nlm.nih.gov/pubmed/28840962","//doi.org/10.1001/jama.2010.236","//www.ncbi.nlm.nih.gov/pubmed/20215599","//doi.org/10.1186/1471-2407-14-718","//www.ncbi.nlm.nih.gov/pubmed/25256166","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4136888","//doi.org/10.1093/neuonc/nou005","//www.ncbi.nlm.nih.gov/pubmed/24510240","//doi.org/10.1016/j.bbcan.2014.05.004","//www.ncbi.nlm.nih.gov/pubmed/24880135","//doi.org/10.1056/NEJMoa043331","//www.ncbi.nlm.nih.gov/pubmed/15758010","//doi.org/10.1200/JCO.2007.15.7164","//www.ncbi.nlm.nih.gov/pubmed/18565887","http://jhc.sagepub.com/content/63/7/481","//doi.org/10.1369/0022155415581689","//www.worldcat.org/issn/0022-1554","//www.ncbi.nlm.nih.gov/pubmed/25809793","https://web.archive.org/web/20160109014011/http://jhc.sagepub.com/content/63/7/481","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3566603","http://adsabs.harvard.edu/abs/2013NatSR...3E1095P","//doi.org/10.1038/srep01095","//www.ncbi.nlm.nih.gov/pubmed/23393614","//doi.org/10.1016/j.bbcan.2014.04.004","//www.ncbi.nlm.nih.gov/pubmed/24747768","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4232089","//doi.org/10.1093/neuonc/nou152","//www.ncbi.nlm.nih.gov/pubmed/25074540","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3263536","//doi.org/10.5402/2011/590249","//www.ncbi.nlm.nih.gov/pubmed/22389824","//doi.org/10.1148/rg.272065155","//www.ncbi.nlm.nih.gov/pubmed/17374867","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4086528","//doi.org/10.1007/s11060-006-9303-1","//www.ncbi.nlm.nih.gov/pubmed/17171441","//doi.org/10.1007/s11910-006-0024-9","//www.ncbi.nlm.nih.gov/pubmed/16822352","//doi.org/10.3171/jns.2001.95.2.0190","//www.ncbi.nlm.nih.gov/pubmed/11780887","//doi.org/10.1016/S1470-2045(06)70665-9","//www.ncbi.nlm.nih.gov/pubmed/16648043","//doi.org/10.3171/jns.1978.49.3.0333","//www.ncbi.nlm.nih.gov/pubmed/355604","//doi.org/10.1016/j.ijrobp.2007.03.045","//www.ncbi.nlm.nih.gov/pubmed/17499453","//doi.org/10.1007/BF00170946","//www.ncbi.nlm.nih.gov/pubmed/1335044","//doi.org/10.2217/fon.10.123","//www.ncbi.nlm.nih.gov/pubmed/21062158","https://www.clinicaltrials.gov/show/NCT01465347","//doi.org/10.1056/NEJMoa043330","//www.ncbi.nlm.nih.gov/pubmed/15758009","https://books.google.com/books?id=mDhxMg5UXvIC&pg=PA37","//doi.org/10.1017/S1748232105000054","https://web.archive.org/web/20150317021325/http://books.google.com/books?id=mDhxMg5UXvIC&pg=PA37","https://web.archive.org/web/20070815232444/http://www.cancer.gov/clinicaltrials/results/glioblastoma0604","http://www.cancer.gov/clinicaltrials/results/glioblastoma0604","//doi.org/10.1007/s11060-006-9241-y","//www.ncbi.nlm.nih.gov/pubmed/16944309","//doi.org/10.1007/s11060-008-9663-9","//www.ncbi.nlm.nih.gov/pubmed/18688571","//doi.org/10.1002/14651858.CD008218.pub3","//www.ncbi.nlm.nih.gov/pubmed/25242542","http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm465744.htm","https://web.archive.org/web/20160323083354/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm465744.htm","http://www.accessdata.fda.gov/cdrh_docs/pdf10/p100034a.pdf","https://web.archive.org/web/20150922095543/http://www.accessdata.fda.gov/cdrh_docs/pdf10/p100034a.pdf","//doi.org/10.1001/jama.2015.16669","//www.ncbi.nlm.nih.gov/pubmed/26670971","//doi.org/10.1001/jama.2015.16701","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4767251","//doi.org/10.1093/neuonc/now012","//doi.org/10.1093/brain/awm204","//www.ncbi.nlm.nih.gov/pubmed/17785346","//doi.org/10.1007/s11060-006-9292-0","//www.ncbi.nlm.nih.gov/pubmed/17164975","//doi.org/10.1097/NEN.0b013e31822713f0","//doi.org/10.1159/000339319","//www.ncbi.nlm.nih.gov/pubmed/22776797","http://www.neurooncology.ucla.edu/Performance/GlioblastomaMultiforme.aspx","https://web.archive.org/web/20120609070823/http://www.neurooncology.ucla.edu/Performance/GlioblastomaMultiforme.aspx","//doi.org/10.1016/S0360-3016(03)00843-5","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3538124","//doi.org/10.1007/s12035-012-8349-7","//www.ncbi.nlm.nih.gov/pubmed/23054677","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5457688","//doi.org/10.1038/aps.2016.167","//www.ncbi.nlm.nih.gov/pubmed/28317871","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3543505","//doi.org/10.1136/jnnp-2012-302946","//www.ncbi.nlm.nih.gov/pubmed/22993449","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2819130","//doi.org/10.1517/14712598.7.2.197","//www.ncbi.nlm.nih.gov/pubmed/17250458","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5626408","//doi.org/10.1084/jem.2017109","//www.ncbi.nlm.nih.gov/pubmed/28874392","//doi.org/10.1038/nj7660-693a","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3795377","//doi.org/10.3390/cancers5031020","//www.ncbi.nlm.nih.gov/pubmed/24202332","//doi.org/10.1517/17425247.2013.790887","//www.ncbi.nlm.nih.gov/pubmed/23586809","//doi.org/10.1007/s11060-013-1346-5","//www.ncbi.nlm.nih.gov/pubmed/24398618","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4497427","//www.ncbi.nlm.nih.gov/pubmed/26175929","https://clinicaltrials.gov/ct2/show/NCT02704858","https://web.archive.org/web/20170120055208/https://clinicaltrials.gov/ct2/show/NCT02704858","//doi.org/10.1615/JEnvPathToxOncol.v22.i2.60","//www.ncbi.nlm.nih.gov/pubmed/14533876","//doi.org/10.1007/s11060-007-9432-1","//www.ncbi.nlm.nih.gov/pubmed/17619826","//doi.org/10.1016/j.pathophys.2009.01.003","//www.ncbi.nlm.nih.gov/pubmed/19268551","https://www.wikidata.org/wiki/Q282142","http://apps.who.int/classifications/icd10/browse/2016/en#/C71","http://www.icd9data.com/getICD9Code.ashx?icd9=191","https://progenetix.org/subsets/?term_id=icdom:9440_3","https://omim.org/entry/137800","https://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&term=D005909","http://www.diseasesdatabase.com/ddb29448.htm","http://www.emedicine.com/neuro/topic147.htm","http://www.emedicine.com/med/topic2692.htm#","http://www.abta.org/understanding-brain-tumors/types-of-tumors/glioblastoma.html","https://web.archive.org/web/20111214210812/http://rad.usuhs.edu/rad/handouts/jsmirnio/Astrocytoma_2008_March%20HO.pdf","https://web.archive.org/web/20111214214044/http://rad.usuhs.edu/medpix/parent.php3?mode=image_finder&srchstr=glioblastoma&srch_type=all","https://d-nb.info/gnd/4157617-2"],"sections":[{"toclevel":1,"level":"2","line":"Signs and symptoms","number":"1","index":"1","fromtitle":"Glioblastoma","byteoffset":6943,"anchor":"Signs_and_symptoms"},{"toclevel":1,"level":"2","line":"Risk factors","number":"2","index":"2","fromtitle":"Glioblastoma","byteoffset":7667,"anchor":"Risk_factors"},{"toclevel":2,"level":"3","line":"Genetics","number":"2.1","index":"3","fromtitle":"Glioblastoma","byteoffset":7980,"anchor":"Genetics"},{"toclevel":2,"level":"3","line":"Environmental","number":"2.2","index":"4","fromtitle":"Glioblastoma","byteoffset":8683,"anchor":"Environmental"},{"toclevel":1,"level":"2","line":"Pathogenesis","number":"3","index":"5","fromtitle":"Glioblastoma","byteoffset":10916,"anchor":"Pathogenesis"},{"toclevel":2,"level":"3","line":"Molecular alterations","number":"3.1","index":"6","fromtitle":"Glioblastoma","byteoffset":14152,"anchor":"Molecular_alterations"},{"toclevel":2,"level":"3","line":"Glioblastoma stem-like cells","number":"3.2","index":"7","fromtitle":"Glioblastoma","byteoffset":20872,"anchor":"Glioblastoma_stem-like_cells"},{"toclevel":2,"level":"3","line":"Metabolism","number":"3.3","index":"8","fromtitle":"Glioblastoma","byteoffset":23903,"anchor":"Metabolism"},{"toclevel":2,"level":"3","line":"Ion channels","number":"3.4","index":"9","fromtitle":"Glioblastoma","byteoffset":25857,"anchor":"Ion_channels"},{"toclevel":1,"level":"2","line":"Diagnosis","number":"4","index":"10","fromtitle":"Glioblastoma","byteoffset":26743,"anchor":"Diagnosis"},{"toclevel":1,"level":"2","line":"Treatment","number":"5","index":"11","fromtitle":"Glioblastoma","byteoffset":29915,"anchor":"Treatment"},{"toclevel":2,"level":"3","line":"Symptomatic therapy","number":"5.1","index":"12","fromtitle":"Glioblastoma","byteoffset":30932,"anchor":"Symptomatic_therapy"},{"toclevel":2,"level":"3","line":"Palliative therapy","number":"5.2","index":"13","fromtitle":"Glioblastoma","byteoffset":32208,"anchor":"Palliative_therapy"},{"toclevel":3,"level":"4","line":"Surgery","number":"5.2.1","index":"14","fromtitle":"Glioblastoma","byteoffset":32616,"anchor":"Surgery"},{"toclevel":3,"level":"4","line":"Radiotherapy","number":"5.2.2","index":"15","fromtitle":"Glioblastoma","byteoffset":35083,"anchor":"Radiotherapy"},{"toclevel":3,"level":"4","line":"Chemotherapy","number":"5.2.3","index":"16","fromtitle":"Glioblastoma","byteoffset":39246,"anchor":"Chemotherapy"},{"toclevel":3,"level":"4","line":"Other modalities","number":"5.2.4","index":"17","fromtitle":"Glioblastoma","byteoffset":43363,"anchor":"Other_modalities"},{"toclevel":1,"level":"2","line":"Prognosis","number":"6","index":"18","fromtitle":"Glioblastoma","byteoffset":45548,"anchor":"Prognosis"},{"toclevel":1,"level":"2","line":"Epidemiology","number":"7","index":"19","fromtitle":"Glioblastoma","byteoffset":52773,"anchor":"Epidemiology"},{"toclevel":1,"level":"2","line":"History","number":"8","index":"20","fromtitle":"Glioblastoma","byteoffset":53103,"anchor":"History"},{"toclevel":1,"level":"2","line":"Research","number":"9","index":"21","fromtitle":"Glioblastoma","byteoffset":53555,"anchor":"Research"},{"toclevel":2,"level":"3","line":"MicroRNA","number":"9.1","index":"22","fromtitle":"Glioblastoma","byteoffset":53569,"anchor":"MicroRNA"},{"toclevel":2,"level":"3","line":"Gene therapy","number":"9.2","index":"23","fromtitle":"Glioblastoma","byteoffset":54236,"anchor":"Gene_therapy"},{"toclevel":2,"level":"3","line":"Virotherapy","number":"9.3","index":"24","fromtitle":"Glioblastoma","byteoffset":55611,"anchor":"Virotherapy"},{"toclevel":2,"level":"3","line":"Intranasal drug delivery","number":"9.4","index":"25","fromtitle":"Glioblastoma","byteoffset":56242,"anchor":"Intranasal_drug_delivery"},{"toclevel":2,"level":"3","line":"Risk factors","number":"9.5","index":"26","fromtitle":"Glioblastoma","byteoffset":58472,"anchor":"Risk_factors_2"},{"toclevel":1,"level":"2","line":"See also","number":"10","index":"27","fromtitle":"Glioblastoma","byteoffset":60241,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"11","index":"28","fromtitle":"Glioblastoma","byteoffset":60294,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"12","index":"29","fromtitle":"Glioblastoma","byteoffset":60322,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Glioblastoma","iwlinks":[{"prefix":"d","url":"https://www.wikidata.org/wiki/Q282142","*":"d:Q282142"},{"prefix":"commons","url":"https://commons.wikimedia.org/wiki/Category:Glioblastoma_multiforme","*":"commons:Category:Glioblastoma multiforme"}],"properties":[{"name":"wikibase_item","*":"Q282142"}]}}